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Abstract 
 
Microarray  technology  allows  the  simultaneous  measurement  of  the 
abundance  of  thousands  of  transcripts  in  living  cells.  The  high-throughput 
nature of microarray technology means that automatic analytical procedures 
are required to handle the sheer amount of data, typically generated in a single 
microarray experiment. Along these lines, this work presents a contribution to 
the automatic analysis of microarray data by attempting to construct protocols 
for the validation of publicly available methods for microarray.  
 
At the experimental level, an evaluation of amplification of RNA targets prior 
to  hybridisation  with  the  physical  array  was  undertaken.  This  had  the 
important consequence of revealing the extent to which the significance of 
intensity ratios between varying biological conditions may be compromised 
following  amplification  as  well  as  identifying  the  underlying  cause  of  this 
effect. On the basis of these findings, recommendations regarding the usability 
of RNA amplification protocols with microarray screening were drawn in the 
context of varying microarray experimental conditions. 
 
On  the  data  analysis  side,  this  work  has  had  the  important  outcome  of 
developing an automatic framework for the validation of functional analysis 
methods  for  microarray.  This  is  based  on  using  a  GO  semantic  similarity 
scoring  metric  to  assess  the  similarity  between  functional  terms  found  
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enriched by functional analysis of a model dataset and those anticipated from 
prior  knowledge  of  the  biological  phenomenon  under  study.  Using  such 
validation system, this work has shown, for the first time, that ‘Catmap’, an 
early  functional  analysis  method  performs  better  than  the  more  recent  and 
most  popular  methods  of  its  kind.  Crucially,  the  effectiveness  of  this 
validation  system  implies  that  such  system  may  be  reliably  adopted  for 
validation of newly developed functional analysis methods for microarray.   
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CHAPTER I:     INTRODUCTION 
 
 
1.1.   The London Pain Consortium research mission 
 
The work presented in this thesis is part of the ongoing collaborative efforts by 
members  of  the  London  pain  Consortium  (LPC)  to  achieve  a  better 
understanding  of  the  origin  of  chronic  pain,  under  neuropathological 
conditions. The LPC is a group of scientists that was formed in 2002 funded 
by the Wellcome Trust and has since undertaken exciting research to reveal 
mechanisms  of  chronic  pain  from  a  variety  of  different  angles,  including 
screening for gene expression regulation. Different animal models of painful 
neuropathies  have  been  used  by  LPC  experimentalists  to  generate  large 
amount  of  gene  expression  data,  with  the  hope  of  identifying  common 
mechanisms of pain. In this project, our role as members of the LPC has been 
to  assist  with  the  analysis  of  these  expression  data  using  bioinformatics 
approaches, notably via integration with other useful types of data as will be 
discussed in the work chapters of this thesis.  
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1.2.   Neuropathic pain mechanisms 
 
Pain is usually the natural consequence of tissue injury that serves to trigger an 
appropriate defensive response and is therefore an important mechanism for 
survival.  Normally,  pain  subsides  as  the  healing  process  commences;  this 
usual  form  of  pain  is  known  as  acute  pain  and  is  distinct  from  the  rather 
pathological long lasting pain known as chronic pain. Unlike acute pain that 
serves to promote healing and preserve tissue integrity, chronic pain has no 
physiological  role  as  it  is  rather  debilitating  often  causing  depression  and 
reducing the sufferers’ quality of life. Chronic pain is hence a disease state that 
needs to be treated.  
 
There are two forms of chronic pain: nociceptive and neuropathic pain; which 
are the products of different neuro-physiological processes. While nociceptive 
pain is caused by the continuous stimulation of pain receptor fibres by nerve 
sensitising  substances  (examples  are  inflammatory  substances  such  as 
histamine, bradykinin and substance-P), neuropathic pain is caused by damage 
to  or  pathological  changes  in  the  peripheral  or  central  nervous  systems. 
Examples of nociceptive pain are post-operative pain, pain associated with 
trauma,  and  the  chronic  pain  of  arthritis.  As  for  neuropathic  pain,  clinical 
examples  are  post  herpetic  neuralgia,  reflex  sympathetic  dystrophy  (nerve  
1. Introduction 
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trauma), entrapment neuropathy and peripheral neuropathy most commonly 
caused by diabetes or chronic alcohol use. 
         
For  years,  the  chronic  pain  of  neuropathy  has  confounded  scientists. 
Traditional pain treatments, including powerful medications of the last resort 
such as morphine, rarely help. To date, neuropathic pain has been the subject 
of much research in an attempt to shed more light on its mechanisms and 
develop  more  effective  treatments.  One  important  advance  in  the  field  of 
neuropathic  pain  research  has  been  the  development  of  animal  models  of 
painful neuropathies, whereby the occurrence of nociceptive behaviour such as 
agitation and avoidance is taken to indicate the presence of pain. The best-
established types of these models involve a form of experimentally induced 
injury to the nervous system, either peripherally (involving nerves innervating 
parts of the body, notably the limbs) or centrally (consisting of the brain and 
the spinal cord).  More recently, animal models of disease induced neuropathic 
pain have also been developed; examples are those mimicking human clinical 
conditions such as diabetic and cancer neuropathy. 
 
Current  knowledge  of  the  mechanisms  of  neuropathic  pain  is  limited  and 
biased  by  a  focus  on  the  well-established  animal  models  of  peripheral 
neuropathy. Before describing these mechanisms, it is important to understand 
the  nature  of  common  injuries  to  the  peripheral  nerve  involved  in  these  
1. Introduction 
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models, which entails the need for a brief description of the anatomy of the 
peripheral nervous system. Figure 1.2.1 illustrates a section of the peripheral 
nervous system, featuring the sciatic nerve that innervates most of the skin of 
the back paw. The sciatic nerve consists of a bundle of axons from sensory 
and motor neurons whose cell bodies lie in the dorsal root ganglions (DRG). A 
second branch of axons extends from the DRG sensory neurons upwards to 
synapse with the spinal horn neurons in the spinal cord, creating an interface 
with the central nervous system. The models of peripheral nerve injury shown 
on Figure 1.2.1 vary in the type of injury as well as the location of injury, 
affecting either the whole of the sciatic nerve or its branches distal or at close 
proximity from the DRG compartments.    
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With  peripheral  nerve  injury,  mechanisms  of  neuropathic  pain  involve 
sensitisation and neuronal plasticity of the peripheral nervous system, leading 
in turn to the recruitment of a more centralised nociceptive activity. Following 
peripheral nerve injury, an increased membrane density of Na
+ channels on 
injured fibres causes spontaneous discharge action potential to be generated in 
Figure  1.2.1.  Injury  models  in 
primary  sensory  neurons.  (1) 
Complete  sciatic  nerve  transection 
(SNT,  also  known  as  axotomy);  (2) 
sciatic  nerve  crush;  (3)  chronic 
constriction  injury  consisting  of  four 
loose ligatures around the sciatic nerve; 
(4) spared nerve injury model  (SNI ) 
involving ligation and section of tibial 
and common peroneal; (5) spinal nerve 
ligation  (SNL,  also  known  as  Chung) 
involves  tight  ligations  of  L5/6  spinal 
nerves;  (6)  dorsal  rhizotomy  lesion 
involving  transection  of  L4  and  L5 
DRGs.  Based  on  the  information  and 
graphical images by (Ueda and Rashid, 
2003)  
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the absence of any stimulation (Woolf, 2004). Such irregular discharge has 
been previously seen in injured and non-injured neighbouring fibres at the site 
of injury or in the dorsal root ganglion tissue (DRG) containing the cell bodies 
of injured neurons (Woolf, 2004). Evidence exists to suggest that increased 
levels of sympathetic activity at the site of injury may increase the ability of 
sprouting  fibres  to  detect  pain  excitatory  substances  (Zimmermann,  2004). 
Indeed,  sympathetic  fibres  may  contribute  to  increased  sensitisation  of  the 
growing  fibres  to  inflammatory  substances  within  the  milieu  of  injury  by 
releasing adrenaline and noradrenaline that modulate the activity of receptors 
on the growing fibres. Uninjured nerves adjacent to the site of injury may 
become  involved  as  more  central  processes  produce
  a  localized  release  of 
sensitizing  neurotransmitters
  (such  as  substance-P,  glutamate,  CRGP,  and 
5HT)  into  uninjured  regions  ultimately  producing  a  self-sustained  state  of 
neurogenic inflammation. 
 
Centrally,  the  continuous  ectopic  discharge  by  injured  afferent  fibres 
peripherally has the effect of sensitising post-synaptic neurons in the dorsal 
horn of the spinal cord. This sensitisation, also known as wind-up, has been 
interpreted  as  a  system  for  the  amplification  of  peripherally  induced 
nociceptive signals in the spinal cord.  Repetitive episodes of wind-up may 
precipitate  long-term  potentiation  (LTP),  which  involves  a  long  lasting 
increase  in  the  efficacy  of  synaptic  transmission.  LTP  is  thought  to  be  an  
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important  mediator  of  hyperalgesia,  an  important  landmark  of  neuropathic 
pain, which describes an exaggerated response to painful stimuli. Moreover, 
anatomical changes in the spinal cord have been observed following peripheral 
nerve injury (Zimmermann, 2004) whereby deep spinal neurons that normally 
receive  and  propagate  non-noxious  peripheral  input  sprout  into  superficial 
spinal regions involved in transmitting high intensity signals. This is thought 
to  explain  the  origin  of  allodynia,  another  landmark  of  neuropathic  pain, 
whereby painful sensations are caused by non-painful stimuli under a diseased 
state of the nervous system. 
  
An  important  underlying  mechanism  to  these  changes  affecting  both  the 
peripheral  and  central  nervous  systems;  in  particular,  those  of  long  lasting 
nature; consists of modification in gene expression at the cellular level (Woolf, 
2004). For instance, the switch in the phenotype of neuronal subtypes centrally 
following neuropathy is thought to be largely mediated by a change in gene 
expression of affected nerve cells in the spinal dorsal horn. Importantly, much 
of these central effects are triggered by a change in the type and levels of 
neurotransmitters released by afferent fibers at the junction with the spinal 
cord as a result of much shift in gene expression activity in DRG nerve cells 
peripherally. Moreover, modification of gene expression at the peripheral level 
not only contributes to the establishment of neuropathic pain, but also supports 
its  long  lasting  nature  via  endogenous  synthesis  of  proinflammatory  
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substances that preserve the pathological conditions surrounding the nervous 
system. This acts as a feedback loop mechanism that ensures a prolonged state 
of reprogrammed gene expression at the cellular level and hence sustained 
shift in sensory neuron excitability both peripherally and centrally (Scholz and 
Woolf, 2007). 
 
Owing to the central role of gene expression regulation in the development of 
chronic  pain  under  neuropathological  conditions,  many  studies  have  used 
microarray technology to characterise the global changes in gene expression in 
nerve tissue in animal models of neuropathy with painful phenotypes (Valder 
et al., 2003; Wang et al., 2002; Xiao et al., 2002). However, a widely accepted 
view is that such an approach is limited since many processes other than those 
featuring  direct  relevance  to  pain  are  equally  affected  by  gene  expression 
regulation;  examples  are  neuronal  regeneration  and  immune/inflammatory 
processes that occur as a natural consequence of the injury to the nerve.  
 
Nonetheless, there has been numerous attempts in literature to optimise the use 
of microarrays with animal models of painful neuropathies to detect changes 
in gene expression specific to pain sensation. The earliest of such attempts was 
made by Valder and colleagues (Valder et al., 2003) who analysed changes in 
DRG gene expression of two varying rat strains either sensitive or resistant to 
nerve injury-induced mechanical allodynia. By examining the injury-induced  
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strain-specific  gene  differential  expression,  Valder  isolated  genes  that  are 
directly  relevant  to  the  development  of  mechanical  allodynia  under 
neuropathic conditions. Along these lines, the LPC has recently developed an 
experimental  strategy  to  identify  pain  specific  changes  in  gene  expression 
using  microarray  that  relies  on  comparison  of  patterns  of  gene  differential 
expression  between  painful  neuropathies  of  different  etiologies.  One 
preliminary study was recently published by LPC member Maratou (Maratou 
et al., 2009), featuring a comparison of patterns of gene expression regulation 
between a model of HIV neuropathy and a model of traumatic nerve injury to 
isolate common pain meditating genes. 
    
However, the current work has a slightly different focus in that it was aimed at 
developing reliable analysis protocols for microarray data that can be applied 
on  individual  datasets.  Being  one  of  the  first  projects  undertaken  in 
collaboration with the LPC, the project addressed the need for exploring with 
ways  of  performing  basic  analysis  of  microarray  data;  thereby,  setting  the 
scene for more sophisticated meta-analyses to be performed in the future from 
combining all LPC microarray datasets. Also, it was only recently that the 
LPC  adopted  the  strategy  of  contrasting  different  pain  models  using 
microarrays  and  hence  many  of  the  currently  existing  datasets  were  not 
available to us at the time when this work was performed. Importantly, in this 
project,  because  the  focus  was  on  individual  microarray  datasets  where  
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differential gene expression relates to a large number of processes other than 
pain, we were inclined to refer to LPC microarray data as neuropathy rather 
than pain expression data.   
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1.3.   Microarray expression profiling 
 
1.3.1.   Microarray technology 
 
For the remainder of this introduction, methods for microarray data analysis 
and  microarray  research  applications  are  discussed  in  detail.  Microarray 
technology allows simultaneous quantification of levels of expression for a 
large number of genes providing a way to study dependencies between their 
patterns of expression. A microarray is technically defined as a solid support 
onto  which  sequences  from  thousands  of  transcripts  are  immobilised,  or 
attached  at  fixed  locations.  The  supports  themselves  are  usually  glass 
microscope  slides,  but  can  also  be  silicon  chips  or  nylon  membranes.  The 
sequences are printed, spotted or synthesised directly onto the support.  
 
Microarray technology relies on the ability of a given mRNA molecule to bind 
the  DNA  template  from  which  it  originated.  In  a  typical  microarray 
experiment,  labelled  target  mRNA  isolated  from  a  tissue  of  interest  is 
hybridised  with  complementary  array  sequences  and  the  amounts  of 
fluorescence from double stranded hybrids are estimated using a scanner to 
determine the level of abundance of individual RNA targets in the original 
biological sample. Most commonly, microarrays are used to compare the gene  
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expression  profiles  of  two  biological  tissues  such  as  ‘wild  type’  and 
‘diseased/treated’. Nowadays, microarray technology has evolved to cover a 
wide  spectrum  of  research  applications  beyond  detection  of  differential 
expression between varying biological conditions. For instance, SNP arrays 
are used to detect polymorphisms within and between populations whilst exon 
junction  arrays  are  designed  to  assist  in  the  measurement  of  alternatively 
spliced forms of transcripts.   
 
The  LPC  is  currently  using  DNA  microarray  technology  in  the  traditional 
sense to detect changes in gene expression following painful neuropathies. Till 
now,  the  LPC  has  used  oligonucleotide-based  arrays  manufactured  by 
Affymetrix whereby 11 to 16 probes are selected among all possible 25-long 
oligonucleotides  to  represent  each  target  transcript.  The  collection  of  these 
probes is known as a probeset and each probeset is given a unique identifier 
on  the  array.  Importantly,  a  gene  may  be  represented  by  more  than  one 
probeset on the same array. Within a probeset, each of the probes exists in two 
forms: a perfect match (PM), which perfectly aligns with the target sequence 
and a mismatch (MM), which has the same sequence as the PM except for the 
middle base which is made different. MMs are used by Affymetrix to provide 
an  assessment  for  the  level  of  non-specific  hybridization.  The  probes  are 
designed  to  bind  to  complementary  RNA  (cRNA)  prepared  from  mRNA 
extracted from the biological tissue.  
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1.3.2.   Microarray low level analysis 
 
After hybridising labelled cRNA with Affymetrix array probes, a picture of 
the array is taken by the scanner and the individual intensities of all probes are 
estimated using the image scanning algorithm. Before analysing the data for 
differential expression, the individual intensities need to be calibrated in order 
to eliminate the experimental variation in the data. Calibration of microarray 
data proceeds through a number of different steps: 
 
1.3.2.1.    Background correction 
 
The  aim  of  this  initial  step  is  to  subtract  the  contribution  of  non-specific 
binding from the overall intensity of each spot measured on the array. Probes 
may bind to sequences other than the target depending on their specificity and 
the  conditions  during  the  hybridisation  step.    Background  fluorescence  is 
another  source  of  non-specificity.  There  exists  a  number  of  methods  for 
correcting background. The method used by Affymetrix relies on using the 
area of the chip with the lowest fluorescence as an estimate of the background, 
whereas MM probe intensities are used to assess binding to non-targets. Other 
methods such as RMA (Irizarry et al., 2003) use a fitted stochastic model to the 
overall distribution of the PM probes (and sometimes the MMs) to estimate  
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background. Recently, a new background correction method GeneChip RMA 
(GCRMA)  (Irizarry  et  al.,  2003)  was  developed  based  on  modelling  the 
binding interactions between probes on the arrays and their target transcripts. 
GCRMA  attempts  to  eliminate  systematic  contribution  to  noise  from  the 
sequence  of  the  probe  and  labelled  nucleotides  in  the  target.  GCRMA 
outperforms the other methods at the low end of the intensity scale where 
much  of  the  signal  is  due  to  noise,  therefore  allowing  changes  in  gene 
expression to be detected more reliably at this range of intensity (Irizarry et 
al., 2003). 
 
1.3.2.2.   Normalization 
 
Normalization  is  then  applied  to  compensate  for  systematic  technical 
differences between arrays in order to emphasize real biological differences 
between samples. Most approaches to normalizing expression levels assume 
that the overall distribution of RNA abundance does not change much between 
samples,  that  is  to  say  that  most  expressed  genes  maintain  a  constant 
expression  level  in  the  different  biological  states  being  investigated.  The 
simplest approach to normalizing Affymetrix data is to re-scale each array in 
an experiment so that the average (or total) signal intensity across all arrays is 
equal. This linear scaling is generally criticized for failing to recognise that the 
array effect is not constant across all range of intensities. Numerous methods  
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implementing  non-linear  normalization  of  array  data  exist.  One  of  such  is 
Quantiles normalization which forces the intensity distribution on each chip to 
be identical by ranking the intensities, and resetting the intensity values in 
each rank across all arrays to the mean of the intensities at that rank. The 
rescaling is therefore different at each rank, which makes this normalization 
rather non-linear across the range of intensities. 
 
1.3.2.3.   Expression Summary 
 
This  step  aims  to  reduce  the  11-16  measures  of  probe  intensity  within  a 
probeset into one value of expression that is indicative of the abundance of the 
corresponding  RNA  target.  This  is  non-trivial  given  that  individual  probes 
show  differences  in  binding  affinities  and  it  is  typical  to  observe  large 
discrepancies  in  the  intensities  of  probes  within  the  same  probeset.  Model 
based approaches for expression summary calculation explore the fact that the 
specific binding efficiency of each probe is inherent to its sequence and is 
constant  across  all  arrays.  Thus,  using  information  from  all  arrays  in  an 
experiment,  such  methods  fit  models  to  the  intensity  data  to  estimate 
parameters such as probe specific effects and the level of mRNA bound to the 
probe on each array. These parameters are then used to derive a summary 
intensity value for each probeset on each array. 
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1.3.2.4.  Statistical analysis of gene differential expression  
 
After calibration comes the actual statistical analysis of the data that allows 
differentially expressed genes to be detected. In the simplest comparison of 
two biologically distinct conditions, t-statistics can be applied with multiple 
testing correction. This is necessary to account for the occurrences of false 
positives  that  are  inevitable  with  the  large  number  of  genes  tested  for 
differential expression on the array. However, it is widely  accepted that t-
statistics may be inflated by the inevitable chance occurrences of very small 
variance with microarray data. That is because, typically with microarrays, 
only  a  handful  of  replicate  measurements  are  available  for  each  gene  and 
furthermore, at low intensity levels, variation in intensity is usually minimal.  
This  flaw  has  been  addressed  by  many  statistical  methods  specifically 
developed  for  differential  expression  analysis  of  microarray  data,  such  as 
Significance Analysis of Microarray (SAM) (Tusher et al., 2001) and Linear 
Models for Microarray data (Limma) (Smyth, 2004). 
 
SAM and Limma are fundamentally similar in that they are both based on a 
moderated t-statistic that features an optimized assessment of within group 
variation.  The  difference,  however,  lies  in  the  mechanism  used  by  either 
method for flooring such variance. With SAM and to make sure that the t-
statistic based scores for genes are not inflated at low intensity levels due to  
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intrinsically  low  variation,  an  offset  value  is  estimated  that  minimizes  the 
variation  in  the  t-statistic  based  scores  as  a  function  of  variability  from 
replicate gene expression measurements. Thus, the SAM statistics are simply 
t-statistics where the pooled standard deviation has been shifted systematically 
by a constant value for all genes. Unlike SAM, Limma fits a linear model on 
an individual gene basis using gene intensity data from all arrays to derive a 
gene-wise residual sample variance estimate that is more robust than ordinary 
variance. 
 
- Multiple testing correction  
 
As  previously  discussed,  microarray  differential  expression  analysis  is  a 
classical case of multiple testing problem. Thus, at p-value 0.01 and given an 
overall number of 10000 genes on the array, we may expect 100 genes to 
appear significant by chance. In classical statistics, there exists a number of 
methods for multiple testing correction that vary in stringency. These methods 
fall in two broad categories and are either based on controlling the family wise 
error  rate  (FWE)  or  the  false  discovery  rate  (FDR).  There  exists  a 
fundamental  difference  between  the  two  approaches  in  that  at  any  given 
significance level p-value=P, the FWE based methods operate by estimating 
the chance of occurrence of at least one false positive given the total number 
of hypotheses tested (meaning genes in the context of microarray). The FDR  
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based approach, on the other hand, is less stringent in that it gives an estimate 
of the expected proportion of false positives with p-value<P given the total 
number  of  hypotheses  tested.  In  many  ways,  the  FDR  multiple  testing 
correction approach is more practical with microarray data in that a protection 
against just one single false positive is far too stringent and does not justify the 
parallel  loss  in  power.  That  is  because  even  though  the  number  of  false 
positives  is  lower  with  the  more  stringent  multiple  testing  correction 
procedures, there is an associated increase in the number of false negatives 
corresponding to a loss in statistical power.  
 
Nonetheless,  stringent  multiple  testing  corrections  have  been  incorporated 
with  microarray  data  analysis  such  as  the  Bonferroni  correction  and  the 
Bonferroni Step-Down (Holm) correction. In addition to being too stringent, 
these two FWE based multiple testing correction methods may be unsuitable 
for  use  with  microarray  data  as  they  assume  test  independency;  which  is 
hardly  true  given  that  genes  may  be  co-expressed.  Dudoit  and  colleagues 
(Dudoit  et  al.,  2004)  were  the  first  to  use  a  more  appropriate  FWE  based 
procedure: the Westfall and Young step-down approach that allows for test 
dependency by using a permutation type analysis to estimate the FWE. 
 
However, because the FDR approach is least stringent and provides a good 
balance between discovery of statistically significant genes and limitation of  
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false positive occurrences, it has become more popular with microarray than 
the FEW-based methods. The original FDR based procedure by Benjamini and 
Hochberg (Benjamini and Hochberg, 1995) assumed test independency in a 
similar  manner  to  the  FWE  controlling  Bonferroni  and  Holms  correction 
procedures.  However,  due  to  high  interest  by  the  microarray  community, 
adaptations of the FDR based multiple testing correction to test dependency 
have  been  developed.  Yekutieli  and  Benjamini  (Benjamini  and  Yekutieli, 
2001)  introduced  one  early  procedure  to  control  the  FDR,  under  test 
dependency, based on resampling. Tusher and colleagues (Tusher et al., 2001) 
similarly proposed a permutation based strategy for evaluation of the FDR to 
accompany  their  proposed  algorithm  for  microarray  differential  expression 
analysis  SAM  (a  moderated  form  of  t-statistics,  discussed  earlier).  More 
sophisticated ways for adaptation of FDR based multiple testing correction for 
microarrays have since been developed, such as those by Efron and colleagues 
(Efron and Tibshirani, 2002) and Storey (Storey, 2003) that use a Bayesian 
framework to achieve local FDR analysis. 
 
1.3.3.   Microarray datamining 
 
Microarray  data  are  best  exploited  when  intelligently  mined  for  biological 
information.  There  are  two  broad  categories  of  datamining  approaches  for  
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microarray:  unsupervised  clustering  and  supervised  classification.  With 
clustering, coherent patterns of gene expression may be identified across a 
number  of  related  biological  conditions.  Such  a  trend  is  biologically 
meaningful  as  co-expressed  genes  are  likely  to  be  involved  in  the  same 
biological  process.  By  contrast,  classification  approaches  are  supervised  in 
that  they  are  based  on  identification  of  marker  genes  that  can  distinguish 
between varying biological conditions.  
 
However, the most illuminating form of microarray datamining is achieved by 
incorporation of other types of biological data, in order to achieve a system-
wide  view  of  biological  phenomena.  Owing  to  the  complexity  of  living 
organisms and their pathological and diseased states, it is often necessary to 
combine  data  from  different  sources  and  disciplines  to  reach  useful 
conclusions.  Microarray  data  only  provide  insights  into  the  transcriptional 
activity of living cells, which is a limited view to complex biological systems 
and activities involving other forms of key biological events such as protein-
protein  interactions  and  protein  post-translational  modification.  Moreover, 
microarray  data  are  inherently  noisy.  This  means  that  even  at  the  level  of 
transcriptional activity, incorporating further information on gene expression 
from additional sources has the benefit of improving data quality. 
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One recent example of a successful attempt to integrate genomic data with 
literature  mined  protein-protein  interaction  data  is  the  work  by  Li  and 
colleagues (Li et al., 2006); which was aimed at characterizing the molecular 
mechanism  of  angiogenesis:  a  process  that  involves  the  growth  of  new 
capillary blood vessels in healthy organisms and is particularly important for 
the  progression  of  cancer.  Initially,  text-mining  approaches  were  used  to 
search  pubmed  articles  for  gene/protein  co-citations  in  the  context  of 
angiogenesis. Pairs of potentially interacting proteins were then analysed for 
gene  co-regulation  using  angiogenesis  related  microarray  expression  data 
derived from comparison of wild-type endothelial cells with cells from solid 
tumours, available from the Standford Microarray Database (SMD). Finally, a 
refined  network  of  angiogenesis  was  constructed  revealing  promising  gene 
targets, defining potentially new venues for therapeutic treatment of cancer 
induced angiogenesis.     
 
Another useful form of integrated datamining approaches for microarray is 
functional analysis, which requires the incorporation of functional information 
onto  gene  expression  data.  Functional  analysis  reveals  the  biological 
significance  of  gene  expression  regulation  by  exposing  the  functional 
categories most enriched among the differentially expressed genes. Functional 
analysis is the subject of chapter VI and is there discussed in more details. 
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CHAPTER II:     MICROARRAY ANALYSIS AFTER T7 
BASED RNA AMPLIFICATION CAN DETECT 
PRONOUNCED DIFFERENCES IN GENE EXPRESSION 
 
2.1.   Introduction 
 
Microarray  technology  offers  a  high  throughput  approach  to  transcript 
profiling  on  a  genomic  scale  thereby  providing  deeper  insights  into  global 
gene  interactions  in  complex  biological  networks.  In  Neuroscience, 
microarrays  have  contributed  a  great  deal  to  correlating  gene  expression 
profiles with complex neurological behaviours such as learning, memory (Klur 
et  al.,  2004;  Li  et  al.,  2005;  McClintick  et  al.,  2003)  and  nociception 
processing. However, the complexity and versatility of the functions encoded 
in the nervous system dictates numerous specializations of neuronal cellular 
subtypes  primarily  dedicated  to  certain  aspects  of  information  processing. 
Efficient  characterisation  of  transcriptional  profiles  underlying  specific 
processes of scientific interest requires the ability to select the relevant cellular 
subtypes to enrich key signals otherwise concealed by irrelevant expression 
information.  
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One  recent  advance  in  single  cell  isolation  that  has  revolutionised  the 
efficiency of microarray screening is the laser capture microdissection (LCM) 
technique, which has been already applied in characterising single neuronal 
cells  with  considerable  success  (King  et  al.,  2005;  Paulsen  et  al.,  2009). 
However, it  has proved a  major challenge to integrate single cell isolation 
technology  with  subsequent  transcriptional  profiling  using  microarrays, 
primarily due to the impracticality of isolating enough target cells to achieve 
an optimum yield of RNA sufficient for chip hybridisation. This limitation is 
further  enlarged  by  the  need  for  replicate  samples,  essential  for  statistical 
inference. 
 
Parallel  to  technological  advances  in  single  cell  excision,  increasingly 
sophisticated  approaches  to  RNA  amplification  from  small  tissue  samples 
have been developed and enhanced continuously for use with microarrays. Of 
great concern to the credibility of information obtained from screening for 
transcriptional regulation is the ability of the amplification process to maintain 
faithful representation of the abundance of the individual transcripts in the 
original sample. From this prospective, the T7 based amplification approaches, 
with  their  linear  characteristics,  have  gained  more  popularity  than  the 
exponential PCR based methods. 
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In brief, the first version of the T7 based amplification protocol was published 
in 1990 by van Gelder and colleagues (Van Gelder et al., 1990) and relied on 
the T7 based in-vitro  transcription of cDNA strands obtained from reverse 
transcription of RNA target molecules from the original RNA sample. This 
became the basis for the Affymetrix standard labelling protocol (Fig 2.1.1). A 
greater fold increase in RNA concentration was the product of an additional 
round  of  T7  linear  amplification  as  proposed  by  Eberwine  and  colleagues 
(Eberwine, 1996). This was later adapted by  Affymetrix to formulate their 
small  sample  amplification  protocol  (Fig  2.1.1).    Modifications  of  the  T7 
amplification  protocol  have  been  explored  to  improve  the  efficiency  and 
quality of the amplified transcript. One of the most fruitful of such was the 
attempt by  Baugh and colleagues (Baugh et al., 2001) to reduce  template-
independent product by reducing the amount of primer and overall reaction 
volume. Kenzelmann and colleagues (Kenzelmann et al., 2004) improved the 
sensitivity of the T7 linear protocol by increasing the temperature during the 
RT reaction.  
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Despite the numerous benefits of the T7  based small sample amplification 
protocol,  most  notably  its  linearity  and  independence  of  transcript  copy 
number  in  comparison  to  PCR  based  procedures,  studies  have  reported 
Figure 2.1.1. The Affymetrix T7 based small sample protocol. Briefly, RNA targets are first 
converted into cDNAs via a reverse transcription (RT) step using T7 promoter conjugated 
primers.  The  DNA  strands  complementary  to  the  resulting  cDNAs  are  taken  through  a 
transcription  step  to  yield  antisense  RNA  using  the  T7  polymerase.  Together,  these  steps 
define  the  Affymetrix  standard  labelling  protocol,  which  precedes  RNA  labelling, 
fragmentation and hybridision onto the arrays. With the small sample protocol, an additional 
round  of  transcription  is  performed  to  achieve  higher-order  amplification  of  the  original 
sample. Hence, the antisense RNA from the previous round is converted back to cDNA via RT 
using random primers before a second transcription step is performed.  
Antisense    RNA  converted 
back  to  cDNA  for  an 
additional  round  of 
transcription 
 Label, fragment and hybridize 
3’ 
 
        
Random  
primers 
AAAA’3 
UUUU’5  
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occasional failure to maintain the true abundance of targets, evidenced by a 
distortion  in  signal  intensity  with  microarrays  (Klur  et  al.,  2004;  Li  et  al., 
2005;  Wilson  et  al.,  2004).  This  was  attributed  to  a  3’  bias  effect  that  is 
thought  to  be  related  to  the  use  of  random  hexamers  to  prime  the  reverse 
transcription (RT) reaction in the second round of transcription, corresponding 
to the additional round of amplification (Dumur et al., 2004; King et al., 2005; 
McClintick et al., 2003; Singh et al., 2005; Wilson et al., 2004). With priming 
that is remote from the 3’ end of template antisense RNA (Fig 2.1.1), RT may 
not be successfully completed yielding truncated DNA strands that get lost in 
subsequent steps. This causes array probes originating from the 5’ region of 
corresponding RNA templates (that is the 3’ end of their antisense strands) to 
report artificially diminished intensity signals. 
 
Importantly,  a  widely  reported  observation  from  studies  featuring  the 
assessment  of  the  T7  small  sample  RNA  amplification  protocol  for 
microarrays is the high reproducibility of the protocol. Signal intensities from 
independent  amplifications  of  RNA  samples  from  identical  sources  had 
proven  highly  correlated,  implying  that  signal  distortions  were  consistently 
reproduced by the protocol in biologically equivalent samples. The aim of this 
study  is  to  address  the  question  of  whether  such  distortions  are  also 
reproducible  in  biologically  distinct  samples,  which  would  imply  that  they  
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may  be  cancelled  when  taking  the  ratios.  Thus,  in  this  work,  we  take  a 
different  approach  to  the  assessment  of  the  T7  small  sample  protocol  for 
microarrays by focussing on the intensity ratios instead of the absolute values 
of the intensities. This seems appropriate given that the usual prime target 
from  microarray  experiments  is  the  analysis  of  the  ratios  to  detect  gene 
differential expression.   
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2.2.   Methods 
 
2.2.1.   Microarray experiment design 
 
In order to assess the effect of RNA amplification using the T7 Affymetrix 
small sample protocol on expression ratios, RNA samples were obtained from 
three  biologically  different  tissue  pools:  the  spinal  dorsal  horn  tissue  from 
naïve  animals  (SN),  the  spinal  dorsal  horn  tissue  from  animals  with 
axotomised sciatic nerve (SA) and the dorsal root ganglion (DRG) tissue from 
naïve animals.  The Affymetrix standard protocol was used to generate three 
labelled cRNA samples from each tissue pool using 5 µg of total RNA as 
starting  material  whilst  the  T7  based  small  sample  protocol  was  used  to 
generate 4 labelled samples using 50 ng of starting material from each tissue 
pool (Fig 2.2.1). Material from the 21 RNA preparations was then hybridised 
to  MOE430A  arrays.    For  the  rest  of  the  article,  we  shall  refer  to  the 
Affymetrix standard protocol and the small sample  protocol as the OneRA 
(one round amplification) protocol and the TwoRA (two rounds amplification) 
protocol respectively, because the latter incorporates one additional round of 
amplification  further  to  the  initial  round  of  amplification  featured  by  the 
former (Fig 2.1.1). It is important to note that the experimental phase of this 
study  including  animal  handling,  tissue  collection,  RNA  extraction,  RNA  
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amplification,  labelling  and  hybridization  was  exclusively  performed  by 
experimentalists from the London Pain Consortium (LPC) and that a detailed 
description of the experimental phase can be found in the published version of 
this work (Diboun et al., 2006). 
 
 
 
  
 
 
 
 
 
 
2.2.2.   Microarray data analysis 
 
Feature  intensity  values  from  scanned  arrays  were  background-corrected, 
normalised  and  reduced  into  expression  summaries  using  the  GCRMA 
algorithm  implemented  as  a  function  in  the  GCRMA  library  of  the 
Bioconductor  package  (Gentleman  et  al.,  2004)  of  R,  the  open  source 
environment  for  statistical  analysis.  Arrays  were  then  inspected  for  quality 
Figure 2.2.1. Experimental design. Three biologically distinct tissue pools were obtained. 
From each tissue pool, 3 RNA samples versus 4 RNA samples were obtained using the OneRA 
and the TwoRA protocols respectively.   
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control  using  a  variety  of  built-in  QC  tools  from  the  Bioconductor  Affy 
package. QC consisted of visual examination of probe array images, scatter 
plots from replicate arrays, hierarchical clustering of array hybridisations as 
well as RNA degradation plots performed on probe raw intensities. Detection 
calls indicating the presence or absence of signal from each probeset were 
obtained by processing the raw data with the Microarray Analysis Suite 5.0 
(MAS5). To obtain a consensus detection call across replicate hybridizations, 
a probeset was considered to be present if it received a P (present) detection 
call from all replicates or n-1 replicates with an M (marginal) call from the 
remaining  replicate.  Consensus  A  (absent)  detection  calls  across  replicates 
were determined in the same way. 
 
For further analysis investigating the 3’ bias effect by the TwoRA protocol, 
probesets 3’ locations were obtained by downloading the MOE430A probe 
annotation  files  made  available  by  the  Affymetrix  online  support  at 
http://www.affymetrix.com/analysis/index.affx.  A  probeset  location  was 
considered equal to the 3’ distance of the probe most distal from the 3’ end of 
the corresponding RNA target in the set. To test for differential expression, we 
used the Bayesian adjusted t-statistics from the Bioconductor Limma (linear 
models  for  Micoarray  data)  package  (Smyth,  2004),  applied  with  an  FDR 
multiple testing correction.  
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2.3.   Results 
 
In  this  study,  we  undertake  a  detailed  analysis  of  RNA  amplification  for 
microarrays  using  the  Affymetrix  small  sample  protocol  (TwoRA).  This 
analysis was performed using control data from standard protocol (OneRA) 
preparations as reference. While, the main objective of this study is to assess 
the extent to which biologically relevant variations in gene expression can be 
detected in the TwoRA, we begin by confirming the reproducibility of the 
TwoRA protocol and show comprehensive evidence for the protocol 3’ bias 
effect. 
 
2.3.1.   Reproducibility and fidelity in maintaining expression 
levels 
 
Scatter plots of log2 intensities from paired TwoRA replicates from all three 
biological groups show expectedly high level of consistency similar to that 
observed with the OneRA replicates from all groups (Fig 2.3.1-A&B); with (r) 
ranging from 0.990 to 0.994. However, comparing the average log2 intensity 
values from the OneRA versus the TwoRA (Fig 2.3.1-C) for a single tissue,  
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we  see  evidence  of  variability  confirming  that  the  TwoRA  protocol 
occasionally distorts the signal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  2.3.1.  Correlation  of  log2 
intensities  within  and  between 
protocol groups. (A&B) Scatter plots of 
log2  signal  intensities  from  a  selected  
pair of DRG replicates treated with the 
OneRA  and  the  TwoRA  respectively. 
(C) Scatter plot of log2 signal intensities 
averaged  across  the  OneRA  replicates 
versus  that  from  the  TwoRA  replicates 
for  the  DRG  group.  The  coefficient  of 
correlation  (r)  value  is  given  for  each 
scatter  plot.  Similar  results  were 
obtained  with  the  SN  and  SA  sample 
groups. 
 
A  B 
C  
2. Microarray analysis after T7 based amplification can detect 
pronounced differences in gene expression. 
     2.3. Results   
 
 
 
  47 
We  used  an  ANOVA  approach  to  confirm  that  the  variability  between 
protocol groups is greater than that among replicates within each group. In 
particular, a one-way two-levels ANOVA analysis was performed for each 
gene  separately  with  3  measurements  from  the  OneRA  (level1)  and  4 
measurements from the TwoRA (level 2). First, the between group mean sum 
of  squares  MSA  as  well  as  the  mean  residual  sum  of  squares  MSE  were 
calculated. The median of the MSA (across the genes) was higher than the 
median of the MSE (given in parenthesis) in all biological groups: DRG 0.050 
(0.023), SN 0.062 (0.016), SA 0.068 (0.02). 
 
To test whether protocol variability is significantly greater than the residual 
variability, we derived p-values from the F-values (MSA/MSE) for each gene 
(using the upper tail of an F-distribution with 1 and 3 + 4 – 2 degrees of 
freedom). In fact, the p-values were far from uniformly distributed. Storey 
suggests the following estimate of the proportion of hypotheses from the null 
using p-values: the fraction of p-values above the median p-value m, divided 
by (1-m) (Storey and Tibshirani, 2003). This results in the following estimates 
of the proportion of genes with significantly higher amplification variability: 
DRG 47%, SN 50%, SA 41%. That is, in all cases at least 40% of genes show 
differences between protocols, which are not explained by variability within 
replicates.  The  ANOVA  analysis  was  advised  on  by  Prof  Lorenz  Wernish  
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from Birkbeck College, who jointly supervised this work with LPC principle 
investigator Prof Martin Koltzenburg. 
 
Distortions in signal intensity following TwoRA are likely to be caused by the 
TwoRA protocol 3’ bias effect whereby, as explained in the introduction, the 
use of random hexamers to prime the RT step during the second round of 
amplification favors the representation of parts of the RNA close to the 3’ end. 
To affirm the 3’ bias feature of the TwoRA protocol, individual array probes 
from each probeset were numbered 1 to 11 from the 5’ end of corresponding 
transcripts. For each chip, raw intensities corresponding to the same probe 
number  across  all  probesets  were  averaged.  The  resulting  probe  average 
intensities were correlated with the corresponding probe numbers. The results 
appear in Figure 2.3.2.  
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The mean probe intensity from the OneRA target hybridisations seems to be 
fairly  constant  across  the  ranks  of  the  various  probes  in  Figure  2.3.2.  In 
contrast,  probe  mean  intensity  from  the  TwoRA  hybridisations  is  clearly 
dependent on probe location and is highest at close proximity from the 3’ end. 
Importantly,  array  normalisation  seemed  to  have  no  effect  on  the  bias 
                TwoRA 
                OneRA 
Figure  2.3.2.  RNA  digestion  plot.  Probes  from  each  probeset  were 
numbered  by  distance  from  the  5’  end  of  target  RNA  (probe  numbers 
shown on the x-axis). For each chip, the average raw intensity value from 
probes with the same probe number across all probesets were calculated 
(y-axis). Each line corresponds to a single chip.    
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observed  (this  was  done  by  repeating  the  analysis  on  normalised  probe 
intensities).  
 
In this study, in addition to the RNA digestion plot (Fig 2.3.2) used frequently 
in the literature to highlight the TwoRA protocol 3’ bias effect, we undertook 
a different analysis that associates, for the first time, distortions in the signal 
following TwoRA to probeset location on template RNA targets. This analysis 
was performed using data from the DRG tissue pool and similar results were 
obtained with the remaining tissue pools SA and SN. Thus, we correlated the 
differences in log2 intensity in the DRG samples following TwoRA (∆log2IN 
= log2INTwoRA - log2INOneRA) with the probesets 3' locations on corresponding 
targets (see methods for a description of how these locations were obtained) 
(Fig 2.3.3). The trend suggests that probesets distal from the 3' end are more 
likely to endure an attenuation of signal intensity following TwoRA whilst 
those close to the 3' end are likely to show intensification of signal. 
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In a separate but related analysis, probesets whose absolute ∆log2IN values 
were greater than 2 were reviewed for their 3' location distribution. This was 
compared to the distribution of 3' location of all probesets on the array (Fig 
2.3.4). The latter appears to be skewed and peaks at around 600 bp (Fig 2.3.4). 
The distribution of 3’ location from probesets with intensified signal following 
TwoRA (∆log2IN>2) shows an additional peak to the left suggesting a distinct 
population of probesets closer than average to the 3' end of RNA targets (Fig 
2.3.4-A). This is further highlighted by a decrease in the 25% quantile relative 
to  the  overall  population  of  probesets  in  the  boxplot  on  Figure  2.3.4-C. 
Figure  2.3.3.  Deviation  in  log2 
intensity  following  TwoRA 
(∆log2IN)  as  a  function  of 
probeset  3'  distance  rank. 
∆log2IN  values  on  the  y-axis 
were calculated by subtracting the 
mean  OneRA  from  the  mean 
TwoRA probeset log2 intensities. 
The  x-axis  shows  the  ranks  of 
probesets  locations.  Probesets 
locations are relative to the 3' end 
of  the  transcripts.  Since  the 
probesets locations have a skewed 
distribution, their ranks were used 
instead  of  their  absolute  values; 
this  allows  dispersion  of  data 
points.  The  actual  probesets 
locations  that  correspond  to  the 
rank  intervals  on  the  x-axis  are 
shown on the blue horizontal axis 
on  the  top  of  the  figure.  The 
regression  line  is  shown  in  red. 
Only  data  from  the  DRG 
preparation  were  used,  similar 
results were obtained with the SN 
and SA groups.  
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Conversely, the 3’ location distribution from probesets with attenuated signal 
shows a second peak to the right indicating an overrepresentation of more 
distal  probesets  relative  to  the  3'  end  of  RNA  targets  (Fig  2.3.4-B).  This 
corresponds to an increase in the 75% quantile (Fig 2.3.4-C).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Interestingly, with both populations of deviant probesets (fig 3.4-A&B), there 
is a peak that overlaps with that from the distribution of the overall population.  
 
 
Figure  2.3.4.  Distribution  of  3'  distances 
from  probesets  with  the  most  discrepant 
signal  intensities  following  TwoRA 
(absolute ∆log2IN >= 2). (A&B) Histograms 
of  3'  locations  from  the  probesets  at  large 
represented  on  the  MOE430A  chip  (green) 
versus those showing at least 2 fold increase 
(red)/decrease (blue) in log2 signal intensity 
following TwoRA respectively. (Solid line): 
DRG. (Dashed lines): SA. (Dotted lines): SN. 
Arrows  indicate  additional  peaks  in  the 
distributions  apart  from  that  of  the  overall 
population.  (C)  A  box  and  whisker  plot 
showing  the  0%  and  100%  quantiles  as 
whiskers,  the  25%  and  75%  quantiles  as 
boxes  and  the  50%  quantile  as  horizontal 
dash within the box. The plot summarises the 
distributions  shown  in  A  and  B.  On  the  y-
axis, (+) indicates increase in signal intensity 
following TwoRA, (-) indicates decrease in 
signal intensity following TwoRA.   
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2.3.2.   Fidelity in mainting expression ratios 
 
The ultimate aim of microarrays is the identification of differential expression. 
Thus,  a  good  amplification  protocol  should  faithfully  maintain  expression 
ratios. To verify this, we cross-compared expression ratios from biologically 
distinct tissue samples treated with the OneRA and the TwoRA protocols. 
 
First, we considered the (SA,SN) pair. Expression ratios on log2 scale from 
the OneRA samples were correlated with their equivalents from the TwoRA 
(Fig  2.3.5-A).  The  significant  changes  in  expression,  including  the  well 
established activating transcription factor 3 (Wiggins et al., 2004) and small 
proline-rich  repeat  protein  1A  (Wright  and  Snider,  1995)  in  the  literature, 
seem to be consistent in the TwoRA and the OneRA groups (Fig 2.3.5-A). 
However,  there  are  relatively  few  differences  in  gene  expression  between 
these two biological samples, probably due to the fact that the tissue from the 
injured animals included areas of the spinal cord not affected by the axotomy, 
which could have caused a dilution of effect in the relevant areas. To reliably 
evaluate  the  effect  of  the  TwoRA  protocol  on  ratios,  a  larger  profile  of 
differential expression is needed. This was possible with the (DRG,SN) pair. 
Thus, we decided to base our assessment of the effect of the TwoRA on ratios 
from the (DRG,SN) samples.  
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Encouragingly, log2 expression ratios from  the (DRG,SN)  treated with the 
OneRA and the TwoRA protocols are comparable (Fig 2.3.5-B); though they 
show  more  variability  than  their  counterparts  from  the  (SA,SN)  pair  (Fig 
2.3.5-A). Moreover, the regression line (shown in blue, Fig 2.3.5-B) appears to 
be shifted from the diagonal in a way that suggests that the expression ratios 
are on average slightly lower in the TwoRA relative to the OneRA with the 
(DRG,SN) pair.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPRR1A 
ATF3 
B 
A 
Figure  2.3.5.  Correlation  of  log2 
ratios  from  the  OneRA  and  the 
TwoRA  for  the  (SA,SN)  and  
(DRG,SN)  sample  pairs,  A&B 
respectively. Not many changes in 
gene  expression  are  detected  with 
the (SA,SN) pair in A. Many more 
changes  in  gene  expression  are 
observed with the (DRG,SN) pair in 
B. The regression line is shown in 
blue and indicates that the TwoRA 
ratios are overall smaller than their 
OneRA counterparts.  
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-Variation in ratios 
 
From our previous analysis, we know that the TwoRA protocol may shift the 
absolute intensity levels. However, this only affects expression ratios if the 
intensity is shifted unequally in the two biological samples. That is, deviations 
in intensity (∆log2IN) following TwoRA, that differ in the two samples, can 
result in variability in the expression ratios from the OneRA and the TwoRA 
groups. To get further insights into how unequal shifts in the intensity level 
following amplification of different biological samples affect the expression 
ratios, we ranked probesets by the absolute difference in their OneRA and 
TwoRA log2 expression ratios in a descending order and selected the top 100 
for further analysis. Specifically, we examined the average intensities from 
these selected probesets in all four groups: the OneRA and the TwoRA DRG, 
SN.  The  resulting  intensity  profiles  were  classified  into  four  categories 
depending on the direction of change in intensity after TwoRA and the tissue 
where this change occurred (Fig 2.3.6). The most populated categories show a 
significant reduction in the intensity in one of the samples whilst the intensity 
in the other sample is minimally reduced (Fig 2.3.6-A&C). Less frequently, 
the intensity increases after TwoRA in one of the samples but not in the other 
sample (Fig 2.3.6-B&D).  
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Figure 2.3.6. Intensity profiles of probesets with top 100 most deviant expression ratios 
following TwoRA. The profiles are classified into four categories: A&C, the intensity is reduced 
in  the  tissue  sample  where  the  gene  is  more  expressed  (DRG,  SN  respectively)  following 
TwoRA. B&D, the intensity is increased in the sample where the gene is less expressed (SN, 
DRG respectively). Solid lines mark the shift in intensity from OneRA to TwoRA for one tissue 
sample.  Dashed  lines  link  the  intensity  data  for  equivalent  probesets  in  the  two  biological 
samples. In colour are probesets with absent call in the SN (red) and DRG (blue). 
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Interestingly, with all four categories of deviant probesets shown on Figure 
2.3.6, expression ratios appear to be reduced rather than inflated following 
TwoRA.  Moreover,  the  majority  of  the  selected  probesets  have  varying 
intensity levels in the DRG versus SN, OneRA. Frequently these probesets 
have  absent  calls  in  one  sample  but  are  associated  with  high  levels  of 
expression  in  the  other  sample  (shown  as  coloured  lines  in  Figure  2.3.6); 
which may explain the deviation in expression ratios following TwoRA. If one 
takes the example of HipK2, the log2 intensity in the SN was reduced from 
8.20 in the OneRA to 0.73 in the TwoRA. However, HipK2 is absent in the 
DRG (the OneRA log2 intensity is 0.87), thus an equivalent reduction in the 
intensity level in the DRG sample is not possible (floor effect). As such the 
log2 expression ratio for HipK2 is shifted from -7.33 in the OneRA to 0.15 in 
the  TwoRA.  Alternatively,  in  other  cases,  if  amplification  increases  the 
intensity in one sample, an equal increase in the other sample would not be 
possible if the intensity was close to saturation (ceiling effect).  
 
Thus, distortions in the expression ratios may occur when a shift in intensity 
(∆log2IN) in one sample cannot be mirrored in the other sample because it 
would cause the intensity to fall outside the dynamic range of the scanner. To 
assess  the  extent  to  which  this  phenomenon  explains  the  deviation  in 
expression ratios between the OneRA and TwoRA for the (DRG, SN) pair, we  
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undertook the following analysis. We selected all probesets where a shift in 
intensity following TwoRA in one sample would cause the intensity in the 
other sample to fall outside the detectable intensity range, that is below the 
background noise or higher than the saturation level. These limits were chosen 
to be the 3% and 98% quantiles of the distribution of signal intensity from a 
randomly  selected  chip,  respectively.  The  analysis  was  conducted  by  first 
determining the absolute ∆log2IN = (log2 TwoRA – log2 OneRA)  for 
each probeset from each biological group in the (DRG,SN) pair. Then, if the 
maximum shift in intensity (∆log2IN) is featured in the DRG group, we 
shift the corresponding OneRA log2 intensity from the SN group by the same 
amount and vice versa. If the resulting value is outside the chosen limits, the 
probeset is selected by our analysis.  
 
Since the selected probesets show a floor and ceiling effect, we shall refer to 
them  as  FCE  probesets  for  the  rest  of  the  chapter.  Interestingly,  the  FCE 
probesets  correspond  to  those  probesets  showing  the  most  pronounced 
variation  in  shifts  in  intensity  following  TwoRA,  i.e.  featuring  the  most 
varying∆log2IN  between  the  DRG  and  SN  samples  (colored  in  red,  fig 
2.3.7-A).  Consequently,  these  same  probesets  show  the  most  deviant 
(DRG,SN) expression ratios following TwoRA (colored in red, Fig 2.3.7-B). 
In fact, the correlation between (DRG,SN) expression ratios across protocols  
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(r)  =  0.89  is  improved  to  0.93  when  the  FCE  probesets  are  excluded. 
Interestingly,  we  found  that  the  FCE  probesets  show  consistent  ∆log2IN 
following TwoRA with the (SA,SN) pair (in red, Fig 2.3.7-C). This is because 
unlike the (DRG,SN) pair, the FCE probesets have similar OneRA intensities 
in both biological groups SA and SN (recall, very little differential expression 
was observed between the SA and SN biological groups in Figure 2.3.5-A) 
and hence a shift in intensity in one biological sample should be possible in 
the other sample following TwoRA. 
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Figure 2.3.7. Deviation in log2 expression ratios (DRG,SN) following TwoRA and its 
origin. (A&C) Scatter plots of ∆log2IN values for the (DRG,SN) pair and the (SA,SN) 
pair respectively. (B) Scatter plots of log2 expression ratios from the OneRA and the 
TwoRA for the (DRG,SN) pair. For instance, the log2 OneRA expression ratio for the 
(DRG,SN) pair is log2 OneRA DRG – log2 OneRA SN. ∆log2IN in A&C were calculated 
by subtracting the log2 OneRA intensity from the log2 TwoRA intensity. Points in red in 
(A) are probesets where the intensity in one sample could not be shifted as much as in the 
other sample because the intensity cannot lie outside the dynamic range of the scanner. 
These  are  referred  to  as  FCE  (floor  &  ceiling  effect)  probesets  and  have  varying 
expression ratios with TwoRA (colored in red, B). Though, for these same probesets, the 
∆log2IN values in the SA and the SN groups are fairly consistent (points in red, C). 
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2.3.3.   Maintaining the statistical significance of the expression 
ratios 
 
The primary aim of a microarray experiment is to detect significant changes in 
gene expression. However, our results suggest that large ratios in the OneRA 
may  get  reduced  following  TwoRA,  which  may  hinder  the  detection  of 
differentially  expressed  genes.  Indeed,  we  found  good  evidence  from  the 
literature to suggest that 9 from the 10 genes with the most severely reduced 
expression  ratios  following  TwoRA  are  indeed  differentially  expressed 
between the SN and DRG. 
 
Despite  shifts  in  expression  ratios,  genes  can  remain  significant  following 
TwoRA if their ratios are still large relative to the average in the TwoRA. 
Moreover, among the population of genes with high expression ratios in the 
OneRA  (Fig  2.3.5-B),  many  do  maintain  their  ratios  in  the  TwoRA,  most 
likely due to a faithful two rounds amplification (TwoRA) of transcripts in the 
two biological samples.  
 
We  applied  the  limma  statistical  test  to  identify  transcripts  differentially 
expressed  in  the  (DRG,SN)  tissue  samples  prepared  with  both  protocols 
(OneRA and TwoRA). An FDR based multiple testing correction was used  
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and genes were ranked by their FDR values in ascending order. 87% of the top 
100, 300 and 500 most significant genes were consistently found common to 
the OneRA and the TwoRA comparisons.  
 
For a more global assessment of the effect of distortions in expression ratios 
on their statistical significance, we used a scatter plot of negated ln p-values 
(nlPv) from the limma analysis of the OneRA and the TwoRA (DRG,SN) (Fig 
2.3.8). The FCE probesets are highlighted in red and it can be seen that their 
nlPv are least correlated between the two protocols, due to distortions in the 
expression ratios (scatter on Fig 2.3.7-B).  
 
 
 
 
 
 
 
 
 
 
 
Figure  2.3.8.  Effect  of  distortion  in 
expression  ratios  on  their  statistical 
significance following TwoRA. Scatter 
plots of FDR corrected nlPv (negated log 
transformed  p-value)  from  the  Limma 
analysis of the OneRA and the TwoRA 
DRG  and  SN  samples.  As  a  result  of 
negating the p-values, large nlPv indicate 
stronger  evidence  of  differential 
expression. Data points in red represent 
the FCE probesets. The dashed line is at 
nlPv = 10 in the TwoRA, above which 
genes may be considered significant.  
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Amongst the FCE probesets on Figure 2.3.8, some still show reasonable nlPv 
following TwoRA (>10). Inspection of these genes revealed that they have 
large expression ratios in the OneRA and moderate ratios in the TwoRA (the 
median log2 expression ratios was 5.09, 2.52 respectively). By contrast, those 
FCE  probesets  with  low  nlPv  (<10)  in  the  TwoRA  have  had  their  log2 
expression ratios reduced severely following TwoRA (median log2 ratio in the 
TwoRA = 0.43). Interestingly, the latter have on average moderate expression 
ratios in the OneRA (median log2 ratio in the OneRA = 2.8). This is expected 
since  with  moderate  expression  ratios,  any  reduction  would  have  a  greater 
impact on their statistical significance. Indeed, looking at the whole population 
of probesets, out of those with an nlPv between 10 and 20 in the OneRA, only 
69% have an nlPv above 10 in the TwoRA, compared to probesets with high 
nlPv (> 20) in the OneRA where 87% of them have nlPv above 20 in the 
TwoRA.  This  suggests  that  the  TwoRA  protocol  is  more  suitable  with 
experiments  where  large  differences  in  gene  expression  are  occurring. 
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2.4.   Discussion 
 
Microarray  technology  is  currently  limited  by  the  need  for  relatively  large 
transcript quantities, which makes it incapable of handling small biological 
samples. The T7 in-vitro transcription has been widely explored to achieve a 
linear  amplification  of  RNA  targets  for  microarrays.  Although,  the 
reproducibility of such techniques and their fidelity in maintaining absolute 
levels of expression have been extensively analysed, much less is known about 
their  ability  to  accurately  reproduce  differential  expression  in  distinct 
biological samples; which we hope to have addressed in this study. 
 
Our analysis confirms the high reproducibility of the small sample TwoRA 
protocol and the occasional failure in its fidelity to maintain the original levels 
of gene expression. In this study, robust analyses were used to confirm the 3' 
bias role in signal distortion. Importantly, the fact that the intensity range is 
limited  by  background  noise  on  one  end  and  saturation  on  the  other  end 
implies  that  intensity  may  only  be  shifted  by  a  limited  amount.  This 
relationship bears important consequences on the consistency of the TwoRA 
protocol  in  amplifying  targets  with  varying  intensities  across  different 
samples. Thus, the shifts in intensity following amplification will not appear to 
be equivalent in two different biological samples if the shift in one sample is  
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limited by the range of the scanner. This has the consequence of distorting the 
expression ratios, as clearly demonstrated by our data.  
 
Unsurprisingly, the statistical significance of expression ratios is only affected 
when the expression ratio in the TwoRA is reduced to the point where it can 
no longer be distinguished from noise. Importantly, large ratios are less likely 
to be critically  diminished and  more  likely  to remain significant following 
TwoRA.  This explains why despite the distortions in ratios in our dataset, 
there was up to 87% agreement in the most significant genes (nlPv > 20) from 
the TwoRA and OneRA (DRG,SN). On the other hand, less agreement was 
observed among the less pronounced ratios (69%) since distortions are more 
critical. This leads us to the important conclusion that TwoRA may affect the 
statistical significance of genes with moderate expression ratios to a greater 
extent.   
2. Microarray analysis after T7 based amplification can detect 
pronounced differences in gene expression. 
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2.5.   Conclusion 
 
We conclude that the Affymetix small sample amplification protocol is useful 
with  the  following  caveats:  First,  it  should  be  only  used  when  tissue 
homogeneity  is  a  crucial  factor  and  sufficient  amounts  of  starting  material 
cannot be obtained by any other means. Secondly, target amplification using 
the  small  sample  protocol  appears  to  be  suitable  in  situations  where  big 
differences in gene expression are expected. Fortunately, it is reasonable to 
expect large differential expressions with experiments characterizing different 
cells  within  a  mixed  tissue  where  amplification  of  transcript  is  necessary. 
However,  expression  data  obtained  from  amplified  samples  might  be  less 
suitable  for  more  comprehensive  numerical  analysis,  for  example 
characterizing regulatory networks, due to the problems caused by possible 
shifts in signal and expression ratios. 
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CHAPTER III:     A DATABASE OF GENE EXPRESSION 
DATA FROM ANIMAL MODELS OF PERIPHERAL 
NEUROPATHY 
     
3.1.   Introduction 
 
3.1.1.   Gene expression databases 
 
Microarray  databases  are  essential  for  effective  management  of  microarray 
data.  Besides  storing  raw  and  processed  numerical  data,  various  types  of 
annotations  need  to  be  recorded  that  capture  information  on  the  scanning 
process  of  individual  array  hybridisations  and  downstream  analysis  steps 
leading to the data. Also, from earlier stages in the microarray experiment, 
annotations  describing  the  origin,  extraction  and  the  manipulation  of  the 
biological  material  as  well  as  the  array  platform  used  provide  essential 
contextual information that is crucial for a correct biological interpretation of 
microarray data and integration of discrete microarray datasets. To this end, 
MIAME or the minimum information about a microarray experiment (Brazma 
et  al.,  2003),  was  developed  as  a  data  model  standard  for  microarray  data 
capture. The MIAME guidelines were later formally encapsulated within an  
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object model framework (MAGE-OM) and an accompanying data exchange 
format based on the XML language (MAGE-ML) (Spellman et al., 2002); an 
effort that was jointly coordinated by members of the MGED society . 
 
The development of standards for microarray data annotation and exchange 
formats  laid  the  ground  for  public  microarray  data  repositories  to  be 
developed. Most popular among these are ArrayExpress (Brazma et al., 2003), 
GEO (Barrett et al., 2009), the Stanford Microarray Database (Demeter et al., 
2007) and CIBEX (Ikeo et al., 2003). Furthermore, requirements were put in 
place for microarray studies to be made accessible in public microarray data 
repositories in the MIAME format by prominent scientific journals as part of 
the  submission  process.  This  allowed  microarray  data  repositories  to  fulfil 
their maximum potential by leveraging the great amount of expression data 
produced worldwide in a standard format that is amenable to exchange. 
 
However, the need for local microarray database facilities that serve the needs 
of small communities undertaking collaborative research projects  was soon 
acknowledged.  Tools  emerged  that  distribute  their  full  source  code  and 
provide  built-in  facilities  for  microarray  data  storage,  data  analysis  and 
management of user accounts; providing an ideal easy to use platforms for 
specialised labs undertaking microarray work. One of the earliest of such tools  
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that  is  MIAME-compliant  is  the  BioArray  Software  Environment  (BASE) 
(Saal  et  al.,  2002).  BASE  uses  a  server-client  architecture  framework  that 
features  a  centralised  database  core  for  storing  the  data  at  the  server  side 
whilst allowing online user access to the database at the client side. BASE 
features an integrated framework for the storage and analysis of microarray 
data. Within BASE, analysis scenarios may be created that combine varying 
steps of data manipulation and further more explore variations at each analysis 
step.  Results  are  stored  in  a  hierarchical  structure  that  reflects  both  the 
specificity and the timing of each analysis step in the workflow. Users may 
share data and analysis results between them according to well-enforced rules; 
thereby allowing management of microarray data at a laboratory/project scale. 
 
Other  free  software  microarray  platform  solutions  also  exist  that  feature 
varying points of focus. For instance, with many tools, the main aim was to 
provide a comprehensive built-in suite of analysis tools that is fully integrated 
with  the  internal  microarray  data  structure;  examples  are  TM4  and  Gecko 
(Saeed et al., 2006; Theilhaber et al., 2004). More recently, more free software 
platform  solutions  have  emerged  that  extend  the  classical  set  of  analysis 
methods applicable to individual datasets to provide the necessary tools that 
allow disparate datasets, possibly originating from different array platforms, to 
be efficiently combined (WebArray, Xia et al., 2005). Other microarray data  
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management systems have focussed on usability with respect to data analysis 
(EzArray, Zhu et al., 2008), capture of the microarray data and experimental 
details in MIAME as well as ease of import/export of such standardised data 
(maxd, Hancock et al., 2005). Finally, systems have also been developed that 
address the need for fine-tuned user privileges that reflect the varying ways in 
which different types of users may wish to interact with the data (MiMiR, 
Tomlinson et al., 2008). 
 
It is a fact that at the biological level, the potential of microarray technology is 
only fully realised when disparate microarray expression datasets pertaining to 
a  common  biological  subject  are  combined  together  and  furthermore 
integrated  with  other  types  of  biologically  relevant  data.  Indeed,  there  are 
many  examples  in  the  literature  of  biologically  specialised  microarray 
databases that were designed to serve research communities dedicated to a 
particular research subject in an effort to consolidate their data. Examples are 
the  Genopolis  Microarray  Database  specialised  in  immunopathology 
(Splendiani et al., 2007), the Gene Aging Nexus (GAN) database (Pan et al., 
2007), the Cancer microarray database OncoMINE (Rhodes et al., 2004) and 
the  Staphylococcus  Aureus  Microarray  meta-database  SAMMD  (Nagarajan 
and Elasri, 2007).     
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Ironically, with respect to the microarray data capture model, many of such 
subject  dedicated  microarray  databases,  including  GAN,  OncoMINE,  the 
Pancreatic Expression database (Chelala et al., 2007) and SAMMD, don’t use 
MIAME. Rather, they tend to only  capture essential information about the 
microarray experiments that are most relevant to the interpretation of the data 
relative to the key common biological topic. This is because, for most of these 
resources,  the  mission  is  to  corroborate  information  on  gene  differential 
expression via combining biologically relevant datasets obtained from public 
repositories whilst the full MIAME specifications of the original microarray 
experiments  are  already  defined  in  the  source  repository.  Typically,  these 
biologically  specialised  microarray  databases  tend  to  have  their  own  data 
model and analysis tools and focus on methods that allow integrative analysis 
of  disparate  microarray  datasets  such  as  cross-platform  analysis  and 
normalisation. 
 
On the other  hand, there have been examples where research communities 
have successfully adopted free generic microarray software platforms to set up 
local microarray databases tailored to their specific research needs. The use of 
free software implies the chance to benefit from an already existing platform 
for data storage and analysis that can be further extended. For instance, in the 
Institute of Food Research (IFR),  BASE was successfully used to create a  
3. A database of gene expression data from animal models of peripheral 
neuropathy  
    3.1. Introduction 
 
 
 
  72 
local database capturing more than 4600 prokaryote and eukaryote microarray 
hybridisations and is being continuously extended and optimised (Mark Alston 
et al.,2004). 
 
The maxd software (Hancock et al., 2005) has had even more success among 
specialised  microarray research communities. Already two  major  consortia: 
the Generation Challenge Programme (GCP) , an international consortium of 
agricultural  research  centres,  and  the  Environmental  Genomics  Working 
Group  (EGWG)    have  adapted  customized  versions  of  maxd  to  capture 
extended  MIAME-based  annotations  of  their  microarray  experiments 
(MIAME/plant,  MIAME/Env)  (Zimmermann  et  al.,  2006;  Morrison  et  al., 
2006) that reflect the specificity of their respective biological topic of interest.  
 
Maxd is a comprehensive free software environment that features three main 
components:  maxdLoad2,  maxdView  and  maxdBrowse.  MaxdLoad2  sits  at 
the core of maxd and features a friendly interface to an underlying relational 
database that allows data input, query searches and data editing. There are a 
handful  of  attractive  features  to  maxdLoad2:  first,  the  ability  to  handle 
formatted annotations of microarray experiments; most notably, in the form of 
spreadsheets and the ability to generate structured summary reports of these 
annotations.  Second,  and  most  importantly,  the  ability  to  customise  the  
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annotations  by  extending  the  MIAME  standards  with  domain  specific 
information. This is a winning feature that has certainly contributed to the 
popularity of maxd among domain focussed microarray research communities. 
As a complement to maxdLoad2, maxdBrowse features a comprehensive web-
server  platform  for  browsing  the  content  of  maxdLoad2  in  a  multi-layer 
fashion that reflects the specific needs of various types of users. MaxdView, 
on the other hand, is the component of maxd that deals with data analysis and 
visualisation and is modular in nature allowing straightforward incorporation 
of additional functionality. 
 
3.1.2.   Functional annotation data 
 
An essential part of setting up a gene expression database is to capture the 
biological  role  of  the  genes  by  associating  them  with  their  functional 
annotations. Luckily, gene functional annotation is a task that has been widely 
explored  in  bioinformatics  and  many  public  resources  exist  nowadays  that 
offer  functional  annotations  for  complete  genomes.  Thus,  incorporating 
functional data into locally established databases is often an operation that 
involves  no  more  than  mirroring  gene  functional  associations  from  source 
databases,  by  establishing  links  between  internal  gene  identifiers  from  the 
local database and the source annotation database. In the following, we give a  
3. A database of gene expression data from animal models of peripheral 
neuropathy  
    3.1. Introduction 
 
 
 
  74 
brief  overview  of  the  essence  of  gene  functional  annotation  from  a 
bioinformatics perspective. 
 
3.1.2.1.   Modelling of biological functions 
 
Before  genes  may  be  associated  with  functional  terms,  a  standardised 
vocabulary needs to be defined to formalise those terms that cover the range of 
known  biological  functions.  This  is  a  non-trivial  task  involving 
conceptualisation  of  domain  knowledge  and  this  has  been  appropriately 
resolved with the use of ontologies. The gene ontology (GO) initiative (The 
Gene  Ontology  Consortium,  2008)  currently  hosts  the  largest  and  most 
comprehensive set of gene functional concepts. Importantly, GO recognises 
three distinct components of a gene/protein function that are independent of 
each  other:  the  molecular  activity  carried  out  by  the  protein,  the  broad 
biological process in which the protein performs this molecular activity and 
finally the site of action within the cell. Thus, a gene may be associated with 
one  or  more  instances  of  biological  processes,  one  or  more  instances  of 
molecular  functions  and  one  or  more  instances  of  cellular  locations. 
Importantly, these different aspects of function are independent of each other; 
thus, as an example, the receptor binding molecular activity mediates many  
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biological processes including signal transduction as well as the translocation 
of viruses into host cells. 
 
Along  these  lines,  a  separate  ontology  was  developed  for  each  of  these 
functional themes, as part of the GO database that categorises instances of the 
theme.  Importantly,  GO  features  a  top-down  categorisation  approach  that 
provides a step-wise specification of a concept semantics. Importantly, such a 
framework exposes similarities between concepts by revealing broad common 
functional themes that capture their semantics. An example GO subgraph is 
shown in Figure 3.1.1. 
 
 
Figure  3.1.1.  A  model  GO 
subgraph  illustrating  GO 
terms  and  relationships 
between them. 
is_a  
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Thus, the ‘cytokinesis’ biological process is a type of ‘cell division’ process, 
which is in turn a type of ‘cellular physiological process’; whilst the biological 
processes ‘cytokinesis’ and ‘meiotic cell cycle’ have in common the fact they 
are both instances of ‘cellular physiological process’ (Fig 3.1.1). Importantly, 
beside  the  ‘is_a’  relationship  that  indicates  that  concepts  provide  an 
abstraction  of  the  semantics  of  other  concepts  from  lower  levels  in  the 
hierarchy, the ‘part_of’ relationship is used by GO to reflect the fact that many 
low level biological processes may come together to give rise to higher level, 
more complex, biological systems within the cell (Fig 3.1.1).     
 
Importantly, GO uses a directed acyclic graph structure to organise the set of 
terms from each ontology; with the main difference to tree structures being the 
possibility of having more than one parent term for a given child term. An 
important rule that applies to GO is the true path rule, stating that the meaning 
of a term implies the semantics of all its ancestor terms. This has important 
consequences at the level of gene annotations in that for any given gene-term 
association, every parent of the term is also a valid annotation for the gene. 
The GO vocabularies are constantly revised, with new terms and relationships 
being added by curators in consultation with biological experts. 
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Various other forms of structured vocabularies for biological functions exist in 
the public domain. Examples are the Functional Catalogue (FunCat) (Surmeli 
et al., 2008), which provides a tree-like categorisation of functions at varying 
levels  of  specificity  and  the  Kyoto  Encyclopedia  of  Genes  and  Genomes 
(KEGG)  collection  of  biological  pathways  annotated  with  higher-order 
functions from KEGG BRITE supplement classification of biological systems 
(Okuda  et  al.,  2008).  Also,  the  Enzyme  Classification  (EC)  providing  a 
hierarchical classification of enzymatic reactions that is also used for enzyme 
nomenclature.  However,  GO  remains  the  most  comprehensive  resource  of 
biological  functions  and  the  most  widely  used  in  biological  research 
applications. This despite many limitations, notably, the separation between 
the three different ontologies that hinders the appreciation of the multi-level 
nature of biological functions; in addition to the lack of consistency while 
defining relations between terms.  
   
3.1.2.2.   Methods for deriving gene function 
 
Formalised  functional  vocabularies  provide  the  mechanism  for  associating 
genes  with  functional  terms  that  best  describe  their  functions.  There  are 
broadly two main approaches for gene function discovery: experimental, based 
on laboratory direct assays and the inference-based approach that relies on  
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educated prediction from knowledge of functions of related genes. The former 
has the quality of rigor but the drawback of being slow whilst the latter is 
known to produce quick information, which can be at the expense of accuracy.  
 
The notion of functional conservation in evolution has been a major principal 
in gene function prediction in bioinformatics.  With the emergence of fully 
sequenced genomes from eukaryotic organisms, it became apparent that gene 
sequences,  structures  and  functions  are  shared  between  species.  Such 
similarity in genetic characteristics between species is due to shared ancestry, 
commonly  referred  to  as  homology.  Homology  comes  in  two  flavours: 
orthology  and  paralogy.  Orthologous  sequences  are  sequences  originating 
from a speciation event, which is when a species diverges in evolution to give 
rise to two separate species. Paralogous sequences on the other hand, are the 
result of a gene-duplication event in the same organism. With paralogy, the 
additional  copy  of  the  gene  may  acquire  new  functional  characteristics 
because  the  availability  of  the  original  copy  implies  no  constraint  for 
functional diversion; as such, paralogous sequences tend to be functionally 
less similar than orthologous sequences. 
 
In  the  context  of  exploring  homology  for  function  prediction,  important 
bioinformatics research has identified thresholds of sequence similarity above  
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which function is likely to be conserved.  For instance, the study by Todd and 
Orengo  (Todd  et  al.,  2001)  indicated  that  EC  numbers,  consisting  of  a 
numerical code that expresses the enzymatic reaction class of enzymes by the 
Enzyme Classification database, rarely vary at sequence identity above 40%. 
This was reiterated by the more recent study by Tian and Skolnick (Tian and 
Skolnick,  2003)  suggesting  that  the  first  digits  of  the  EC  numbers, 
corresponding to higher-order classes of enzymes, may be reliably transferred 
at  sequence  similarity  above  40%.  Inheriting  functional  information  using 
homology  is currently considered the  most  efficient way for characterising 
protein function and has proven wrong the long time assumption that a protein 
function may only be predicted when its three-dimensional structure is fully 
characterised.   
 
To assist with homology based functional prediction, many public resource 
databases  have  arisen  to  provide  family  based  classification  of  biological 
sequences across genomes. For instance, PANTH (Thomas et al., 2003) uses 
curated  family  and  subfamily  classification  to  organise  known  protein 
sequences  and  derives  HMM  profiles  from  the  functionally  distinct 
subfamilies  to  identify  novel  homologues  from  newly  sequenced  genomes. 
The  SYSTERS  database  (Meinel  et  al.,  2005)  uses  a  two-tier 
family/superfamily clustering approach to organise proteins from the Swiss- 
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Prot/TrEMBL database and derives a list of key functional attributes for each 
family. HAMAP (Lima et al., 2009) is another family based database that hosts 
sequences from microbial genomes. Importantly, HAMAP protein families are 
curated manually and propagation of functional annotations to uncharacterised 
homologues is supervised with high level of care from template sequences 
from  the  family  whose  functions  have  been  characterised  by  experimental 
means. 
 
The  BioMap  database  (also  known  as  the  CATH-Gene3D  family/function 
database,  (Maibaum,  2004)),  used  in  this  work,  features  a  multi  level 
classification of protein sequences originating from a large number of fully 
sequenced  genomes.  At  the  top  of  the  classification  hierarchy  are  protein 
families that define sets of evolutionary related proteins. The latter are formed 
using  the  PFScape  protocol  (Lee  et  al.,  2005)  that  exploits  the  TribeMCL 
clustering  algorithm  (Enright  et  al.,  2003;  Enright  et  al.,  2003).  Protein 
sequences  from  the  same  family  are  subsequently  grouped  into  clusters  of 
sequences with at least 30% sequence identity; the latter are in turn partitioned 
into  even  finer  clusters  featuring  35%  or  more  sequence  identity.  More 
granular clustering at increasing levels of sequence identity follows to yield 
clusters  of  increasingly  similar  sequences  (Fig  3.1.2).  Importantly,  at  each 
level of sequence identity, the resulting clusters are given unique numbers and  
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at the end of the clustering process, each protein sequence is assigned a cluster 
number by concatenating the numbers of the clusters featuring the sequence 
from consecutive rounds of clustering (illustrated in Fig 3.1.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With GO, the process of deriving functional information for genes is carried 
out by members of the GO consortium. These are research organisations that 
have committed to the sequencing and subsequent annotation of genomes from 
different organisms, such as the Arabidopsis Information Resource (TAIR) and 
Figure  3.1.2.  Diagram  illustrating  the  nested  homology  based  classification  of  sequences  by 
BioMap. The outer circle in black delineates the protein family.  Inner circles in red indicate the 30% 
sequence identity clusters whilst those in blue the nested 35% sequence identity clusters. The latter may 
then be divided into clusters of sequences featuring more than 40% sequence identity and likewise 
increasingly more granular clusters are formed at 50%, 60%, 70%, 80%, 90%, 95% and 100% sequence 
identity levels (not shown on the diagram). The numbering of clusters from each round of clustering is 
indicated. On the basis of the family->30%->35% classification illustrated in the diagram, the example 
sequence in bold may be assigned the cluster number 1.2.1. 
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the Mouse Genome Informatics (MGI) database. Similarly, the Gene Ontology 
Annotation (GOA) initiative (Barrell et al., 2009) aims to annotate proteins 
from the UniProt database with GO terms thereby providing a comprehensive 
source of annotation of proteins from all species. 
 
In  order  to  capture  the  different  ways  in  which  functions  of  genes  are 
identified  by  annotators  from  the  GO  consortium,  GO  provides  a  set  of 
annotation  evidence  codes.  The  latter  extend  the  broad 
experimental/inference-based  classification  of  gene  function  discovery 
methods (discussed earlier) to account for the many practical details that arise 
during  the  process  of  gene  functional  annotation.  For  instance,  functional 
information  derived  via  a  process  of  homology  inference  is  classified 
differently  by  GO  depending  on  whether  such  information  was  curated 
manually or generated purely via computational work. 
 
The  GO  annotation  evidence  codes  are  fully  described  at 
http://www.geneontology.org/GO.evidence.shtml;  but  briefly,  they  fall  into 
the following classes:  
1.  Experimental, involving direct experimental work. 
2.  Computational, where the information on function is derived on  the 
basis of  sequence or structural similarity but curated manually.  
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3.  From author statement, usually from review type of articles where the 
evidence for the information is mentioned in the form of a reference to 
the original experimental work. 
4.  Curatorial,  where  the  information  was  reasonably  inferred  by  the 
curator, but for which no direct evidence is available.  
5.  Electronic, usually involving large-scale computational annotation of   
            sequences and genomes featuring no manual curation. 
          
3.1.3.   Chapter aim 
 
The main aim of this chapter is the setting up of a database of functionally 
integrated gene expression data from animal models of peripheral neuropathy. 
We refer to this database as the LPD standing for the ‘London pain database’ 
as from the LPC perspective, the primary objective of the database is the study 
of the pain aspect of neuropathy. The expression data in the LPD originate 
from microarray initiatives undertaken by the LPC, as well as published work. 
The  functional  annotations  of  the  genes  from  the  expression  datasets  were 
obtained by exploring various annotation pipelines, notably Biomap the family 
oriented functional database. 
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At the time this work was underway, only few free software microarray data 
storage platforms were available, namely BASE. Unfortunately, BASE did not 
offer much support for cross platform integration of microarray datasets and 
meta-analysis of lists of differentially expressed genes. Thus, similar to many 
biologically specialised databases such as SAMMD and GAN, the LPD was 
designed to use a simple, other than MIAME, model to store the data and 
annotations of experiments whilst featuring a greater focus on providing the 
type  of  exploratory  tools  that  will  allow  efficient  integration  of  different 
microarray datasets. The advantages and disadvantages of such an in-house 
system as oppose to adaptation of free software solutions are discussed in the 
conclusion section at the end of this chapter. 
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3.2.   Data types and data acquisition   
 
The LPD hosts three main types of data: microarray expression data, gene 
annotation and family data as well as biological domain data. These different 
types of data and methods for their acquisition are described below in detail: 
 
•  Microarray  expression  data:  The  primary  source  of  expression  data 
captured in the LPD consists of the set of microarray experiments run by 
the LPC. Additional microarray datasets were obtained from the following 
published studies (Costigan et al., 2002; Valder et al., 2003; Wang et al., 
2002; Xiao et al., 2002; Yang et al., 2004). These studies were selected on 
the  basis  of  biological  relevance  to  the  animal  models  of  neuropathy 
investigated by LPC microarray work. Datasets from these studies were 
not  available  for  electronic  download;  instead,  information  on 
differentially expressed genes was identified in the corresponding articles 
and  manually  entered  in  the  LPD.  Table  3.2.1  gives  a  survey  of  all 
microarray expression studies captured in the LPD, listing the name of the 
main  experimenter  and  the  animal  model  investigated.  
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Microarray Study  Experimental model investigated 
Tony Dickenson (unpublished) 
Murine model of bone cancer pain (Schwei et al., 1999): Following injection of tumor cells in the femur bone, animals tend to 
guard the affected limb showing clear evidence of pain-related behaviour. The progression of bone destruction and consequent 
increase in pain is accompanied by clear neurochemical change in the spinal cord. 
(Maratou et al., 2009; Valder et 
al., 2003; Wang et al., 2002; 
Yang et al., 2004) 
Selective nerve ligation, also known as SNL/CHUNG  (Kim and Chung, 1992): As illustrated in Figure 1.2.1, SNL involves 
unilaterally tying the L5 and L6 spinal segments of the sciatic nerve proximal to their DRGs. 
Andrew Rice (unpublished) 
Rat model of Zoster-associated pain, or VZV (Kim and Chung, 1992): Involves the subcutaneous injection of VZV-infected 
fibroblasts into the left hind foot. The virus then undergoes retrograde axonal transport along the sciatic nerve to establish a 
latent infection in the corresponding DRG. 
(Maratou et al., 2009) 
HIV model of neuropathy (Maratou et al., 2009): This model consists of injecting the HIV coat protein gp120 into the paw of 
the animal. Since the antiviral drug ddC is known to contribute to neuropathy in human subjects, the drug is also injected in the 
paw to fully mimic the neuro-pathology of HIV infection. 
Maria Fitzgerald (unpublished)  Spared Nerve Ligation (SNI) (Decosterd and Woolf, 2000): As shown in Figure 1.2.1, the model consists of transection of 
common perineal and tibial branches of the sciatic nerve. 
Geranton & Hunt (unpublished)  Arthritis CFA-induced model (Geranton et Hunt, unpublished): A model of inflammatory pain achieved by injection of the 
inflammatory substance CFA in the ankle joint. 
John Wood (unpublished)  Nav1.7 knockout: featuring the knock-out of the sodium channel Nav 1.7. 
John Wood (unpublished)  Nav1.8 knockout: featuring the knock-out of the sodium channel Nav 1.8. 
John Wood (unpublished)  ASIC1 knockout: featuring the knock-out of the acid channel ASIC1. 
(Rabert et al., 2004)  Brachial plexus spinal root avulsion: Avulsed DRG removed by surgery from patients suffering from brachial plexus lesions. 
(Costigan et al., 2002; Xiao et 
al., 2002)  Involving sciatic nerve transection (Fig 1.2.1) 
Table 3.2.1. Source microarray studies of the expression datasets stored in the LPD. Microarray studies by the LPC are indicated in red whilst those taken from 
literature are indicated in black. Because the LPC main research interest is the study of pain, expression datasets featuring animal models with phenotypes indicative 
of pain of non-neuropathic origin were also included in the LPD, such as models of inflammatory and cancer pain. 
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•   Annotation and family data: Functional annotations of the genes in the 
LPD were derived from within a family based setting using BioMap, the 
Oracle  implemented  data  warehouse.  Additional  functional  annotations 
were obtained from Ensembl via the EnsMart (Kasprzyk et al., 2004) web 
facility and the array manufacturer online annotation centre NetAffx (Liu et 
al., 2003). Functional annotations from all these different sources consisted 
of GO and KEGG pathway information.  
 
•  Domain  related  data:  The  final  type  of  data  in  the  LPD  consists  of 
biological  knowledge  in  relation  to  neuropathy  and  pain,  mainly 
descriptions  of  animal  models  used  to  generate  hosted  expression  data. 
Such information is crucial not only for documenting the type of pathology 
being  investigated  in  individual  experiments  but  also  to  assure  that 
comparisons of separate microarray experiments are biologically sensible. 
Formalised descriptions of animal  models of neuropathy and pain were 
obtained from the literature (Eaton, 2003; Wang and Wang, 2003) and via 
consultation with experimentalists from the LPC. In the future, the LPD 
may evolve to integrate additional neuropathy related data such as clinical 
data.   
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3.3.   Data structure: the LPD schema 
 
The different types of data in the LPD were used to derive a logical conceptual 
data model, which was implemented in a relational setting using the MySQL 
platform.  Thus,  major  entities  in  the  data  were  identified  and  captured  in 
tabular  structures  that  include  a  specification  of  the  entity  properties  and 
attributes. Relationships between the entities were also modelled that indicate 
how  instances  from  different  entities  relate  to  each  other.  The  diagram  on 
Figure 3.3.1 shows the LPD data structure. Importantly, tables from each data 
type (consisting of expression data, annotation and domain data) are shown in 
different  colours.  The  LPD  data  model  including  entities  and  their 
relationships is discussed in full in the following paragraphs.  
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one 
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one 
one 
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one 
     many 
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-  feature_id: char 
- seq_id: char(32) 
- genBank_id: char 
 
one 
Figure 3.3.1. The LPD data structure. Green tables correspond to gene expression data including experiment annotations, blue tables store 
gene annotations while the pink table captures domain information consisting of definitions of experimental models of neuropathy and pain.  
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3.3.1.   Domain data tables 
 
Beginning  with  the  biological  domain  data,  the  LPD  schema  features  one 
unique entity: the Pain Model or perhaps more appropriately the Experimental 
model  entity.  Owing  to  variations  in  the  experimental  procedures  used  to 
realise these animal models, only basic but common features of the models 
were  taken  to  define  the  attributes  of  the  representative  class  Pain  Model. 
These  consisted  of  the  model  common  names,  the  original  study  that  first 
developed the model and keywords capturing the pathological and phenotypic 
characteristics of the model. The latter may be more formally expressed using 
the Mammalian phenotype ontology (Smith et al., 2005), part of the Open 
Biomedical Ontologies (OBO) .  
 
3.3.2.   Gene expression data tables 
 
 As for the gene expression data, two main entity classes were recognised: the 
Microarray  Pain  Study  class  and  the  Gene  List  class.  The  former  class 
captures summaries of microarray experiments, including information on the 
experimenter and various useful experimental details such as the animal model 
investigated  (hence  the  link  to  the  Pain  Model  entity),  species/strain 
information, array platform and handling of the RNA material. The Gene List  
3. A database of gene expression data from animal models of peripheral 
neuropathy 
     3.3. Data structure: the LPD schema     
 
 
 
  91 
class on the  other hand, captures the gene expression data outcome of the 
microarray study; in particular, genes found most differentially expressed and 
their fold changes. Importantly, with some array platforms such as Affymetrix, 
the expression measurement is identified with a probeset identifier instead of 
the  gene  identifier  and  many  probesets  may  map  to  the  same  gene. 
Consequently,  the  Gene  List  entity  features  a  generic  feature_identifier 
attribute, which can take the value of an Affymetrix probeset identifier or a 
gene identifier (usually GenBank or UniGene).  
 
3.3.3.   Functional annotation data tables 
 
A number of tables exist in the LPD that hold functional annotations of the 
array genes, corresponding to different sources of annotation. These include 
the  Affymetrix  Annotation  table,  the  Ensembl  Annotation  table  and  the 
GO/KEGG  Annotation  tables  derived  from  BioMap.  Logically,  functional 
annotations  should  be  modelled  as  a  single  entity  since  the  source  of 
annotation is merely an attribute of the annotation. However, owing to the 
differences  in  the  way  functional  information  is  encoded  in  each  source 
database and also for ease of maintenance, it was decided to keep annotations 
from the different sources in separate tables. For instance, with Ensembl and 
unlike the rest of the source databases, the GO annotation terms from all three  
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ontologies: functional process, molecular function and cellular component are 
given together in a single string without indication of their ontology type. It is 
important to note that the reason why annotations from different sources were 
pulled together in the LPD is because it was noticed that they complemented 
each  other  and  for  many  array  genes,  functional  annotations  were  only 
available from one source and not the rest. 
 
The  BioMap  functional  annotation  data  have  the  special  feature  of  being 
linked to protein family classification data and are arranged in a special data 
table structure that requires more explanation.  One key table is Cluster Data. 
This table was mirrored from the BioMap database and hosts information on 
family  classification  of  sequences  by  linking  all  BioMap  proteins  to  their 
corresponding sequence cluster numbers. Each protein entry in Cluster Data is 
functionally  annotated  via  association,  where  possible,  with  one  or  more 
entries from the GO Annotation and KEGG Annotation tables. 
 
As  an  interface  between  the  gene  expression  data  and  the  functional 
annotation  data,  an  additional  table  capturing  the  entity  Gene  was  created. 
Importantly, the latter defines important information for each array feature, 
notably sequence and identifier attributes of the corresponding gene. This has 
the important consequence of revealing probeset association to identical genes  
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with Affymetrix based expression datasets (more details will follow in the 
next section).  
 
Importantly, the association to BioMap protein identifiers in the Gene table 
allows each array feature (gene) to be linked to the corresponding BioMap 
cluster number, by reference to the Cluster Data table. Knowing the BioMap 
cluster number for a given array feature (gene) allows functional information 
to  be  retrieved  from  homologous  BioMap  proteins  at  a  desired  level  of 
sequence identity. For instance, if an array feature/gene associated BioMap 
cluster number is 1.2.1.3.4.1.5.3.6.1.1, then all BioMap proteins with BioMap 
cluster numbers beginning with the same first four digits 1.2.1.3 in Cluster 
Data, are in the same S40 cluster; that is sharing at least 40% sequence with 
the  array  gene  protein.  Functional  annotations  may  then  be  inherited  from 
these homologs from the GO and KEGG annotation tables (for more details on 
BioMap cluster numbers, refer to Figure 3.1.2).  
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3.4.   Data integration 
 
The essence of the LPD is to store expression values of the genes as well as 
their  functional  annotations.  However,  because  gene  expression  data  were 
derived from a number of different sources (both in-house and from literature) 
utilising  varying  array  platforms  and  similarly  gene  annotation  data  were 
obtained from various annotation databases, it was possible for the same gene 
to be referred to by different identifiers in the different datasets. Clearly, data 
integration was necessary to eliminate redundancy and promote data unity. It 
is worth noting that such mapping between identical entries from the various 
datasets is exclusively captured in the Gene table, as will be explained later. 
 
In the following, the methodology used for integrating the different datasets in 
the LPD is summarised. We begin by describing our strategy for integrating 
expression  data  from  the  varying  sources  and  proceed  by  examining  the 
manner by which gene expression data were integrated with annotation data. 
 
3.4.1.   Integrating gene expression data  
 
As mentioned before, the LPD expression datasets originated from two main 
sources: the in-house datasets derived from LPC microarray experiments were  
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based  on  Affymetrix  arrays  and  feature  Affymetrix  probeset  identifiers  as 
primary identifiers. On the other hand, published expression data are typically 
identified by GenBank and UniGene identifiers.  Luckily, the Affymetrix array 
manufacturer  provides  mappings  of  Affymetrix  probeset  identifiers  to  all 
common  gene  identifiers  used  by  popular  repositories  of  biological  data 
including  GenBank  and  UniGene.  However,  because  UniGene  provides  an 
automated  partitioning  of  GenBank  sequences  into  non-redundant  sets  of 
gene-oriented clusters, it was deemed more appropriate to map all expression 
data  to  UniGene  identifiers.    Thus,  entries  from  the  published  expression 
datasets that were only named with their GenBank identifiers were mapped to 
UniGene  identifiers  using  the  NCBI  web  service  Elink  (Baxevanis,  2008). 
Elink allows cross-linking of identifiers from various NCBI databases and in 
our case, it was used to map the GenBank identifiers to UniGene identifiers.  
 
However, since not all GenBank identifiers from the LPD expression datasets 
were successfully mapped to UniGene identifiers, it was necessary to perform 
sequence  comparison  to  identify  additional  identical  entries  between  the 
various  expression  datasets.  Thus,  nucleotide  sequences  were  obtained  by 
querying the NCBI web service Efetch (Baxevanis, 2008) with the GenBank 
identifiers from the expression datasets. Efetch allows linking of various gene 
identifiers (including  GenBank identifiers)  with appropriate NCBI database  
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entries  and  the  retrieval  of  useful  information  from  the  selected  records 
including  nucleotide  and  peptide  sequences.  Sequences  from  the  various 
expression datasets showing 100% sequence identity revealed an additional set 
of identical entries between datasets, amounting to 10% of the overall number 
of gene entries in the LPD.  
 
Importantly, such a sequence comparison based approach may fail when the 
sequences are partial i.e. not spanning the whole length of the gene, such as 
ESTs. The problem of EST mapping to genes is non-trivial, but luckily the 
many EST sequences submitted to GenBank are regularly classified into gene-
centric clusters via robust EST annotation protocols by UniGene. Thus, our 
original  mapping  to  UniGene  identifiers  may  have  been  complementary  to 
sequence comparison searches since the former is more robust at dealing with 
ESTs and partial matches than the latter. In the LPD and to keep track of 
equivalent  entries  between  the  various  expression  datasets,  UniGene 
identifiers as well as nucleotide sequences MD5 digests (unique 32 character 
strings  computed  from  the  sequences)  were  captured  in  the  Gene  table  in 
columns unigene_id and seq_id respectively (Fig 3.3.1). Table 3.4.1 shows 
examples  where  sequence  and  UniGene  identifiers  were  instrumental  to 
recognising identical entries from different expression datasets whilst Figure  
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3.4.1 shows a flowchart summarising the steps performed for integrating these 
datasets. 
 
Microarray Study   GenBank identifier  Sequence MD5  UniGene ID 
(Wang et al., 2002)  K02248  11eaacf2431bafb6ec8
0cec311d77b5f  Not known 
(Xiao et al., 2002)  NM_012659  11eaacf2431bafb6ec8
0cec311d77b5f  395919 
(Costigan et al., 2002)  X53054  Ytgrf5643ijnbf62as1
qqkl90867fgvd  395454 
(Valder et al., 2003)  AF084934  00lki87yhbfr5ffcdsnh
8777maa520  395454 
 
Table 3.4.1. Identical gene entries from different published expression datasets stored in the 
LPD. Genbank entries K02248 and NM_012659 were mapped to the same gene due to identical 
sequences (shown in blue) (sequences are denoted by unique 32 character long strings referred to as 
MD5),  whilst Genbank entries X53054 and AF084934 were found biologically equivalent due to 
identical UniGene identifiers (shown in red). 
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3.4.2.  Integrating expression data with functional annotation data 
 
As previously mentioned, the functional annotations by the Affymetrix array 
manufacturer  and  Ensembl  stored  in  the  LPD  were  originally  tailored  for 
Retrieve UniGene identifiers using Elink  Retrieve nucleotide sequences using Efetch 
Identify entries with identical UniGene 
identifiers 
Identify entries with identical 
sequences 
Gene expression datasets with 
redundant array feature/gene 
identifiers 
Gene expression datasets with 
nonredundant array feature/gene 
identifiers 
Figure 3.4.1. Flowchart showing the combined methodology used for identifying equivalent 
biological entries across the different LPD expression datasets. NCBI web services, Elink and 
Efetch, were used to retrieve UniGene identifiers and nucleotide sequences for array features using 
their GenBank identifiers. Equivalent biological entries across the different datasets were identified 
by  means  of  identical  UniGene  identifiers  and/or  identical  sequences.  The  two  strategies 
complemented each other: UniGene mapping allows entries featuring partial sequences of the same 
gene to be identified while sequence matches are more appropriate when UniGene identifiers are 
unknown.  
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Affymetrix arrays and hence needed no further integration with the Affymetrix 
based  expression  datasets  in  the  LPD.  However,  one  important  aim  of  the 
current  work  was  to  derive  functional  annotations  for  the  genes  from  the 
various  expression  datasets  by  exploiting  the  BioMap  family  oriented 
annotation framework. Using BioMap, additional functional information for 
uncharacterised  genes  may  be  gained  from  other  functionally  characterised 
homologs. This was particularly important as the average functional coverage 
for  the  arrays,  achieved  by  either  annotation  source  (Affymetrix/Ensembl), 
was rather limited. Furthermore, functional information derived from BioMap 
may  be  assessed  by  considering  the  extent  of  functional  variation  within 
individual  protein  families.  Finally,  exploiting  BioMap  provided  an 
opportunity  to  annotate  the  LPD  expression  datasets  originating  from 
literature,  which  were  not  based  on  Affymetrix  arrays  and  needed  to  be 
explicitly annotated.  
 
Initially, the protein sequences from LPD array features/genes were obtained 
by querying the NCBI Efetch web service with the corresponding GenBank 
identifiers. To check whether these protein sequences existed in BioMap and 
hence already classified in the appropriate BioMap sequence clusters, their 
MD5 digests were matched against BioMap protein identifiers based similarly 
on MD5 digests of corresponding sequences. Where no match was found, the  
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BioMap protocol for assigning new sequences to existing clusters was used. 
Finally, the updated Cluster Data table from BioMap containing mappings of 
all  BioMap  proteins  (including  LPD  array  protein  sequences)  to  BioMap 
cluster numbers was mirrored in the LPD.  
 
To assess the overall efficacy of the BioMap functional annotation of genes 
performed  in  this  work,  we  compared  the  extent  of  functional  coverage 
achieved  with  various  Affymetrix  arrays  by  BioMap,  Ensembl  and  the 
Affymetrix  array  manufacturer.  It  is  worth  noting  that  with  BioMap, 
functional  information  was  inherited  from  related  BioMap  sequences  at  a 
sequence  identity  level  greater  or  equal  to  40%;  that  is  functionally 
characterised homologs from S40 clusters.   
 
The results are shown on Figure 3.4.2. Rather disappointingly, the BioMap 
based  annotation  seems  to  be  only  slightly  better  than  that  by  the  array 
manufacturer.  Moreover,  the  Ensembl  annotation  appears  to  be  more 
comprehensive  for  certain  arrays,  mainly  the  Rat230_2,  RatU34B  and  the 
RatU34C. The explanation for this lies in the fact that these arrays feature a 
high percentage of EST sequences, meaning that the probesets in these arrays 
were mostly derived from short EST sequences instead of full-length genes 
(Fig 3.4.2). This is rather problematic with the BioMap annotation framework  
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as EST sequences are usually of unknown gene origin and it is hence difficult 
to obtain protein sequences for them that may be searched against BioMap 
protein sequences. By contrast, the annotation strategy used by Ensembl is 
based on nucleotide instead of protein sequence comparison, whereby probe 
sequences (including those derived from ESTs) may be mapped to genomic 
cDNA  sequences  from  the  appropriate  organism  according  to  well-defined 
rules. 
 
 
Array                         
EST   
content 
        47%           82%            11%         91%           91% 
 
  Figure 3.4.2. Percentage of functionally characterised probesets from various Affymetrix arrays 
by  the  different  annotation  approaches:  BioMap,  Ensembl  and  Affymetrix.  Note  that  the 
percentages are relative to the total number of probesets on the arrays. 
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In Figure 3.4.3, the extent of functional annotation of Affymetrix arrays by 
BioMap at varying homology levels is shown. The analysis reveals that about 
95%  of  functional  assignments  were  derived  from  highly  similar  BioMap 
sequences  with  greater  than  95%  sequence  identity,  the  majority  of  which 
featured  exact  matches.  This  implies  that  annotations  inferred  from 
homologous  sequences  at  lower  levels  of  sequence  identity  were  not 
substantial; presumably, owing to the fact that the arrays subject to annotation 
in this work featured functionally well characterised genomes from the mouse 
and rat species. This seems to explain why the BioMap annotation pipeline did 
not perform better than the Ensembl and the array manufacturer annotations 
(Fig 3.4.2), as the former is based on exploiting homology to derive functional 
attributes  for  genes.  However,  despite  the  marginal  gain  in  function 
assignment,  the  mappings  between  individual  Affymetrix  genes  and  the 
BioMap protein families achieved in this work can be used to inherit various 
other forms of useful information such as protein-protein interactions. Such 
data have been largely generated for yeast and are not directly available for the 
mouse and rat species except through family inheritance. 
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Figure  3.4.3.  Number  of  annotated  probesets  at  any  given  sequence  similarity  threshold 
expressed as a percentage from the total number of annotated probesets per array. Note that ID 
means sequence identity.   
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3.5.   Data retrieval: the database web interface 
 
A set of web pages were set up to allow a user-friendly interface to the LPD 
(Fig  3.5.1),  which  can  be  found  at 
http://w3pain.biochem.ucl.ac.uk/idiboun/develop/search/searchCommonGenes
/introduction.php. The web pages allow retrieval of various types of data from 
the LPD and were designed in accordance with a set of anticipated use cases 
specified by potential users from the LPC. One important use case was the 
possibility to retrieve genes showing a similar pattern of expression regulation 
across a number of microarray pain experiments. Figure 3.5.1 shows the form 
that allows this search to be conducted. Various drop-down menus and free-
text fields are used to allow the user to specify the required search parameters. 
Among these, the pain model(s) of interest so that all microarray experiments 
featuring this model(s) are compared or alternatively, a subset of experiments 
that are of particular interest to the user. In addition, the desired fold change or 
significance value, allowing the most significant subset of the common genes 
to be filtered out. Importantly, the ability to identify common genes between 
different experiments is powered by the mapping between the heterogeneous 
gene identifiers from the different array platforms, discussed earlier. 
 
        
3. A database of gene expression data from animal models of peripheral 
neuropathy 
     3.5. Data retrieval: the database web interface 
 
 
 
  105
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 3.5.1. LPD meta-analysis web pages. Showing (A) the search form that allows genes 
commonly regulated in a number of selected expression studies or pain/neuropathy models to 
be retrieved, (B) the result from this search.   
A 
B  
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Figure 3.5.1-B shows the results from a search of commonly regulated genes 
across a number of randomly selected studies. The results for each gene are 
shown in a separate table. The rows of the table describe information about the 
gene  as  specified  by  each  selected  dataset;  including  the  gene  identifier,  a 
textual description of the function of the gene and the fold change. 
 
Further to searching for commonly regulated genes across varying microarray 
experiments, an important use case scenario consisted of the ability to browse 
functional information of lists of genes of interest; such as the ones obtained 
from cross-comparing microarray experiments.  Figure 3.5.2 shows the LPD 
web interface that allows functional information for a given gene in a gene list 
to be broken down by homology to the protein annotation source as well as the 
type of annotation consisting of KEGG or GO. 
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Figure  3.5.2.  LPD  functional  annotation  web  pages.  For  each  gene/probeset,  GO  and 
KEGG  functional  information  are  broken  down  by  sequence  identity  to  BioMap  protein 
homologs serving as the source of annotation.   
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3.6.   Conclusion 
 
Microarray  screening  is  characterised  by  a  sheer  genomic  scale  amount  of 
data. Setting up a microarray database that is capable of handling such data 
efficiently  is  a  non-trivial  task  and  is  further  compounded  by  the  need  to 
project  functional  annotations  on  the  gene  expression  data.  The  latter  are 
heterogeneous in nature and often use different nomenclature schemes to refer 
to  the  same  genes;  which  adds  significantly  to  the  complexity  of  the  task 
involved.  Furthermore,  the  need  to  capture  information  on  the  microarray 
experimental procedure implies an additional layer of data, leading to an even 
more complex underlying database schema. 
 
The work presented in this chapter has certainly shed light on some of the 
overheads with the setting up of a microarray database. First, the integration of 
disparate gene expression and functional datasets proved rather challenging 
and is a process that requires considerable amount of time and resources to be 
maintained. Second, our choice to use a simplified data model than MIAME, 
although beneficial from the point of view of reducing the complexity of the 
data  model,  proved  occasionally  inefficient  for  failing  to  capture  more 
complex  microarray  experimental  designs  such  as  time  course  experiments  
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and  also  for  offering  little  assistance  with  constructing  MIAME  compliant 
descriptions of LPC microarray experiments.   
 
In  effect,  many  of  these  complex  tasks  such  as  the  formalisation  of 
descriptions of microarray experiments based on the MIAME standard and 
data integration are fairly non-specialised procedures that can be handled with 
generic software. This is because the MIAME data model was designed to be 
fairly general to accommodate all different microarray experimental designs 
that might be applied to study any biological phenomenon. Similarly, industry 
manufactured genomic-wide arrays, such as Affymetrix arrays, are becoming 
very  popular  among  research  communities  undertaking  microarray  work. 
Because of their popularity, robust functional annotations for these arrays have 
already  been  assembled  and  are  constantly  revised  by  many  independent 
sources; examples are the annotations by Ensembl and Bioconductor. 
 
Microarray  free  software  platforms  are  key  to  leveraging  generic  software 
solutions intended to serve routine handling of microarray data. For instance 
and as outlined in the introduction of this chapter, many provide user friendly 
tools for experimental data input in the MIAME format and deploy the logic 
of the MIAME model to support downstream statistical analysis of the data. 
Array  probes  functional  annotations  are  provided  built-in  and  additional  
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annotations may be easily incorporated, which also provides a mechanism for 
easy updates.  Moreover, many free software microarray platforms provide 
generic tools for meta-analysis of the data; notably, cross comparisons of gene 
lists across different datasets of similar array platforms. 
 
In  effect,  open  source  software  systems  constitute  ideal  microarray  data 
management  platforms.  Thus,  in  addition  to  offering  basic  generic 
functionality  for  handling  microarray  data,  these  tools  are  often  fully 
extendable;  which  allows  them  to  harbour  additional  tools  tailored  to  the 
specific needs of specialised research communities. In the future, the LPD will 
benefit from the open source software solution by adapting the maxd software 
(highlighted in the introduction section), for its numerous benefits. First, the 
fact that maxd accepts and assists in the development of customised MIAME 
data model is an attractive feature that, together with the use of ontologies, 
will  help  the  LPD  evolve  into  a  pain  knowledge-base  repository.  Second, 
maxd  has  a  range  of  data  browsing  and  analysis  tools  that  would  allow 
members of the LPD to conduct basic manipulations and searches of the data. 
Finally,  maxd  is  configured  to  allow  easy  incorporation  of  additional 
functionality.  This  feature  will  be  used  to  incorporate  in-house  analysis 
protocols as well as other free analysis software tools such as MatchMiner 
(Bussey et al., 2003). The latter is a tool that allows mapping of heterogeneous  
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gene  identifiers,  which  is  instrumental  for  cross-comparison  of  microarray 
results obtained with different array platforms.   
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CHAPTER IV:       A GENE ONTOLOGY BASED 
MODEL OF THE FUNCTIONAL CHARACTERISTICS 
OF PERIPHERAL NERVE INJURY 
 
 
4.1.   Introduction 
 
4.1.1.   Aim of the chapter 
 
The  current  chapter  follows  on  from  the  previous  chapter  and  aims  to 
assemble a library of gene functions induced at the transcriptional level under 
the  condition  of  peripheral  neuropathy  using  the  expression  data  from  the 
LPD. This will be used in chapter VI as a gold standard to validate the efficacy 
of functional analysis  methods applied to a spinal nerve transection (SNT) 
microarray dataset from LPC experimental work.  
 
In addition to identifying this set of nerve injury related functions, one further 
aim  to  this  chapter  is  to  reveal  the  specific  biological  relevance  of  each 
function  in  the  set  to  the  biology  of  nerve  injury.  To  substantiate  this 
biological  analysis  and  as  an  introduction  to  this  chapter,  the  molecular  
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mechanisms underlying the physiological response to peripheral neuropathy 
are  discussed.  This  is  rather  different  to  the  material  presented  in  the 
introduction  chapter,  which  focussed  primarily  on  the  mechanisms  of 
peripheral  neuropathic  pain.  As  for  the  GO  functional  paradigm,  used 
extensively in this chapter, we feel that it has been adequately described in the 
introductory material of the previous chapter and needs no further explanation 
at this stage. 
 
4.1.2.   Pathophysiology of peripheral nerve injury: a molecular 
perspective  
 
Peripheral  neuropathy  refers  to  the  conditions  that  result  when  nerves  that 
connect to the spinal cord from the rest of the body are damaged or diseased. 
Experimentally,  the  best  studied  form  of  peripheral  neuropathy  is  that 
involving  direct  injury  to  the  peripheral  nerve  as  it  is  relatively  easily 
mimicked  in  animal  models  than  the  more  complex  forms  of  peripheral 
neuropathies such as diabetic neuropathy. Despite the significant advances in 
understanding the molecular machinery deployed under the condition of nerve 
damage made with these models, the main challege remains to characterise 
these molecular changes in terms of cause and effect; in particular, in relation 
to the development of neuropathic pain.  Examples of experimental models of  
4. A Gene ontology based model of the functional characteristics of peripheral     
neuropathy 
     4.1. Introduction   
 
 
 
  114
peripheral nerve injury were illustrated in the diagram in Figure 1.2.1 in the 
introduction chapter. This was used to give an overview of the anatomy of the 
peripheral nervous system which is essential for understanding the effect of 
nerve  injury  on  DRG  neurons  in  these  models.  This  constitutes  useful 
background for some of the material that follows.  
 
In what follows, the pathophysiology and underlying molecular response to 
the  most  common  form  of  experimentally  induced  nerve  injury,  involving 
nerve cut (axotomy), is discussed. Peripheral nerve axotomy is a significant 
occurrence to affected neurons that triggers a whole series of adaptive events, 
primarily aimed at extending the axon to regain contact with target territories 
(being the parts of the body innervated by the injured nerve).  Maintaining 
contact with target territories is fundamental to the integrity of neurons since 
the  latter  depend  on  target-derived  growth  factors,  also  known  as  trophic 
factors, for normal function. Following injury, axonal regeneration leading to 
target  reinnervation  holds  the  key  for  neuronal  survival,  though  this  repair 
process is known to be limited and highly dependent on a number of factors 
such as the type and site of lesion. Moreover, reestablishment of connectivity 
with targets does not usually result in full recovery of lost sensory or motor 
functions as regrown axons may show poor target specificity and reinnervation 
adequacy.  
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To fully appreciate the reaction of neurons to axonal injury, it is important to 
consider the cascade of events first taking place at the site of the lesion. This is 
illustrated  in  Figure  4.1.1  (it  is  worth  noting  that  most  of  the  information 
presented in Figure 4.1.1 and discussed in the following paragraphs was taken 
from the following two reviews: (Navarro et al., 2007; Scholz and Woolf, 
2007). Thus, upon injury, the axon is split into two parts: the part that loses 
contact  with  the  cell  body  is  called  the  ‘distal  part’  as  opposed  to  the 
‘proximal part’ that stays attached (Fig 4.1.1). The axonal segment distal to 
the  lesion  begins  to  degenerate  concurrently  with  the  disintegration  of 
surrounding  myelin  sheaths.  This  degenerative  process  results  in  the 
formation  of  debris  that  attracts  the  early  immune  cells,  mainly  local 
macrophages,  causing  Schwann  cells  to  become  reactive  to  injury.  Active 
Schwann cells release cytokines such as leukemia inhibitory factor (LIF) and 
interleukin  (IL)-1  (Tofaris  et  al.,  2002)  that  further  attract  macrophages 
capable of phagocyting myelin and axonal debris. Cytokines are subsequently 
produced by the activated macrophages. The events that lead to the destruction 
of the distal stump are known as the Wallarian degeneration (Fig 4.1.1). 
   
More important are the events taking place at the proximal end of the injured 
axon. Since the proximal stump remains attached to the cell body, it serves as 
a communication bridge between the site of injury and the cell body allowing  
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injury signals to be transduced to the inside of the cell, which causes the cell to 
respond to injury.  Overall, the response may have one of two outcomes: cell 
growth and survival or cell death. There is a fine balance between the two 
opposing  effects  and  much  less  is  known  about  the  pathway  mechanisms 
contributing  to  neuronal  death  following  injury,  probably  due  to  greater 
research interest in identifying growth promoting molecules. What is known 
though is that the same pathway mechanism could lead to either outcomes 
depending on the timing of the individual reactions and the pattern of cross-
talking between the pathways. 
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Figure 4.1.1. Schematic diagram showing the events that take place following peripheral nerve injury both at the lesion site and distal within the 
DRG where the injured nerve cell bodies reside. Note that the dotted lines represent the second axonal process that projects to the spinal cord, the latter is 
included in the figure for the sake of completion. The figure was based on the information in (Navarro et al., 2007 & Scholz and Woolf, 2007).  
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The first signal reaching the cell body of injured neurons is a burst of action 
potential resulting from a rapid depolarisation that occurs immediately after 
the  axon  is  exposed  to  the  extracellular  medium  following  rupture  of  its 
axoplasmic  membrane.    Additional  signals  follow  consisting  of  early 
deprivation from target trophic factors and later on partial compensation by 
retrograde  transport  of  neurotrophins  such  as  nerve  growth  factor  (NGF), 
brain-derived  neurotrophic  factor  (BDNF)  and  glial  cell-line  derived 
neurotrophic factor (GDNF) released by active Schwann cells at the site of 
injury.  The  cell  body  also  comes  under  the  influence  of  proinfammatory 
substances building up at the site of the lesion such as cytokines. Moreover, 
recent work has led to renewed interest in the axon endogenous proteins that 
undergo  posttranslational  shifts  following  injury,  known  as  ‘positive  injury 
signals’, and their potential role in conveying the nociceptive message to the 
cell body. These signals originate from the site of injury and are transmitted to 
the cell body via the process of retrograde transport (Fig 4.1.1).  
 
In addition to the lesion environment, injury to the axon is also signalled to the 
cell body by neighbouring non-neural cells within the DRG tissue. Following 
injury, macrophages invade the DRG and begin to release cytokines that in 
turn  stimulate  resident  Schwann  cells  and  glial  satellite  cells  to  produce 
neurotrophins.  In  addition  to  their  effect  on  sensory  neurons,  these  locally  
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produced growth molecules are thought to play a prominent role in stimulating 
sprouting of sympathetic fibres within the DRG into basket-like structures that 
surround neurons (Ramer et al., 1998) (Fig 4.1.1). Sympathetic input is one 
factor in establishing nociceptive sensitisation and neuropathic pain. 
 
Cellular  transduction  of  signals,  originating  from  both  the  DRG  local 
environment as well as the site of the lesion, involves the activation of many 
signalling pathway genes.  For instance, recruitment of TRAF receptors by the 
proinflammatory cytokine TNF-α activates MAP kinases JNK and p38 while 
protein kinase A and B (PKA, PKC) may potentially be activated by the early 
influx of calcium upon injury. The downstream events consist of activation of 
potent  transcription  factors.  Thus,  taking  the  example  of  cytokine  induced 
JNK, we find it associated with the expression and phosphorylation of c-Jun, a 
transcription factor with wide functionality following nerve injury. Active c-
Jun  has  been  implicated  in  nerve  cell  growth  and  survival;  it  was  also 
associated  with  neuronal  death  (Elmquist  et  al.,  1997)  in  conjunction  with 
other key growth regulators following axonal injury. In addition, it appears to 
regulate the expression of a variety of neurotransmitters such as VIP and NPY 
(Son et al., 2007) as well as substance P and CGRP.  
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Similarly, phosphorylated p38 kinase activates the NFκβ transcription factor 
thought to promote neuronal growth (Aggarwal, 2003), though also implicated 
in  neuronal  death  following  transection  of  the  optic  nerve  (Kikuchi  et  al., 
2000).  The  significance  of  p38  phosphorylation  lies  furthermore  in  the 
resulting  increase  in  the  density  of  tetrodotoxin  (TTX)-resistent  sodium 
channel  currents  in  nociceptors  following  injury  (Jin  and  Gereau,  2006). 
STAT3  is  another  transcription  factor  that  is  thought  to  be  induced  by 
cytokines to promote neuron survival and regeneration (Lee et al., 2004).  
 
Trophic factors play a prominent role in modulating intracellular signalling 
reactions  in  injured  neurons.  For  instance,  the  early  activation  of  survival 
inducing transcription factor ATF-3 is thought to be due to the early loss of 
target  derived  NGF  and  GDNF  (Averill  et  al.,  2004)  whilst  the 
phosphorylation of transcription factor CREB is dependent on the presence of 
compensatory neurotrophins (Miletic et al., 2004) released by active Schwann 
cells and DRG satellite cells following injury. 
 
In surviving neurons, the functional outcome of promoting gene expression is 
the synthesis of molecules that support and stimulate axonal growth; among 
these  are  membrane  lipids,  adhesion  molecules,  growth  associated  proteins 
and  cytoskeletal  proteins  that  mediate  the  anterograde  transport  of  growth  
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material to the growing end of the axon. On the other hand, neurotransmitter 
metabolism  is  given  a  lower  priority,  though  with  a  marked  plasticity 
following  injury.  Research  has  described  a  marked  decrease  in  excitatory 
neurotransmitters content such as substance P and CGRP in small neurons 
(Butler et al., 1984) and an opposing increase in inhibitory neurotransmitters 
such as Galanin (Zhang et al., 1998). This, in addition to the upregulation of 
NPY, VIP and peptide histidine isoleucine, which are thought to play a role in 
communicating nociceptive injury signal to dorsal horn neurons, potentially 
contributing  to  neuropathic  pain.  Interestingly,  the  expression  of  excitatory 
neurotransmitters  was  found  to  be  upregulated  in  large  DRG  neurons 
following injury suggesting a possible role in central sensitisation. Since large 
fibres are natural sensors of innocuous mechanical stimuli, it was speculated 
that they might be implicated in establishing mechanical allodynia (painful 
sensations caused by non-painful mechanical stimuli) following injury.  
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4.2.   Methods 
 
4.2.1.   The gold standard term set  
 
Published  expression  datasets  from  the  LPD,  featuring  direct  injury  to  the 
peripheral nerve, were selected in order to assemble a library of biological 
functions enriched at the transcriptional level during peripheral neuropathy. 
These included two SNL as well as two axotomy datasets (details about these 
animal models can be found in Figure 1.2.1) from the following published 
microarray studies: (Costigan et al., 2002; Valder et al., 2003; Wang et al., 
2002;  Xiao  et  al.,  2002).  A  fifth  and  final  dataset  was  obtained  from  a 
literature survey conducted in the Costigan study of genes previously found to 
be  regulated  in  animals  with  injured  sciatic  nerve  by  a  variety  of  wet  lab 
experimental techniques. Thus, the fifth dataset is not a microarray dataset, 
though, it was deemed worth including as it reported expression data that were 
validated experimentally.  
 
Following dataset selection and by reference to the functional tables in the 
LPD, the most specific GO terms associated with each gene from the five 
chosen datasets were obtained. Since the ultimate goal in compiling this set of 
functional  terms  is  to  achieve  a  gold  standard  reference  for  validating  
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functional  analysis  of  a  nerve  injury  LPC  microarray  dataset  (presented  in 
chapter VI), we refer to this set as the gold standard term set.  
 
Clearly, one important criterion for the gold standard terms is reliability. Thus, 
beyond  ensuring  the  quality  of  individual  datasets  by  only  referring  to 
published work, our approach of combining a number of expression datasets 
was meant to deal with the inherently noisy nature of microarray data. We thus 
look for commonalities between the different datasets following the logic that 
frequently occurring functional terms are likely to be the most believable.  
 
To quantify the level of confidence associated with each term from the gold 
standard term set, we counted the number of studies featuring the term or its 
progeny as the term semantics are also implied by its descendents. We refer to 
this measure as the term study occurrence measure. We used functions from 
the  GOstats  package,  an  interface  to  GO  from  within  the  programming 
environment of Bioconductor, to identify the descendents of any given term 
from the gold standard term set. 
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4.2.2.   Categorisation of the gold standard terms 
 
In order to explore the biological significance of the gold standard terms, we 
sought  to  categorise  them  by  the  broad  sense  of  their  functions.  This  is 
particularly useful as the gold standard term set is relatively large. We used the 
Gene Ontology Categoriser (GOC) algorithm (Joslyn et al., 2004) to classify 
the gold standard terms into a handful of functional groups that are easier to 
study.  
 
GOC comes as part of the software POSOC (Joslyn et al., 2004) designed to 
capture, manipulate and analyse the structures of graph based ontologies and is 
available at http://www.c3.lanl.gov/posoc/. The GOC algorithm is meant to 
provide a solution to the problem of categorising ontology terms: thus, given a 
set  of  terms  of  interest,  what  broad  terms  best  summarise  them  in  the 
ontology? In GO, parent terms are intrinsically an abstraction of the semantics 
of their children. As such, GOC considers all parents to the terms of interest as 
potential  categorisation  points.  Among  the  many  possible  parents,  the 
selection is made on the basis of the desired balance between coverage and 
specificity. Thus, taking the example of the model ontology graph shown on 
Figure 4.2.1, we find that the query terms (shown in green) ‘d’, ‘e’, ‘j’, ‘k’ and 
‘l’ are all children of term ‘A’; as such, category ‘A’ shows the best level of  
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coverage.  However,  we  may  decide  that  ‘A’  is  associated  with  a  far  too 
general meaning and decide to choose the more specialised term ‘C’ instead, 
despite the fact that the new category fails to include the query term ‘d’. 
 
  
 
 
 
 
 
 
 
 
 
The GOC score (described in detail in appendix 4.5.1) for any given parent is 
a reflection of the parent’s fitness to achieve the desired level of abstraction of 
the functions of the query terms it subsumes. In the GOC mathematical model, 
the desired level of specificity is set via parameter s. A positive s emphasises 
specificity and as such the highest scores are given to the most specialised 
parents. On the other hand, a negative s downweights specificity in favor of 
coverage  and  as  such  the  top  scores  are  granted  to  parents  with  broader 
k  j 
d 
C 
A 
l 
e  F 
G  I 
B 
Figure 4.2.1. A model ontology graph.  
Nodes d, e, j, k, l are the targets  for the 
categorisation process.                                                                                               
4. A Gene ontology based model of the functional characteristics of peripheral     
neuropathy 
     4.2. Methods 
 
 
 
  126
semantics.  In  appendix  4.5.1,  we  explain  in  detail  the  way  parameter  s 
modulates the dynamics of specificity and coverage in the GOC mathematical 
model.  
 
In this work, we applied GOC to categorise the gold standard term set (which 
is the set of terms associated with the genes from the published microarray 
nerve  injury  studies).  These  are  the  so-called  ‘query  terms’  in  the  GOC 
vocabulary. The input to GOC consisted of a file listing the gold standard 
terms, a second file containing GO in XML file format as well as a chosen 
value for parameter s; all other parameters were set to default. Moreover, we 
experimented with varying the value of s; thus, we ran GOC with s set to one 
of three values –1, 1 and 2. Expectedly and as a general trend, the higher the s 
the more specialised were the resulting clusters. However, we noticed that at 
any given value of s, individual clusters may vary in their levels of specificity. 
This is because in the GOC model, specificity is expressed as a relative entity 
so that for any given parent, specificity is based on how far up in the GO 
graph the parent is from child query terms (more details in appendix 4.5.1). 
Since query terms from different clusters may be at different levels in the GO 
graph,  so  will  the  root  terms  for  the  clusters.  Given  this  observation,  we 
combined the results from different GOC runs featuring varying s values and 
selected a final set of clusters that featured a comparable level of semantic  
4. A Gene ontology based model of the functional characteristics of peripheral     
neuropathy 
     4.2. Methods 
 
 
 
  127
specificity,  on  the  basis  of  reasonable  judgment.  However,  where  clusters 
overlapped with each other, we felt that it was necessary to make the clusters 
slightly more specialised to cut down on the amount of overlap.   
 
The previous analysis was largely done by manual inspection of the clusters, 
which depended on our ability to visualise the clusters. For that, we used the 
graph  visualisation  and  manipulation  tool  yEd  available  from 
www.yworks.com/products/yed. yEd is a java-based software that allows fine 
drawing of graphs using a variety of different layouts. Moreover, the graph 
images by yEd are dynamic and can be edited in a variety of ways. More 
importantly, yEd provides a wide selection of graph manipulation tools. For 
instance, for any given target node(s), it is possible to select predecessor or 
successor nodes or generally any node reachable from the target(s). All graph 
images presented in the work were generated using the yEd software.      
 
yEd is designed to take in various file formats of graph structures such as 
XML, the graph modelling language (GML) and its XML derivative XML-
based GML. Unfortunately, the clusters from the GOC output were given in a 
format that is not recognised by yEd: the ‘dot file’ format. Therefore, scripts 
were written to convert the output clusters from GOC to the GML file format 
to make them compatible with yEd.  
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4.3.   Results & discussion 
 
4.3.1.   Reliability of the gold standard terms 
 
In this chapter, we extracted the GO term annotations of genes from published 
studies featuring direct injury to the nerve, in an attempt to build a formal 
model  of  the  functions  enriched  at  the  transcriptional  level  following 
peripheral nerve injury. The resulting set of terms, which we named the ‘gold 
standard term set’, is  composed of 560 unique terms originating from 346 
unique  genes.  Table  4.3.1  shows  the  count  of  genes  and  terms  from  each 
study. 
 
Table 4.3.1. Genes and terms counts from all five selected studies. 
 
  Wang et al  Xiao et al  Costigan et al  Valder et al  Literature 
survey 
Genes  127  119  230  114  69 
GO Terms  229  171  298  85  92 
 
 
One important requirement for the gold standard term set is consistency with 
the biology of nerve injury.  We use the term study occurrence (see methods, 
section  4.2.2)  as  a  measure  of  confidence,  following  the  logic  that  terms 
occurring  most  frequently  across  the  studies  are  most  believable.  
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Unfortunately,  examining  the  distribution  of  term  study  occurrence  values 
from all terms in the gold standard set, we find that half of the terms occur in 
only one of five selected studies (table 4.3.2). 
 
 
Table 4.3.2. The distribution of term study occurrence values from all gold standard terms. The 
counts of terms scoring a term study occurrence value of 1,2,3,4 and 5 are given.  
 
Study occurrence  1  2  3  4  5 
Term count  278  118  65  50  49 
 
 
Instead of seeking exact term matches between the studies, it is likely to be 
more  efficient  to  look  for  similarities  between  the  terms  by  exploiting  the 
relationships between them in the ontology. This approach is more efficient 
for two main reasons: first, the fact that we are combining slightly different 
models  of  peripheral  neuropathy  (axotomy,  SNT);  second,  functionally 
equivalent  genes  from  different  datasets  may  be  annotated  with  terms 
capturing varying levels of the function semantics. It is important to note that 
this chapter simply discusses the idea of considering semantic relationships 
with terms from the gold standard set while evaluating the evidence for each 
individual term in this set. Chapter VI on the other hand, takes this concept 
further by incorporating it into the mathematical model used to benchmark the 
results from functional analysis of an LPC nerve injury dataset against the 
gold standard set of terms.   
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For now and in order to further study the semantic relationships between the 
gold standard terms, we will analyse their induced GO subgraph. This consists 
of  the  part  of  the  GO  graph  that  features  all  paths  leading  from  the  gold 
standard terms to the root term (Fig 4.3.1). The resulting subgraph has the 
benefit  of  encapsulating  the  set  of  gold  standard  terms  within  a  unified 
ontology based structure that captures the logical relationships between them.   
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Figure 4.3.1. The gold standard term set induced GO subgraph. Shown as a whole 
in (A) and partly magnified in (B). Nodes in color represent the gold standard set of 
terms whilst those transparent are the ancestors of the gold standard terms. A color 
scheme was applied to indicate the term study occurrence for the gold standard terms 
(red,  orange,  yellow,  green,  blue  for  5,4,3,2,1  study  counts  respectively).  The  term 
name and accession are given on each node. Nodes in color feature additionally the 
study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to 
Wang  et  al,  Xiao  et  al,  Costigan  et  al,  Valder  et  al  and  the  literature  survey  from 
Costigan et al respectively). It is interesting to see how single study terms (appearing in 
blue on the magnified part of the graph) may be subsumed by parent terms that occur 
more frequently across the studies. 
A 
B  
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Close  examination  of  the  gold  standard  term  induced  subgraph  (Fig  4.3.1) 
revealed that many terms in the gold standard term set are ancestors to other 
terms in the same set. More important is the observation that many of the 
subsumed terms are those single study occurring terms that account for half of 
the gold standard term set, while their subsumers appear to be more common 
across the studies. Arguably, frequent occurrences of parent terms could add 
to the confidence level of their children. In many cases, low study occurrence 
terms correspond to those featuring very specialised functions as it is generally 
a  feature  of  the  GO  graph  that  the  most  specialised  terms  are  the  least 
populated with genes and as such least likely to be common across the studies. 
One example is the term ‘axon regeneration in the peripheral nervous system 
(GO:0014012)’ which only appears in the Wang study; going one level up, we 
find  that  the  less  specialised  parent  ‘axonogenesis  (GO:0007409)’  is  more 
common across the studies as it also features in the Xiao and Costigan studies 
(Fig 4.3.1-B). Naturally, our confidence about the child term increases when 
we consider association with the parent.      
  
Subsumption by parent terms is not the only relationship observed in the gold 
standard term induced subgraph. Other, perhaps more distal relationships are 
also  visible.  For  instance,  some  terms  are  cousins  thus  sharing  common 
ancestors (Fig 4.3.1-B). Going one level higher from pair relationships, we  
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could  consider  concentrations  of  terms.  These  more  complex  relationships 
should  also  be  explored  to  boost  our  confidence  about  participating  terms. 
However,  such  inference  has  to  be  handled  with  care  and  should  only  be 
allowed in the presence of a strong semantic link. For instance, terms with a 
general meaning should not be used to reinforce our confidence about their 
progeny and a similar level of caution should be applied with distant cousins. 
 
4.3.2.   Analysis of clusters of gold standard terms 
 
Semantically, concentrations of terms are biologically important as they define 
major functional themes that take part in the complex biological response to 
peripheral nerve injury. The complexity of this response is certainly visible on 
the gold standard term induced subgraph shown on Figure 4.3.1. Hence, it was 
considered useful to split the subgraph into major components. Splitting the 
subgraph is equivalent to categorising the gold standard terms under parents 
terms that provide an abstraction of their functions; a task that can be handled 
by  the  gene  ontology  categoriser  GOC  (described  briefly  in  the  methods 
section 4.2.3 and in detail in appendix 4.5.1). It is important to note that the 
purpose of this clustering analysis is to assist in the biological interpretation of 
the gold standard terms and not to provide a mechanism for exploiting the  
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relationships  between  them  to  evaluate  their  evidence,  as  this  is  rather  the 
subject of chapter VI.   
 
After a few GOC runs at varying values of specificity parameter s, the output 
was visualised with yEd and manual refinement was performed to yield 14 
distinct clusters. The criterion for cluster selection was based on achieving the 
highest  level  of  abstraction  that  preserves  the  essence  of  the  function. 
Although, sometimes clusters were chosen to be more specialised in order to 
avoid extensive overlap. Out of the 560 terms in the gold standard term set, the 
clustering excluded 70 terms, of which 45 are singletons while the rest either 
corresponded  to  very  general  terms  or  formed  small  clusters,  which  were 
deemed insignificant. The clusters are referred to by the name of their root 
terms and are listed in table 4.3.3, together with the count of the gold standard 
terms and genes associated with them. It is important to note that although the 
clusters  are  referred  to  by  their  root  terms,  each  cluster  only  contains  the 
progeny  of  the  root  term  that  is  part  of  the  gold  standard  term  induced 
subgraph.  
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Table 4.3.3. Clusters from the gold standard term induced subgraph obtained using GOC and 
further refined manually. The count of gold standard terms and genes associated with each cluster is 
given in absolute numbers as well as percentages with respect to the overall number of gold standard 
terms and their gene associates from the five published datasets respectively. 
 
Cluster   Term count (%)  gene count (%) 
Nervous system development (GO:0007399)  25 (4)  51 (11) 
cell cycle process (GO:0022402)  8 (1)  24 (5) 
Cellular component organization and biogenesis  
(GO:0016043)  56 (10)  66 (14) 
cell adhesion (GO:0007155)  9 (2)  22 (5) 
Inflammatory response (GO:0006954)  8 (1)  13 (3) 
Metabolic process (GO:0008152)  140 (25)  177 (38) 
Apoptosis (GO:0006915)  20 (4)  38 (8) 
Immune system response (GO:0002376)  36 (7)  41 (9) 
reproduction (GO:0000003)  18 (3)  19 (4) 
Signal transduction (GO:0007165)  62 (11)  129 (28) 
behavior (GO:0007610)  13 (2)  24 (5) 
transport (GO:0006810)  54 (10)  103 (22) 
Neurological system process (GO:0050877)            23 (4)  54 (12) 
Organ development (GO:0048513)   31 (5)  35(7) 
 
 
Inspection  of  the  resulting  clusters  leads  to  some  interesting  observations. 
Satisfyingly, there are clusters that describe the changes to nerve cells and the 
neuronal processes they mediate following injury: mainly the ‘nervous system 
development  (GO:0007399)’  and  the  ‘neurological  system  process 
(GO:0050877)’  clusters.  Other  specialised  functions  are  also  observed:  the 
‘immune  system  response  (GO:0002376)’  and  surprisingly  ‘reproduction 
(GO:0000003)’.  
 
By contrast to the immune response, justifiable by the invasion of the DRG 
tissue by immune cells following injury, the reproduction function is clearly  
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absent from the DRG tissue and so are the terms describing the development 
of other than neuronal or immune related organs in the ‘organ development 
(GO:0048513)’ cluster. Therefore, these clusters seemed to be false positives 
and were consequently discarded from the rest of the analysis. The explanation 
of  their  occurrence  may  lie  in  the  versatility  of  gene  function  in  different 
anatomical  environments  so  that  the  same  genes  acting  upon  nerve  injury 
could also be essential to sustaining other cell types residing in other organs. 
Taking the example of the FGF2 (fibroblast growth factor 2) gene that triggers 
the  fibroblast  growth  factor  receptor  signalling  pathway,  this  pathway  is 
known to be critical for the development of many different tissues beyond 
neuronal  ones,  such  as  reproductive  gonads,  inner  ear,  lung  and  muscle 
tissues.  
 
In addition to these biologically specialised clusters, we also note the presence 
of clusters featuring generic biological functions that seem applicable to all 
cell types. Examples are the ‘cellular component organization and biogenesis 
(GO:0016043)’,  ‘apoptosis  (GO:0006915)’  and    ‘transport  (GO:0006810)’ 
clusters. Further inspection of the clusters reveals that the more specialised 
clusters  correspond  to  complex  system  processes  such  as  ‘nervous  system 
development  (GO:0007399)’  whilst  the  generic  ones  encapsulate  simpler 
biological processes which may be sorted by their level of granularity into  
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molecular,  subcellular  and  cellular  processes.  The  molecular  processes  are 
those involving the synthesis or manipulation of biological molecules such as 
metabolic  processes,  the  subcellular  class  refers  to  processes  that  affect 
particular structures inside the cell such as organelles and finally the cellular 
processes are those altering the functioning of the cell as a whole such as 
apoptosis and the cell cycle. Table 4.3.4 organises the GOC clusters into the 
four  classes  of  biological  processes  outlined  above:  system,  cellular, 
subcellular and molecular.  
 
Table 4.3.4. Classification of GOC clusters by increasing complexity of the biology process they 
encapsulate.  
 
Biological process class  GOC clusters 
Molecular   Metabolic process (GO:0008152) 
Transport (GO:0006810) 
Signal transduction (GO:0007165) 
Subcellular   Cellular component organization and biogenesis (GO:0016043) 
Cellular   Cell adhesion (GO:0007155) 
Cell cycle process (GO:0022402) 
Apoptosis (GO:0006915) 
System  Nervous system development (GO:0007399) 
Neurological system process  (GO:0050877) 
Immune system process (GO:0002376) 
Behavior (GO:0007610) 
Inflammatory response  (GO:0006950) 
 
 
The  reason  the  clusters  show  varying  levels  of  biological  complexity  is 
because  the  gold  standard  terms  they  include  are  also  at  varying  levels  of 
semantic granularity. This is because the gold standard terms were obtained 
from gene candidates and genes are usually annotated with terms of varying  
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granularity in an attempt to capture the semantic complexity of their mediated 
biological  processes.  Taking  the  example  of  the  trophic  fibroblast  growth 
factor 2 (FGF2) from the Wang and Costigan studies, we find it associated 
with the following terms:                                            
 
‘neurite morphogenesis (GO:0048812)’ 
‘activation of MAPK activity (GO:0000187)’ 
‘nuclear translocation of MAPK (GO:0000189)’ 
‘positive regulation of transcription (GO:0045941)’ 
 
The term ‘neurite morphogenesis (GO:0048812)’ specifies the type of cellular 
activity undertaken by FGF2 as part of the nervous system response to injury, 
presumably referring to the process of axonal elongation that allows injured 
neurons to regain contact with the target. The rest of the terms provide insights 
into the intracellular  molecular processes that drive neurite  morphogenesis. 
Thus, it appears that FGF2 acts by activating the key MAP kinase, which once 
transported to the nucleus induces the transcriptional activity within the cell 
body  of  injured  neurons,  presumably  leading  to  the  synthesis  of  essential 
growth material for the growing axon. 
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4.3.2.1.  Cluster gene overlap analysis 
  
As reflected by FGF2, the dependencies between biological processes from 
varying  biological  complexity  levels  are  revealed  in  the  context  of  gene 
function.  Thus,  we  looked  to  find  genes  common  between  pairs  of  GOC 
clusters across the hierarchy of biological process classes outlined in table 
4.3.4 in order to characterise the functional dependencies between them. In 
particular, by revealing how biological processes from the different levels in 
the hierarchy may in turn take part in more complex processes from higher 
levels,  this  analysis  enabled  us  to  reach  a  better  understanding  of  the 
biological  significance  of  the  generic  GOC  clusters  (from  the  molecular, 
subcellular  and  cellular  levels)  by  ultimately  associating  them  with  either 
major  system  processes  induced  following  injury  to  the  peripheral  nerve 
(being neuronal/neurological and inflammatory/immune systems).   
 
Since genes may be associated with terms that are not functionally related; 
either due to erroneous annotations or because they capture different functions 
mediated by the same gene in different biological contexts, the occurrence of 
genes annotated with terms from two clusters may not necessarily imply a 
functional association between them. On the other hand, we would expect two 
functionally  related  clusters  to  show  an  amount  of  gene  overlap  that  is  
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significantly higher than an unrelated pair of clusters. This was investigated by 
calculating the gene overlap from all possible pairs of clusters from within and 
across  the  different  classes  of  biological  processes  outlined  in  table  4.3.4. 
Moreover, for the gene overlap value to be comparable across all cluster pairs, 
it was normalised for the sizes of clusters within the pairs. This was done by 
expressing the gene overlap as a fraction of the total gene count from both 
clusters in the pair. Examination of the resulting distribution of gene overlap 
values revealed that a value of 0.1 may be a reasonable significance threshold 
as only 20% of all possible cluster pairs scored a higher value. The results 
from the gene overlap analysis for all cluster pairs are shown in table 4.3.5.   
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  Transport 
0006810 
metabolic 
process 
0008152 
Signal 
transduction 
0007165 
Cellular 
component 
organization 
and 
biogenesis 
0016043 
Cell 
adhesion 
0007155 
cell cycle 
process 
0022402 
apoptosis 
0006915 
nervous 
system 
development 
0007399 
Neurological 
system 
process 
0050877 
immune 
system 
process 
0002376 
behavior 
0007610 
inflammatory 
Response 
0006950 
Transport 
0006810  103  (0.05) 16  (0.06) 15  (0.15) 26  (0.01) 2  (0.02) 3  (0.04) 6  (0.13) 20  (0.14) 22  (0.07) 10  (0.04) 5  (0.01) 2 
metabolic process 0008152    177  (0.10) 31  (0.03) 8  (0.02) 4  (0.02) 5  (0.07) 16  (0.12) 28  (0.03) 8  (0.12) 28  (0.05) 11  0 
signal transduction 0007165      129  (0.04) 8  (0.03) 5  (0.07) 10  (0.14) 24  (0.11) 20  (0.11) 21  (0.07) 13  (0.08) 13  (0.02) 3 
Cellular component 
organization 
and biogenesis 0016043 
      66  (0.07) 6  (0.05) 5  (0.14) 15  (0.12) 14  (0.04) 5  (0.03) 3  (0.03) 3  (0.03) 3 
Cell adhesion 
0007155          22  (0.02) 1  (0.03) 2  (0.11) 8  (0.01) 1  (0.16) 10  (0.04) 2  0 
cell cycle 
process 0022402            24  (0.04) 3  (0.13) 10  0  (0.10) 7  (0.02) 1  0 
Apoptosis 
0006915              38  (0.11) 10  (0.03) 3  0  (0.05) 3  (0.02) 1 
Nervous 
system development 0007399                51  (0.10) 10  (0.04) 4  (0.06) 5  (0.03) 2 
Neurological system 
process 
0050877 
                54  (0.01) 1  (0.13) 10         (0.03) 2 
immune  system 
process 0002376                    41  (0.07) 5  (0.14) 8 
Behavior 
0007610                      24  0 
Inflammatory 
Response 
0006950 
                     
13 
 
 
Table 4.3.5. Gene overlap analysis.  For each pair of clusters, the number of genes in common is given in absolute numbers and as a fraction of the total number of 
genes from both clusters (shown in between parentheses). A gene overlap amounting to a fraction that is greater or equal to 0.1 is considered significant (shown in 
red). For each cluster, the total number of genes is shown in green.  
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4.3.2.2. Cluster term overlap analysis 
 
In addition to gene overlap analysis, an ontology term overlap analysis was 
also conducted, again to investigate the functional dependencies between the 
various GOC clusters. Here, we check whether two clusters share the same 
ontology terms. We use the diagram on Figure 4.3.2 to illustrate the difference 
between the gene and term overlap analyses. Thus, the two clusters of terms in 
Figure 4.3.2, delimited by blue and  red dashed lines, feature two terms in 
common (shown in purple) which constitute their term overlap. As for the 
gene overlap, there are 5 genes in common to both clusters (shown in bold and 
underlined); these are NPY, FGF, GDNF, ATF3 and BDNF.  
 
 
 
 
 
 
 
 
 
 
Figure 4.3.2. Diagram illustrating the gene and term overlap analyses between clusters of terms. Two 
clusters are visible on the diagram: clusters 1 and 2 delimited by dashed lines in blue and red respectively. 
Terms in blue correspond to cluster 1 whilst those in red correspond to cluster 2. Terms in purple are shared 
between the two clusters. Genes are shown below the terms that annotate them. Importantly, a gene may be 
annotated  with  two  different  terms  from  different  clusters.  Genes  likewise  shared  between  clusters  are 
indicated in bold and underlined. 
ATF3, 
BDNF 
GDNF 
NPY 
NPY  BAX 
FGF 
FGF  CALCA 
   
Cluster 1  Cluster 2  
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Importantly, overlap in terms between clusters implies overlap in genes as the 
terms  and  the  genes  annotated  with  them  are  collectively  shared  by  the 
clusters. The opposite is not true since the same genes could be associated 
with different terms from two clusters. The reason why we opted to use the 
term overlap analysis in addition to the gene overlap analysis despite the fact 
that the latter is implied by the former is that where the gene overlap between 
two clusters falls below the significance threshold, the existence of a common 
term would re-establish the evidence for a functional association between the 
two clusters.  
  
The  rational  behind  using  the  term  overlap  analysis  to  trace  functional 
relationships  between  different  GOC  clusters  is  that  ontology  terms  from 
deeper  levels  in  the  GO  graph  are  more  granular,  reflecting  additional 
functional  details  that  may  uncover  unanticipated  links  with  higher-order 
functions. For instance, the term ‘Notch signalling pathway involved in neuron 
fate  commitment  (GO:0021880)’  depicts  the  involvement  of  the  Notch 
signalling pathway in the process of neuron fate commitment. The term in 
question  is  common  to  the  ‘signal  transduction  (GO:0007165)’  and  the 
‘nervous system development (GO:0007399)’ GOC clusters (Fig 4.3.3) from 
the molecular and system classes respectively. Importantly, the term appears 
to relate to the root term from the ‘signal transduction (GO:0007165)’ cluster  
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via a chain of ‘is a’ type of relationships while it links to the ‘nervous system 
development  (GO:0007399)’  cluster  via  a  ‘part  of’  relationship.  This 
illustrates  the  essence  of  the  term  overlap  analysis,  whereby  functional 
associations  between  GOC  clusters  from  varying  levels  of  biological 
complexity (outlined in table 4.3.4) are revealed by means of identifying terms 
from clusters from low complexity levels whose functionality is inherently 
partial to higher-order biological processes from clusters from higher levels.    
 
The  term  overlap  analysis  was  based  on  identifying  gold  standard  terms 
common to pairs of clusters but could have been also targeted at the overlap in 
the progeny of gold standard terms from the two clusters, since child terms are 
semantically indicative of their parents in the gene ontology. This applies to 
the previous example: term ‘Notch signalling pathway involved in neuron fate 
commitment  (GO:0021880)’,  which  is  not  a  gold  standard  term  itself  but 
which inherits two gold standard parent terms: the ‘Notch signalling pathway 
(GO:0007219)’  and  the  ‘neuron  differentiation  (GO:0030182)’  from  the 
‘signal  transduction  (GO:0007165)’  and  the  ‘nervous  system  development 
(GO:0007399)’ clusters respectively (Fig 4.3.3).  
 
The occurrence of a common term between clusters can only arise from a 
functional link between them. As such, unlike the gene overlap analysis, we  
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did not need to infer any significance from the number of common terms. It 
follows that the term overlap measure is expressed in an absolute rather than a 
relative fashion. The results from all cluster pairs are shown in table 4.3.6.  
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Figure 4.3.3. Relationships between low and high level biological processes captured as ‘part-of' relationships in GO. Child terms common to the ‘signal 
transduction   (GO:0007165)’ cluster, the ‘cellular component organization & biogenesis (GO:0016043)’ cluster (both clusters marked in grey boxes) and the ‘nervous 
system development (GO:0007399)’ cluster from the more complex biological system class are shown. Importantly, these common children terms are associated with 
the higher order nervous system development process via ‘part-of’ relationships (shown in dashed lines). Nodes in color represent the gold standard set of terms whilst 
those transparent are the ancestors of the gold standard terms. A color scheme was applied to indicate the term study occurrence for the gold standard terms (red, 
orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on each node. Clusters were truncated to show only parents 
to common child terms.   
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0006950 
Transport 
0006810  54  0  0  16  0  0  0  0  4  0  0  0 
metabolic process 0008152    140  0  10  0  0  1  0  4  5  0  0 
signal transduction 0007165      62  0  0  0  8  0  0  0  0  0 
Cellular component 
organization 
and biogenesis 0016043 
      56  0  1  6  2  0  0  0  0 
Cell adhesion 
0007155          9  0  0  0  0  0  0  0 
cell cycle 
process 0022402            8  0  0  0  0  0  0 
Apoptosis 
0006915              20  0  0  0  0  0 
Nervous 
system development 0007399                25  2  0  0  0 
Neurological 
process 
0050877 
                27  0  0               0 
immune  system 
process 0002376                    39  0  4 
Behavior 
0007610                      17  0 
Inflammatory 
Response 
0006950 
                      8 
Table 4.3.6. Term overlap analysis.  The table shows the number of gold standard terms shared by pairs of clusters. The occurrence of term overlap is indicated in 
red. The total number of gold standard terms from each cluster is shown in green.  
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The results from the term and gene overlap analyses complemented each other 
in  a  variety  of  ways.  Where  there  were  term  overlap  and  significant  gene 
overlap  between  two  clusters  from  the  varying  biological  process  classes 
outlined in table 4.3.4, the ontological terms in common were examined to 
reveal details about the nature of functional association between the clusters in 
the pair. Taking the example of the ‘signal transduction (GO:0007165)’ and 
the  ‘nervous  system  development  (GO:0007399)’  clusters,  a  significant 
proportion  of  genes  seems  to  be  in  common  between  them  indicating  a 
functional interrelationship. Exactly which signalling pathways are involved in 
which  neuronal  processes  is  partly  revealed  by  the  terms  common  to  both 
clusters.  Thus,  as  shown  in  Figure  4.3.3,  a  number  of  signalling  pathways 
seem  to  be  involved  in  the  process  of  neuron  differentiation  that  occurs 
following  nerve  injury  including  the  BMP,  Notch,  Wnt  and  the  fibroblast 
growth factor signalling pathways.  
 
Sometimes,  two  clusters  may  show  an  overlap  in  gene  content  that  is 
significant  enough  to  suggest  a  functional  link  between  their  encapsulated 
functions, yet no terms are found in common between them.  In other words, 
the two clusters show a significant gene overlap but no term overlap. In this 
case, the functions of the genes in common are examined to determine the 
nature of functional relationships between the clusters. The opposing scenario  
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is where clusters show an overlap in constituent terms, but score no significant 
gene overlap. This occurs when the number of genes annotated to the common 
terms amounts to a minor fraction of the clusters total gene count. Here the 
functional  link  between  clusters  is  evident  from  the  term  overlap  analysis 
alone. 
 
4.3.2.3.   Interpretation of cluster biological significance 
 
As mentioned before, the purpose of the gene and term overlap analyses was 
to  expose  the  relationships  between  GOC  clusters  of  processes  featuring 
varying levels of biological complexity and ultimately associate the generic 
clusters  from  lower  complexity  levels  with  clusters  encapsulating  complex 
system processes that are biologically specialised. Interestingly, the gene and 
term overlap analyses also indicate relationships between clusters from the 
same  biological  class.  From  a  biological  point  of  view,  the  relationships 
among  the  system  processes  clusters  are  important  as  they  highlight  the 
functional  integration  of  varying  biological  systems  during  the  response  to 
peripheral  nerve  injury.    One  example  is  how  the  inflammatory  state  that 
builds  up  shortly  following  injury  triggers  and  maintains  the  immune 
response.  
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In the following sections, we review the functional significance of the GOC 
clusters  while  highlighting  the  functional  relationships  between  them  as 
revealed by the gene and term overlap analyses. We follow a top to bottom 
approach:  clusters  from  the  system  processes  class  are  discussed  first, 
followed by those from the cellular, subcellular and finally the molecular class 
range. 
 
4.3.2.3.1.   System process clusters 
 
Among  the  GOC  clusters  featuring  system  processes,  we  begin  with  those 
underlying the neuronal response to injury: the ‘nervous system development 
(GO:0007399)’ and the ‘neurological system process (GO:0050877)’ clusters. 
There is a tight relationship between the two functions as revealed by the gene 
and term overlap analyses (tables 4.3.5 & 4.3.6); which is logical in the sense 
that  changes  to  nerve  cells  have  direct  consequences  on  the  signalling 
processes they mediate. 
 
The  ‘nervous  system  development  (GO:0007399)’  cluster  (Fig  4.3.4-A) 
captures the changes that affect the varying cell types within the DRG tissue 
following  injury.  Thus,  for  the  injured  neurons,  we  find  terms  involved  in 
repair activities whereby the lost part of the axon is replaced in order to regain  
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contact with target territories: example terms are ‘axonogenesis GO:0007409’ 
referring  to  the  process  of  axonal  growth  and  ‘axon  ensheathment 
GO:0008366’ whereby the growing axon is covered with structural myelin 
from differentiated schwann cells. Other types of cells include Schwann and 
satellite glial cells, which seem to undergo differentiation following injury as 
revealed  by  the  term  ‘glial  cell  differentiation  (GO:0010001)’.  Indeed,  the 
differentiation of Schwann cells is an essential part in the process of myelin 
formation whereas glial satellite cells that move to surround injured neurons in 
the DRG following injury are thought to differentiate into neurons to replace 
those lost by apoptosis (Scholz and Woolf, 2007).   
 
The ‘neurological system process (GO:0050877)’ cluster describes alterations 
to signal transmission processes following injury to the axon and the resulting 
effects on sensory perception functions. The plasticity in synaptic transmission 
underlined in part by a change in the level and type of neurotransmitters and 
their  receptors  peripherally  following  injury  (captured  in  the  ‘neurological 
system  process  (GO:0050877)’  cluster,  Fig  4.3.4-B)  serves  to  sensitise  the 
central nervous system resulting in a net enhancement in sensory functions to 
noxious and non-noxious stimuli as well as spontaneous aberrant sensations 
such as neuropathic pain.  
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Pain is likely to affect certain aspects of behaviour in the injured animal such 
as  sleep,  feeding,  mobility  and  social  behavior;  these  processes  are  all 
captured  under  the  ‘behavior  (GO:0007610)’  cluster  (Fig  4.3.4-C).  The 
relationship between the ‘neurological system process (GO:0050877)’ cluster 
and the ‘behavior (GO:0007610)’ cluster is confirmed by the gene overlap 
analysis (table 4.3.5). 
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  Figure 4.3.4-A. Clusters from the gold standard terms induced subgraph: ‘nervous system development (GO:0007399)’. Nodes in color represent the gold 
standard set of terms whilst those transparent are the ancestors of the gold standard terms. A color scheme was applied to indicate the term study occurrence for the 
gold standard terms (red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on each node. Nodes in color 
feature additionally the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 2003; Wang et 
al., 2002; Xiao et al., 2002) and the literature survey from (Costigan et al., 2002) respectively). 
A  
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  Figure 4.3.4-B. Clusters from the gold standard terms induced subgraph: ‘neurological system process (GO:0050877)’. Nodes in color represent the gold standard 
set of terms whilst those transparent are the ancestors of the gold standard terms. A color scheme was applied to indicate the term study occurrence for the gold standard 
terms (red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on each node. Nodes in color feature additionally 
the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 2003; Wang et al., 2002; Xiao et al., 2002)
and the literature survey from (Costigan et al., 2002)  respectively). 
 
B  
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Figure 4.3.4-C: Clusters from the gold standard terms induced subgraph: ‘behavior (GO:0007610)’. Nodes in color represent the gold standard set of 
terms whilst those transparent are the ancestors of the gold standard terms. A color scheme was applied to indicate the term study occurrence for the gold 
standard terms (red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on each node. Nodes in 
color feature additionally the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 
2003; Wang et al., 2002; Xiao et al., 2002) and the literature survey from (Costigan et al., 2002) respectively). 
c  
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Beside neuronal cell types, the DRG tissue contains immune cells, which tend 
to  increase  in  number  following  injury  to  the  nerve.  The  bulk  of  immune 
processes  induced  within  the  DRG  following  peripheral  nerve  injury  is 
captured under the ‘immune system process (GO:0002376)’ cluster (Fig 4.3.4-
D). Such processes consist of differentiation and proliferation of immune cells 
such  as  T-cells  and  macrophages  as  well  as  antigen  processing  and 
presentation, complement activation and immunoglobulin deployment.  
 
The immune response local to the DRG is sustained by an inflammatory state 
induced  by  the  release  of  proinflammatory  cytokines  by  invading 
macrophages following injury. The inflammatory process is captured under 
the  ‘inflammatory  response  (GO:0006954)’  cluster  (Fig  4.3.4-E).  The 
interplay between the inflammatory and immune processes is well manifested 
by the gene and term extent of overlap (tables 4.3.5 & 4.3.6) between the 
‘inflammatory  response  (GO:0006954)’  and  the  ‘immune  system  process 
(GO:0002376)’ clusters. Among the genes in common to the ‘inflammatory 
response  (GO:0006954)’  and  the  ‘immune  system  process  (GO:0002376)’ 
clusters are, of course, key cytokines.  
 
Interestingly,  proinflammatory  cytokines  have  a  well-established  role  in 
signalling injury to neurons via activation of numerous intracellular signalling  
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pathways ultimately altering the transcriptional activity in favour of growth 
and  repair.  In  the  reverse  direction,  there  is  evidence  in  the  literature  that 
suggests induction of expression of cytokine interleukin-6 in sensory neurons 
following injury, which serves to sustain the inflammatory state and related 
immune processes in the DRG tissue, in what could constitute a feedback loop 
mechanism.    However,  such  intermingling  of  neuronal  and 
inflammatory/immune processes is not captured by the gene and term overlap 
analyses,  probably  because  it  only  occurs  under  abnormal  pathological 
conditions which is outside the scope of the GO.   
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Figure 4.3.4-D. Clusters from the gold standard terms induced subgraph: ‘immune system process (GO:0002376)’. Nodes in color represent the gold standard set 
of terms whilst those transparent are the ancestors of the gold standard terms. A color scheme was applied to indicate the term study occurrence for the gold standard 
terms  (red,  orange,  yellow,  green,  blue  for  5,4,3,2,1  study  counts  respectively).  The  term  name  and  accession  are  given  on  each  node.  Nodes  in  color  feature 
additionally the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 2003; Wang et al., 2002; 
Xiao et al., 2002) and the literature survey from (Costigan et al., 2002) respectively). Occasionally, labels from transparent nodes were hidden for picture clarity. 
 
D  
 
 
  159
 
 
 
 
 
 
 
 
 
Figure 4.3.4-E. Clusters from the gold standard terms induced subgraph: ‘Inflammatory reponse(GO:0006954)’. Nodes in color represent the gold 
standard set of terms  whilst those transparent are the ancestors of the gold standard terms.  A color scheme  was applied to indicate the term study 
occurrence for the gold standard terms (red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on 
each node. Nodes in color feature additionally the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 
2002; Valder et al., 2003; Wang et al., 2002; Xiao et al., 2002) and the literature survey from (Costigan et al., 2002) respectively). 
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4.3.2.3.2.   Cellular process clusters 
 
Among the 14 GOC clusters, 3 were representative of cellular processes: these 
are  the  ‘apoptosis  (GO:0006915)’,  ‘cell  cycle  (GO:0022402)’  and  the  ‘cell 
adhesion  (GO:0007155)’  clusters  (Fig  4.3.4-F&G&H).  Intuitively,  cellular 
processes are indicative of the changes affecting the varying cell types within 
the  DRG  tissue  following  injury  to  the  nerve.  For  us  to  understand  the 
significance of these cellular processes in the context of the biology of nerve 
injury, we refer to the results from the term and gene overlap analyses for 
pairs  of  clusters  from  the  cellular  and  system  classes.  For  instance,  there 
appears  to  be  a  significant  proportion  of  genes  common  to  the  ‘apoptosis 
(GO:0006915)’ and the ‘nervous system development (GO:0007399)’ clusters 
(table  4.3.5).  One  example  is  the  BAXA_RAT  (apoptosis  regulator  BAX, 
membrane  isoform  alpha)  gene  annotated  with  both  terms  ‘apoptosis 
(GO:0006915)’ and ‘neuron fate determination (GO:0048664)’. As such, we 
conclude that the apoptotic process is associated with the neuronal cell type, 
which may be a biologically valid statement since it has been postulated in the 
literature  that  a  proportion  of  DRG  neurons  undergo  apoptosis  following 
axonal damage when failing to mount an effective repair reaction to injury.  
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With the ‘cell cycle (GO:0022402)’ cluster, the gene overlap analysis (table 
4.3.5) indicates a link to the ‘nervous system development (GO:0007399)’ as 
well as the ‘immune system process (GO:0002376)’ clusters, suggesting that 
cells from both the nervous and immune systems show increased cell cycle 
activity following nerve damage. This is plausible in the view that the cell 
cycle  is  at  the  heart  of  cell  proliferation  and  differentiation  processes 
important for both the maintenance of the immune response as well as the 
repair activities mounted by the nervous system following injury, mainly the 
differentiation  of  Schwann  cells  to  form  myelin  and  the  probable 
differentiation of satellite cells into neurons. 
 
Similarly, the cell adhesion function appears to be adopted by both immune 
and  nerve  cell  types.  The  significance  of  the  cell  adhesion  process  to  the 
physiology of the nervous system following nerve injury is captured by the 
gene overlap analysis (table 4.3.5) and can be illustrated by the example of the 
TSP4_RAT (Thrombospondin 4 precursor) gene, which encodes an adhesive 
glycoprotein that mediates cell to cell matrix interaction, a process that is vital 
for axonal pathfinding during neurite growth. As for the immune system, the 
term  ‘leukocyte  adhesion  (GO:0007159)’  illustrates  the  applicability  of  the 
cell adhesion function to immune cell types. This is further demonstrated by 
the gene overlap analysis where a significant proportion of genes appears to be  
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common to the ‘cell adhesion (GO:0007155)’ and the ‘immune system process 
(GO:0002376)’  clusters  (table  4.3.5).  
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Figure 4.3.4-F. Clusters from the gold standard terms induced subgraph:  apoptosis (GO:0006915). Nodes in color represent the gold standard set of terms 
whilst those transparent are the ancestors of the gold standard terms. A color scheme was applied to indicate the term study occurrence for the gold standard terms
(red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on each node. Nodes in color feature additionally 
the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 2003; Wang et al., 2002; Xiao et al., 
2002) and the literature survey from (Costigan et al., 2002) respectively). 
F  
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Figure 4.3.4-G&H. Clusters from the gold standard terms induced subgraph: (G) cell adhesion (GO:0007155), (H) cell cycle process (GO:0022402). Nodes in 
color represent the gold standard set of terms whilst those transparent are the ancestors of the gold standard terms. A color scheme was applied to indicate the term study 
occurrence for the gold standard terms (red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on each node. 
Nodes in color feature additionally the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 2003; 
Wang et al., 2002; Xiao et al., 2002) and the literature survey from (Costigan et al., 2002) respectively). 
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4.3.2.3.3.   Subcellular process clusters 
 
The next level in the classification (table 4.3.4) is that of subcellular processes. 
The ‘cellular component organization and biogenesis (GO:0016043)’ cluster 
(Fig  4.3.4-I)  was  alone  affiliated  to  this  class.  In  the  gene  ontology,  the 
‘cellular component organization and biogenesis (GO:0016043)’ term refers to 
the processes that lead to the formation, arrangement of constituent parts, or 
disassembly of cellular components. Both the term and gene overlap analyses 
(table  4.3.5  &  4.3.6)  indicate  a  strong  association  between  the  ‘cellular 
component  organization  and  biogenesis  (GO:0016043)’  and  the  ‘nervous 
system  development  (GO:0007399)’  clusters.  Importantly,  the  process  of 
axonal  elongation  following  injury  entails  a  morphological  change  that 
involves  membrane  biogenesis  and  organisation  of  membrane  proteins  and 
channels. Furthermore, the retrograde transport of signalling molecules to the 
nucleus  as  well  as  the  opposite  anterograde  transport  of  axonal  growth 
substances  towards  the  growing  end  of  the  axon  require  cytoskeletal 
organisation  and  biogenesis.  As  for  neurons  that  commit  to  apoptosis,  the 
cellular  component  structural  diassembly  as  well  as  the  apoptotic 
mitochondrial  changes  are  all  a  form  of  subcellular  processes;  hence,  the 
significant  gene  overlap  with  the  ‘apoptosis  (GO:0006915)’  cluster  (table 
4.3.5).   
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Figure  4.3.4-I.  Clusters  from  the  gold  standard  terms  induced  subgraph:  ‘cellular  component  organization  and  biogenesis 
(GO:0016043)’. Nodes in color represent the gold standard set of terms whilst those transparent are the ancestors of the gold standard 
terms. Some of the transparent nodes were reduced in size for image clarity. A color scheme was applied to indicate the term study 
occurrence for the gold standard terms (red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and 
accession are given on each node. Nodes in color feature additionally the study ID where the term or any of its progeny appear (study ID 
1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 2003; Wang et al., 2002; Xiao et al., 2002) and the literature survey from  
(Costigan et al., 2002) respectively). 
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4.3.2.3.4.   Molecular process clusters. 
 
At the fourth tier of our cluster classification, outlined in table 4.3.4, lie those 
clusters representing core molecular functions that serve to support the cellular 
and  higher  system  processes  induced  following  nerve  injury.    These  core 
functions  appear  in  the  following  clusters:  the  ‘signal  transduction 
(GO:0007165)’,  ‘transport  (GO:0006810)’  and  ‘metabolic  process 
(GO:0008152)’ clusters. 
 
The ‘signal transduction (GO:0007165)’ cluster, shown in Figure 4.3.4-J, is an 
encapsulation of the chain reaction initiated by the interaction of an outside 
signal with membrane receptors, which causes a change in the level or activity 
of  a  second  messenger  or  other  downstream  target,  ultimately  effecting  a 
change  in  the  functioning  of  the  cell.  In  the  context  of  nerve  injury,  the 
variety of signals that build up at the site of the lesion and locally within the 
DRG are transduced to neuronal and non-neuronal cell bodies via a number of 
intracellular cascades ultimately inducing a change in the cell transcriptional 
activity. Examples are the JAK-STAT cascade, the MAPKKK cascade, the 
NF-kappaB  cascade  and  the  cytokine/chemokine  mediated  signalling 
pathways, all captured under the ‘signal transduction (GO:0007165)’ cluster.  
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As elaborated in the introduction section, the transduction of injury related 
signals may result in the induction of apoptotic signalling cascades; hence the 
link  to  the  ‘apoptosis  (GO:0006915)’  cluster.  Indeed,  the  term  ‘apoptotic 
process  (GO:0008632)’  and  descendents  are  common  to  both  the  ‘signal 
transduction  (GO:0007165)’  and  ‘apoptosis  (GO:0006915)’  clusters  as 
revealed by the term overlap analysis (table 4.3.6) whilst the gene overlap 
analysis indicates a significant fraction of genes in common to both clusters 
(table 4.3.5). 
 
Interestingly,  the  shifts  in  cellular  transcriptional  activity  that  result  from 
transduction of injury related signals lead to de novo or increased synthesis of 
additional signalling molecules that help recruit further signalling pathways. 
One example is BMP or bone morphogenesis protein whose pathway appears 
to be critical for the generation of neurons during development (Fig 4.3.3), but 
which may also be involved in generating neurons, following injury, to replace 
those lost by apoptosis. Other signalling metabolites include neurotransmitters 
such  as  glutamate  and  tachykinin  that  play  a  role  in  enhancing  synaptic 
transmission  at  the  junction  with  the  dorsal  horn,  leading  to  central 
sensitisation  mechanisms  that  underlie  many  of  the  abnormal  sensations 
following nerve injury such as hyperalgesia, allodynia and chronic pain. In 
accordance  with  these  observations,  there  exists  significant  gene  overlap  
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between  the    ‘signal  transduction  (GO:0007165)’  cluster  and  the  ‘nervous 
system  development  (GO:0007399)’  as  well  as  the  ‘neurological  system 
process (GO:0050877) clusters’ from the system process class (table 4.3.5).  
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Figure 4.3.4-J. Clusters from the gold standard terms induced subgraph: signal transduction (GO:0007165). Nodes in color represent the gold standard set of terms 
whilst those transparent are the ancestors of the gold standard terms. Some of the transparent nodes were reduced in size for image clarity. A color scheme was applied to 
indicate the term study occurrence for the gold standard terms (red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are 
given on each node. Nodes in color feature additionally the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; 
Valder et al., 2003; Wang et al., 2002; Xiao et al., 2002) and the literature survey from (Costigan et al., 2002) respectively). 
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One further GOC cluster from the molecular process class is the ‘transport 
(GO:0006810)’  cluster  (Fig  4.3.4-K).  From  the  gene  and  term  overlap 
analyses (tables 4.3.5 & 4.3.6 respectively), we find evidence of a functional 
link with the ‘neurological process (GO:0050877)’ cluster. Indeed, following 
injury,  ion  transport  mechanisms  are  enhanced  as  well  as  the  uptake  and 
secretion of neurotransmitters, which has a profound impact on the excitability 
of nerve cells peripherally and centrally.  
 
In addition, the transport function appears to play a role in processes affecting 
the nervous tissue following injury as there appears to be a significant number 
of genes in common to the ‘transport GO:0006810’ and the ‘nervous system 
development (GO:0007399)’ clusters. Effectively, the retrograde transport of 
signalling molecules from the site of the lesion to the nucleus is the primary 
mechanism  for  altering  the  transcriptional  activity  in  the  cell  of  injured 
neurons  to  assist  with  growth  and  repair  whilst  the  anterograde  transport 
guarantees the supply of growth material to the growing end of the axon.  
 
The gene and term overlap analyses also reveal an association between the 
‘transport GO:0006810’ cluster and the ‘cellular component organization and 
biogenesis (GO:0016043)’ cluster from the subcellular process class, which is  
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only  logical  given  that  the  transport  function  is  fundamental  for  the 
organization and localisation of cellular components.  
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Figure 4.3.4-K. Clusters from the gold standard terms induced subgraph: transport (GO:0006810). Nodes in color represent the 
gold standard set of terms whilst those transparent are the ancestors of the gold standard terms. Some of the transparent nodes were 
reduced in size for image clarity. A color scheme was applied to indicate the term study occurrence for the gold standard terms (red, 
orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on each node. Nodes in 
color feature additionally the study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 
2002; Valder et al., 2003; Wang et al., 2002; Xiao et al., 2002) and the literature survey from (Costigan et al., 2002) respectively). 
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The  last  cluster  in  the  molecular  process  class  is  the  ‘metabolic  process 
(GO:0008152)’  cluster.  Upon  damage  to  the  axon,  neurons  shift  their 
metabolism to achieve the molecular repertoire that can support the nature of 
the  response  to  injury.  These  shifts  affect  a  wide  range  of  biological 
molecules:  lipids,  nucleobase  and  nucleic  acid,  proteins,  amino  acids  and 
carbohydrates. From the gene and term overlap analyses (tables 4.3.5 & 4.3.6 
respectively), the metabolic function appears to be associated with most higher 
levels processes including the ‘nervous system development (GO:0007399)’ 
process, the ‘neurological process (GO:00550877)’ and the ‘immune response 
(GO:0002376)’ process.  
 
Upregulation of lipid synthesis serves in part to supply the growing axonal 
membrane with lipid structural constituents in addition to other types of lipids 
such as steroids and prostaglandins associated with the inflammatory/immune 
response (Fig 4.3.4-L).  At the DNA level, injury results in a net enhancement 
in transcriptional activity through activation of transcription factors such as 
NFκB. Furthermore, the DNA replication machinery is also induced to assist 
with the proliferation of glial and immune cells. Apoptosis on the other hand 
entails metabolic fragmentation of the DNA (Fig 4.3.4-L).   
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Figure 4.3.4-L. Clusters from the gold standard terms induced subgraph : metabolic process (GO:0008152), 
showing  only  the  ‘nucleic  acid  metabolic  process’  and  ‘lipid  metabolic  process’  parts.  Nodes  in  color 
represent the gold standard set of terms whilst those transparent are the ancestors of the gold standard terms. Some 
of the transparent nodes were reduced in size for image clarity. A color scheme was applied to indicate the term 
study  occurrence  for  the  gold  standard  terms  (red,  orange,  yellow,  green,  blue  for  5,4,3,2,1  study  counts 
respectively). The term name and accession are given on each node. Nodes in color feature additionally the study 
ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et 
al., 2003; Wang et al., 2002; Xiao et al., 2002) and the literature survey from (Costigan et al., 2002) respectively). 
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Another category of metabolic changes induced upon axonal injury (Fig 4.3.4-
M) is that affecting proteins.  Growth associated proteins, neurotransmitters 
and cytokines are all examples of proteins that get overexpressed following 
injury, in addition to amino acid derivative neurotransmitters (Fig 4.3.4-N). 
The  activity  of  proteins  is  modulated  by  upregulation  of  posttranslational 
modification  machinery  within  the  cell.  An  example  is  the  process  of 
phosphorylation that serves to activate key signalling kinases (Fig 4.3.4-M).  
Furthermore, there are changes to the metabolism of carbohydrates (Fig 4.3.4-
N). Such changes are required to support the energy-consuming processes that 
are induced upon axonal injury, such as the cell cycle as well as the antero-
retrograde forms of molecular transport that occur across the proximal part of 
the axon. 
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Figure 4.3.4-M. Clusters from the gold standard functional dataset: metabolic process (GO:0008152), showing the ‘protein  metabolic process’ part only. 
Nodes in color represent the gold standard set of terms whilst those transparent are the ancestors of the gold standard terms. Some of the transparent nodes were 
reduced in size for image clarity. A color scheme was applied to indicate the term study occurrence for the gold standard terms (red, orange, yellow, green, blue for 
5,4,3,2,1 study counts respectively). The term name and accession are given on each node. Nodes in color feature additionally the study ID where the term or any of its 
progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 2003; Wang et al., 2002; Xiao et al., 2002) and the literature survey from 
(Costigan et al., 2002)  al respectively). 
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Figure 4.3.4-N. Clusters from the gold standard functional dataset: metabolic process (GO:0008152), showing the ‘carbohydrate  metabolic process’ and the 
‘amino acid and derivatives metabolic process’ parts only. Nodes in color represent the gold standard set of terms whilst those transparent are the ancestors of the gold 
standard terms. Some of the transparent nodes were reduced in size for image clarity. A color scheme was applied to indicate the term study occurrence for the gold standard 
terms (red, orange, yellow, green, blue for 5,4,3,2,1 study counts respectively). The term name and accession are given on each node. Nodes in color feature additionally the 
study ID where the term or any of its progeny appear (study ID 1,2,3,4,5 correspond to (Costigan et al., 2002; Valder et al., 2003; Wang et al., 2002; Xiao et al., 2002) and 
the literature survey from (Costigan et al., 2002) respectively). 
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The  above  discussion  of  functional  links  between  the  GOC  clusters  has 
certainly not captured the full extent of the functional intermingling between 
the varying biological processes induced upon damage to the peripheral nerve. 
However, it does have the benefit of hinting at the significance of each cluster 
of  processes  with  respect  to  the  overall  response.  A  summary  of  the 
relationships  between  the  GOC  clusters  from  the  designated  classes  of 
biological processes, outlined in table 4.3.4, is presented in Figure 4.3.5.     
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4.4.   Conclusion 
 
To summarise, this chapter used the GO framework to capture knowledge of 
functions that show enrichment following peripheral nerve injury. This was 
achieved  by  deriving  the  set  of  GO  term  annotations  of  genes  that  were 
reported to show a change in expression following injury to the peripheral 
nerve in a number of published studies. This set of terms, which we refer to as 
the gold standard set of terms, is of particular importance to this work, as it 
will be used in chapter VI to evaluate the results from functional analysis of a 
spinal nerve transection expression dataset by the LPC. 
 
Because genes are often annotated with a number of GO terms in order to 
capture the full extent of their functions, stripping terms of their genes has the 
drawback of flattening the association between them that arise in the context 
of gene function. In this work and in order to reveal the biological significance 
of  the  gold  standard  terms,  originally  derived  from  candidate  genes  from 
published studies, we used the gene and term overlap analyses to trace the 
associations between clusters of these gold standard terms. 
  
From  a  biological  perspective,  it  was  interesting  to  note  how  the 
reprogramming of the transcriptional activity within the DRG tissue, following  
4. A Gene ontology based model of the functional characteristics of peripheral     
neuropathy 
     4.4. Conclusion 
 
 
 
  182
injury to the nerve, affects a complex network of functions, some of which are 
non-neuronal in origin. This is because the DRG tissue compromises a number 
of different cell types: neurons, glial and immune cells. This suggests that 
using  microarray  expression  profiling  technology  with  animal  models  of 
neuropathy, in the traditional sense, to study particular pathological aspects 
such  as  pain  is  rather  limited.  But  this  can  be  optimised  with  intelligent 
experimental design and powerful datamining approaches to allow the most 
relevant information to be obtained. 
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4.5.   Appendices 
 
4.5.1.   The gene ontology categoriser: GOC 
 
In this work, we used the GOC algorithm to categorise the gold standard terms 
by the broad sense of their encapsulated functions. In the context of GO, this 
translates  into  finding  the  most  appropriate  parent  term  for  a  subset  of 
functionally related gold standard terms that preserves the essence of their 
functions. In effect, the process of ontology term categorisation is governed by 
two opposing criteria: specificity and coverage. For instance; considering the 
model  graph  shown  below  (Fig  4.5.1):  the  parent  term  ‘A’  is  the  most 
representative of all query terms (shown in green), yet semantically it is less 
specialised  than  parent  ‘F’,  which  in  turn  covers  less  query  terms  than  its 
predecessor ‘A’. 
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Figure  4.5.1.  A  model  ontology 
graph.  Nodes  d,  e,  j,  k,  l  are  the 
targets  for  the  categorisation 
process;  in  other  words,  the  query 
terms. 
  
4. A Gene ontology based model of the functional characteristics of peripheral     
neuropathy 
     4.5. Appendices  
 
 
 
  184
The GOC mathematical model for ontology term categorisation captures this 
interplay between coverage and specificity and is here described. During the 
categorisation process, for any given parent term, GOC measures the distance 
to each of the query child terms. In its simplest form, the distance is taken to 
be equal to the number of edges connecting the parent to the child term via the 
shortest  path.  The  distance  measure,  given  by  the  symbol  δ  in  the  GOC 
equation  (shown  below),  is  taken  by  GOC  as  an  indication  of  the  parent 
specificity as the more distal the parent is from query child terms, the closest it 
gets to the root hence the least specific it becomes. As such, δ is inversely 
correlated with specificity, which explains the use of the reciprocal of δ in the 
GOC equation: 
 
S(p) =  Σ c’∈ C  1/(      (c’, p) + 1)       
(1) 
 
 
Essentially, for a given parent term p and the set of query terms it subsumes C, 
a score S(p) is given based on the sum of the reciprocal of δ from each query 
term c’ belonging to the set C raised to power 2
s; where s is a user-defined 
parameter. The significance of power s is that by altering the magnitude of the 
specificity indicator δ, it provides a mechanism to adjust the balance between 
specificity and coverage. 
 
δ δ δ δ 
2
s  
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Consider the case of parent ‘F’ and the more distal parent ‘A’ from the model 
graph, the common query child ‘j’ is further away from ‘A’ than ‘F’ (and so 
are  ‘k’  and  ‘l’);  hence,  δ(A,  j)  is  greater  than  δ(F,  j).  A  positive    power    s     
inflates δ(A, j) further with respect to δ(F, j) causing the reciprocal 1/δ(A,j) 
s to be 
even smaller than 1/δ(F,j) 
s the larger s gets. As such, a positive power s has the 
effect of amplifying variation in δ; the effect is more dramatic when using 2
s, 
as featured in the GOC equation.  
 
A negative value of s has the opposite effect in that it acts to suppress the 
differences  in  δ.  This  is  because  raising  δ  to  2
s  where  s  is  negative,  is 
mathematically equivalent to taking the (2
s)th root of δ where s is the 
absolute value of s. Contrary to power transformation, a root transformation 
causes  data  to  shrink,  reducing  larger  data  to  greater  extents;  thereby 
minimising the gap between large and small values. As such, δ(A,j)        is closer 
to  δ(F,j)       the more negative is the value of s. 
 
Just how the power transformation of δ serves to adjust the balance between 
coverage and specificity needs further clarification. Going back to the case of 
the general parent ‘A’ and the more specialised ‘F’ from the model graph, the 
overall scores for both parents are the following respectively: 
2
s 
2
s  
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            S(A) =  Σ c∈ {d,e,j,k,l}  1/(        (c, A) + 1)        
  S(F) =  Σ c∈ {j,k,l} 1/(        (c, F) + 1)        
 
The more negative is s, the smaller are the           from any parent-child pair 
causing  the  sum;  in  other  words,  the  final  score  to  become  increasingly 
governed by the number of individual             contributions from query child 
terms; rather to the advantage of parent ‘A’ as it subsumes more query terms 
than ‘F’. As such, negative s emphasizes coverage. On the other hand, the 
more positive is s, the larger the          from common children ‘j’, ‘k’ and ‘l’ 
for parent ‘F’ than ‘A’; ultimately, overcoming the additional contributions 
from children ‘d’ and ‘e’ exclusive to ‘A’ thereby causing the score from ‘F’ 
to rise above that from ‘A’. As such, positive s emphasizes specificity. 
 
Indeed, in table 4.5.1, we see the actual GOC scores for parents ‘A’, ‘C’ and 
‘F’ from GOC analysis of the model graph shown above for a range of values 
s = {-1,0,1,2}. The very general parent ‘A’ scores the best when s is set to a 
negative value. Moving to positive values of s, there is a shift towards more 
specialised  parents  beginning  by  ‘C’  at s  =  1  and  finishing  with  the  most 
specific parent ‘F’ at the highest value s = 3.   
δ 
2
s 
δ 
2
s 
1/δ 2
s 
1/δ 2
s 
1/δ             2
s  
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Table 4.5.1. Highlighting the different clustering results by GOC while varying ‘s’. 
Results obtained from running GOC on the model graph on Fig 4.5.1 
 
  s = -1  s =0  S =1  s =2 
‘A’  1.84  1.27  0.61  0.14 
‘C’  1.63  1.30  0.9  0.58 
‘F’  1.32  1.16  0.9  0.61 
The top GOC score from each round is shown in red 
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CHAPTER V:  A GO SEMANTIC SIMILARITY METRIC 
TO MEASURE THE SIMILARITY BETWEEN  
GO TERMS 
 
 
5.1.   Aim of the chapter  
 
This chapter aims to introduce some of the aspects of the methodology used in 
the following chapter to validate the GO functions found enriched in a spinal 
nerve transection (SNT) microarray dataset against the set of gold standard 
terms discussed in the previous chapter. In  particular,  the chapter explores 
ways for comparing these two sets of GO functions by means of deriving a 
measure that expresses the semantic similarity between terms in the GO graph.  
 
The outline of the chapter is as follows: First, a review of existing theories for 
measuring the semantic similarity between GO terms is presented. Then, we 
introduce a novel approach, developed as part of this work, that expresses the 
similarity level between two GO terms based on the ontological ‘records’ of 
their immediate common ancestor. The last part of the chapter evaluates the  
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performance of the proposed method against one widely used GO semantic 
similarity approach in the literature.  
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5.2.   Introduction 
 
The GO ontology is a mesh of interconnected terms representing biological 
functions  organized  into  a  hierarchical  structure,  similar  to  a  taxonomy, 
whereby each term is in one or more parent-child relationships to other terms 
in the ontology. In GO, parent terms provide an abstraction of the meaning of 
their child terms. For any given term in the ontology, a series of increasingly 
general  abstractions  of  the  term’s  semantics  is  reflected  by  consecutively 
occurring ancestor terms on the paths leading from the term to the root of the 
ontology.  Such  decomposition  of  function  semantics  by  GO  offers  the 
opportunity to capture similarities between the various functional terms in a 
measurable format. 
 
The notion of semantic similarity was originally developed for taxonomies. 
For example, the earliest studies looking at quantifying conceptual semantic 
similarity were mostly targeted at the WordNet (Fellbaum, 1998), which is a 
lexical  taxonomy  for  the  English  language.  Two  major  approaches  for 
estimating  semantic  similarity  were  soon  presented,  one  that  explored  the 
hierarchical  structure  of  the  taxonomy  and  one  based  on  the  idea  of 
information content. 
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Rada and colleagues presented one of the first instances of semantic similarity 
measures based on the structure of a medical taxonomy (Rada and Bicknell, 
1989).  In  their  work,  the  similarity  between  two  terms  was  based  on  the 
distance in edges linking them along the shortest path, where the smaller the 
distance the higher the similarity. A major drawback from this approach is that 
it makes the assumption that edges denote equal semantic distances, which 
seems  to  be  a  poor  assumption  with  taxonomies.  Resnik  and  colleagues 
pointed  out  this  problem  and  proposed  an  alternative  method  to  quantify 
semantic  similarity  (Resnik,  1995).  The  new  approach  was  based  on  the 
concept  of  information  content  whereby  the  usage  frequency  of  a  term’s 
semantics  is  evaluated  within  a  corpus,  which  implies  counting  the 
occurrences of the term and its children. The ratio of this occurrence value to 
the total number of occurrences of all terms in the taxonomy indicates the 
term’s  probability  of  occurrence.  The  term’s  information  content  value  is 
defined as the negative log of its probability of occurrence value (-log P).   
 
The  Resnik  conceptualisation  of  information  content  is  intuitive  in  that 
frequent terms with high probability of occurrence feature small information 
content  values,  capturing  the  fact  that  they  are  least  informative.  Also,  it 
logically follows the structure of the taxonomy in that the further down in the 
tree  the  higher  the  information  content  value;  owing  to  the  fact  that  the  
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probability of occurrence value from children terms can only be smaller or 
equal to that from their parents. 
 
In  the  work  by  Resnik,  the  idea  of  using  information  content  to  measure 
semantic similarity is  based on the assumption that two concepts  are most 
similar if they share much information between them, which is essentially the 
information content of their immediate common parent. Thus, given two terms 
c1 and c2, the similarity between them is given by the information content of 
the lowest common parent C0 that subsumes them both: 
 
       sim(c1,c2) = −log P(C0)                           (1) 
 
In 1998, Lin suggested an alternative for incorporating information content 
into a semantic similarity metric (Lin, 1998). The new theory was that the 
extent of similarity between two concepts is better evaluated when considering 
the  differences  between  them.  In  the  formal  model  by  Lin,  the  semantic 
similarity measure is defined as the ratio between the information in common 
to the two concepts (which expresses the similarity between them) and the 
bulk  of  information  needed  to  describe  each  of  them  as  a  whole  (which 
accounts for the differences in addition to the similarities in their semantics). 
In  a  taxonomy  domain,  it  is  defined  as  the  ratio  between  the  information  
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content  of  the  lowest  common  parent  and  the  sum  of  information  content 
values from the two terms being compared: 
 
                                2logP(C0)                                              (2) 
                log P(c1) + log P(c2) 
    
One further contribution to the theory of semantic similarity was  made by 
Jiang (Jiang and Conrath, 1997). The Jiang model followed a combinatorial 
approach that uses both information content as well as path distances within 
the taxonomy structure. The idea was that both approaches have strengths and 
weaknesses  and  could  consolidate  each  other  if  used  in  a  complementary 
fashion.  Thus,  the  information  content  approach,  although  theoretically 
plausible, shows a strong dependency on the chosen corpus and may display 
poor  sensitivity  at  the  very  bottom  of  the  taxonomy  tree.  This  is  because 
highly specialised terms may not occur in the corpus, which implies that an 
information content value may not possibly be derived for such terms. The 
distance approach on the other hand is intuitive and is equally applicable to all 
nodes in the tree structure, though it is sensitive to the problem of varying 
edge weights.       
 
sim(c1,c2) =  
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Essentially, the Jiang method is an optimisation of the shortest path distance 
metric whereby a mechanism is devised to adjust for variable edge weight. 
Thus, instead of treating edges homogenously by simply adding their number 
along the path, the Jiang method assigns a weight to each edge on the path 
based on the difference in information content values of the parent and child 
node linked by that edge (Fig 5.2.1). This is rather intuitive in the sense that if 
a parent and a child are semantically close to each other, the difference in their 
information content values should be small. The overall distance between two 
concepts is given as the summation of edge weights along the shortest path 
separating  the  corresponding  nodes  in  the  tree  structure  (illustrated  in  Fig 
5.2.1); which after mathematical simplification is reduced to equation (3). The 
smaller the distance, the higher the similarity between the terms.  
 
                Dist(c1,c2) = 2 * log P(C0) – (log P(c1) + log P(c2))                     (3) 
 
 
 
 
   
 
 
c1 
c4 
C0 
c2 
c3  c5 
Fig  5.2.1.  Illustration  of  the  Jiang  similarity 
metric. The weight of an edge is defined as the 
difference between the information content values 
of the parent term and the child term connected 
by the edge. Thus, the weight from edge (c1->c4) 
is given as (-log P(c1) + log P(c4)). On the other 
hand, the distance between two terms is given as  
the sum of edge weights along the shortest path. 
Thus, for the pair of terms (c1 & c2) featuring the 
shortest path (c1->c4->C0->c2), dist(c1,c2) = (-
log P(c1) + log P(c4)) + (-log P(c4) + log P(C0)) 
+  (-log  P(c2)  +  log  P(C0)),  which  after 
simplification reduces to equation (3) from above.  
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One common problem to the Lin and Jiang models is that the similarity score 
between  two  terms  is  based  on  assessing  their  information  content  values 
relative to that from their common ancestor while taking no account of the 
location of the common ancestor on the graph. This could be problematic at 
close proximity to the root. This is because at high levels in the GO graph, 
terms have general meanings and hence small information content values. This 
implies  that  the  information  content  values  from  a  pair  of  terms  and  their 
common ancestor at this level in the GO graph are equally small and may not 
significantly  differ  from  each  other,  which  results  in  an  artificially  high 
similarity value. This is rather misleading as semantically broad terms cannot 
possibly be similar to each other.  
 
Lord and colleagues were the first to use the information content approach to 
measure semantic similarity between GO terms (Lord, 2003). In their study, 
the Resnik, Lin and Jiang metrics were used to compute semantic similarities 
between GO terms, based on the occurrence frequency of individual GO terms 
in  the  SwissProt  database.  To  validate  the  suitability  of  these  similarity 
measures for GO, Lord explored one important tenet of biology, which is the 
association between sequence similarity and functional conservation. Thus, for 
all pairs of proteins from the SwissProt database, sequence similarity scores 
were obtained using BLAST. As for the functional similarity scores, because  
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proteins are often annotated with a number of terms, for each protein pair, an 
average similarity score was derived from all possible pairs of terms from the 
two  proteins.  Importantly,  Lord  concluded  that  the  Resnik’s  functional 
similarity scores were the most correlated with the sequence similarity scores 
for pairs of proteins, though the correlation level was no higher than 0.577.   
 
In  the  recent  evaluation  study  by  Pesquita  and  colleagues  (Pesquita  et  al., 
2008), the performance of the Resnik, Lin and Jiang similarity measures was 
re-evaluated, similarly by examining the correlation with sequence similarity 
scores from pairs of proteins. Importantly, the study explored different ways 
of deriving a unique similarity value for each pair of proteins; including taking 
the  average  similarity  value  from  all  combinations  of  terms  from  the  two 
proteins  (Lord,  2003)  as  well  as  considering  the  maximal  similarity  value 
(Sevilla et al., 2005). A third approach, also known as the best-match average 
approach, consisted of pairing each term from the first protein with its best 
match  from  the  second  protein  and  vice  versa,  then  deriving  an  average 
similarity value (Couto et al., 2007; Schlicker et al., 2006). 
 
In agreement with the conclusion by Lord (Lord, 2003), the Resnik measure 
proved the best, in particular when used with the best-match average summary 
approach  for  pairs  of  proteins.  The  same  study  investigated  two  other  
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similarity measures that have the distinctive feature of directly calculating a 
unique similarity value for a given pair of proteins. The first of these measures 
is the simUI by Gentleman (Gentleman, 2005) where for any given pair of 
proteins and associated terms including ancestral terms, the similarity value is 
simply  the  ratio  between  the  number  of  terms  in  common  and  the  overall 
number of terms from both proteins. This novel approach was extended by 
Pesquita  to  include  the  information  content  values  of  individual  terms 
(Pesquita et al., 2008). The new method or simGIC, is based on calculating the 
ratio between the sum of information content values for the terms in common 
to the sum of information content values from all terms from both proteins. 
Pesquita reports an improvement using simGIC in comparison to Resnik/best-
match average approach. 
 
The use of information content has certainly improved our ability to measure 
semantic similarity between concepts including GO functional terms. Though, 
one popular view is that the ontology structure is equally relevant and should 
also be considered. Beyond using path distances,  more successful  methods 
have recently emerged that deploy the structure of the ontology to measure 
semantic similarity between GO terms. One such method was proposed by 
Wang and colleagues (Wang et al., 2007). The method defines the similarity 
between two terms by the extent of contribution of common ancestral terms to  
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their semantics whilst the contribution of an ancestor term to a  child term 
semantics is defined as the product of weights of edges in the path to the child. 
Edge weights are generally uniform throughout the GO graph but are slightly 
higher for ‘is a’ than ‘part of’ relationships.  In cases where there are multiple 
paths to the child, the maximum score from all paths is taken to indicate the 
contribution of the ancestor to the child semantics.  
 
Thus, taking the example of the child ‘GO:0043231’ from the GO cellular 
component subgraph shown in Figure 5.2.2, choosing an edge weight value of 
0.8  for  ‘is  a’  (solid  lines)  versus  0.6  for  ‘part  of’  (dashed  lines)  types  of 
relations  and  measuring  the  semantic  contributions  from  parents 
‘GO:0043229’ and ‘GO:0005623’, we find that the former scores 0.8 whereas 
the latter scores 0.288 = (0.8*0.6*0.6); conforming to the fact that the latter is 
an earlier ancestor and hence contributes less to the semantics of the child. 
Thus, this model features the basic idea that the more edges separating the 
child term from its ancestor, the less the contribution of the ancestor to the 
child’s semantics.  
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In the Wang method, the similarity between two terms is given as the ratio 
between the sum of semantic contributions from their common ancestors to 
the  sum  of  semantic  contributions  from  all  ancestors  of  both  term.  This 
captures the logic that the more representative are the common ancestors of 
the terms’ semantics, the more similar the terms are. Thus, given two terms A 
and B, and their set of ancestor terms TA and TB respectively, the similarity 
between them is given as: 
 
 
Figure 5.2.2. A model GO subgraph. Edges in 
solid and dashed lines represent ‘is a’ and ‘part 
of’ relationships respectively.  
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                                  ∑         ( SA(t) + SB(t) ) 
                              (t∈TA∩ TB)                            
                                                                                  (4)                                                 
∑   SA(t)   +   ∑  SB(t) 
                                 (t∈TA)                 (t∈Tb) 
 
where SA(t) denotes the contribution of ancestor ‘t’ to the semantics of child A. 
 
To adapt their similarity metric to proteins, Wang and colleagues adopted the 
best-match  average  approach.  Using  pathway  gene  annotations,  they 
demonstrated  how  their  similarity  measure  correlated  better  than  Resnik’s 
with  human  perception  of  the  extent  of functional  association  between  the 
varying  reactions  in  a  pathway.  For  instance,  genes  mediating  the  same 
reaction in a pathway are expected to be annotated with more similar terms 
than those taking part in parallel or alternative reactions in the pathway. 
     
The advantage of the Wang similarity approach is that it takes account of the 
terms strength of relationships with their ancestors. Thus, unlike the Resnik 
method  where  different  pairs  of  terms  would  score  an  identical  similarity 
value  if  they  share  the  same  most  specialised  ancestor,  the  Wang  score  is 
sensitive  to  the  location  of  each  term  in  the  pair  on  the  GO  graph.  One 
limitation to the Wang approach, also common to the Lin and Jiang methods, 
is the artificially high similarity values at close proximity from the root. This 
sim(A,B) =      
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is because at high levels in the GO graph, terms are usually subsumed by a 
small number of fairly general ancestors. Thus, for any pair of terms, common 
ancestors  (although  with  broad  semantics)  may  appear  to  contribute 
significantly  to  the  semantics  of  the  terms  relative  to  the  remaining 
contributions by few other general ancestors unique to each term (equation 4). 
Perhaps, one extreme example is that of terms ‘Organelle GO:0043226’ and 
‘Cell GO:0005623’ from the model graph shown in Figure 5.2.2. The two 
terms have a unique common ancestor ‘GO:0005575’, which is also the only 
ancestor  for  each  of  them.  As  such,  their  similarity  value  using  the  Wang 
metric (equation 4) would be equal to 1, which is the highest possible value. 
Thus, although these two terms are clearly distinct from each other, they turn 
out to be highly similar according to the Wang metric.   
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5.3.   The GOTrim similarity measure 
 
5.3.1.   Theoretical basis 
 
In this work, we propose a new strategy that explores the GO structure to 
quantify  the  semantic  similarity  between  GO  terms.  Our  method  is 
fundamentally similar to the Resnik approach in that the similarity between 
two  terms  is  indicated  by  the  level  of  specificity  of  their  common  most 
specialised  ancestor.  Though,  instead  of  using  information  content  as  an 
indicator of the semantic specificity of the common ancestor, we derive such 
value from the structure of the ontology. 
 
Our  idea  for  measuring  specificity  is  based  on  the  fact  that  the  semantic 
granularity  of  an  ontology  term  is  the  result  of  a  gradual  semantic 
specialisation process effected by the chain of consecutive ancestor terms on 
the path(s) from the root to the term in the ontology. As such, the specificity of 
a term can be estimated by combining the amount of semantic specialisation 
contributed by each of its ancestor terms.  
 
We define the extent of semantic specialisation by an ancestor term relative to 
the total semantic space captured in the whole of the ontology as the ratio of  
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the ancestor progeny terms to the total number of terms in the ontology. This 
follows the logic that at each ancestor term, the whole range of biological 
functions in GO is restricted to the semantics of the function of the ancestor 
term, which include functional subtypes expressed by all of its descendent 
terms.    Moreover,  along  any  given  path  from  the  root,  moving  from  one 
ancestor to the next one down features the selection of increasingly smaller 
subsets of progeny terms, which allows our method to capture the increase in 
semantic specialisation by each consecutive ancestor in turn along the path. 
This is illustrated in the diagram in Figure 5.3.1. 
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Figure  5.3.1.  Diagram  illustrating  the  process  of  gradual  semantic 
specialisation  effected  by  the  chain  of  ancestral  terms  of  a  given  child 
term. The latter is indicated by a black rectangular box. The path from the root 
to the child term is indicated with bold edges. Moving from one graph to the 
next corresponds to selecting consecutive ancestor terms along the path and 
their progenies (in red). Progressively smaller subsets of progeny terms appear 
for  sequential  ancestors  reflecting  the  progressive  increase  in  semantic 
specialisation along the path.  Numbers indicate the order of ancestor terms 
beginning by the root.  
1 
2 
3 
4  
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The specificity of a given term is then given as the aggregate of the extent of 
semantic specialisation at each ancestor term in the path from the root to the 
term. Thus, given a term t and the set of all its ancestors (together referred to 
as  At),  the  specificity  spf  of  term  t  is  the  cube  root  of  the  sum  of  the 
reciprocals of the ratios of the number of progeny terms to the total number of 
ontology terms for all ancestral terms in set At: 
 
    spf t =  (  ∑    (1/(n at /N)   )
1/3                                                   (5) 
                                  (at ∈ At) 
 
where nat  is the number of progeny terms for ancestor at  and N is the total 
number of terms in GO. Ratios are inversed so that ancestors furthest from the 
root featuring smaller subsets of progeny terms contribute more weight to the 
final specificity score.  The cube root transformation is applied to shrink the 
overall sum so that the specificity scores from all terms cover a confined range 
of  values  (we  chose  to  use  a  root  transformation  as  oppose  to  a  log 
transformation because the former is more linear than the latter and appeared 
to yield similarity values for randomly selected portions of the GO graph that 
were most intuitive).  
 
Our proposed semantic specificity metric from equation (5) features a number 
of important characteristics. First, by combining the ratios from all ancestor  
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terms  by  taking  their  sum,  the  final  score  is  influenced  by  the  individual 
semantic specialisation ‘merits’ of ancestor terms and not solemnly governed 
by  the  number  of  these  ancestor  terms,  as  would  have  been the  case with 
taking the product of these ratios. Thus, analysing the relationship between 
specificity scores calculated, according to equation 5, for all terms from the 
GO biological process ontology and the number of their ancestor terms (Fig 
5.3.2), we find indeed that terms with a similar number of ancestors may show 
a broad range of specificity scores, as indicated by the scatter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Another important feature of our proposed semantic specificity metric  is that the 
specificity score from any child term in the ontology can only be higher than the 
score from any of its parent terms. This is because the child term would feature at 
Figure  5.3.2.  The  relationship 
between  the  specificity  scores 
of  terms  from  the  GO 
biological process ontology and 
the  number  of  their  ancestor 
terms. The scatter indicates that 
the  specificity  scores  are  not 
solely determined by the number 
of ancestor terms.    
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least one more ancestor than its parents. Furthermore, our specificity metric has the 
benefit of allowing specificity scores from all terms in the ontology to be compared 
in  a  meaningful  way.  This  is  so  because  the  specificity  scores  for  all  terms  are 
derived  from  measuring  the  extent  of  semantic  specialisation  by  ancestor  terms 
relative to the same point of reference; that is the overall semantic space given by the 
total number of terms in the ontology. 
 
To further illustrate the GO semantic specificity metric proposed in this work, we 
present a snapshot of a portion of the GO graph and label the terms therein with their 
calculated  specificity  scores  (Fig  5.3.3).  As  expected,  along  any  given  path,  the 
specificity score increases the further we get from the root, reaching a maximum 
value of 9.39 at the leaf term ‘axonogenesis (GO:0007409)’ at the bottom of the 
graph.  
  
 
 
 
 
 
 
 
    
 
 
 
  
5. A GO semantic similarity metric to measure the similarity between GO 
terms 
    5.3. The GOTrim similarity measure                                  
 
 
 
  208
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  5.3.3.  A  portion  of  the  GO  graph  featuring  the  specificity  scores  of  the  terms 
attached as labels to the nodes representing the terms.    
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We now explain how the proposed specificity scores are used to derive the 
semantic similarity between GO terms. As previously mentioned and rather 
similar  to  Resnik’s,  we  define  the  similarity  between  two  terms  as  the 
maximal  specificity  value  from  their  common  ancestors.  Thus,  given  two 
terms a and b, the similarity between them Sim is the specificity score Spf of 
their common ancestor C: 
 
      Sim(a,b)=  Spf(C)                                        (6) 
 
            where C is the common ancestor with the highest specificity score. 
 
 
We shall refer to the proposed similarity measure as the GOTrim similarity 
measure since the specificity of the common ancestor is derived on the basis 
of  accumulating  the  extents  of  successive  trimming  of  GO  by  the  set  of 
predecessor terms of the common ancestor.  
 
5.3.2.   Evaluation of the GOTrim method 
 
To evaluate the performance of the GOTrim similarity method developed as 
part of this work, we compared it to the Resnik method, which formed the  
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current ‘state of the art’ method at the time the work was being performed. 
This  follows  the  benchmarking  strategy  adopted  by  methods  developed 
subsequent  to  Resnik,  such  as  the  more  highly  performing  Wang  and  the 
simGIC similarity methods outlined in the introduction section.  
 
Thus, we compared the semantic similarity scores obtained with each method 
for pairs of GO biological process terms. However, since with both methods, 
the similarity score for a pair of terms is derived on the basis of the specificity 
score  of  the  terms’  immediate  common  ancestor,  we  first  compared  the 
specificity  scores  from  all  terms  by  each  method.  To  obtain  the  Resnik 
information  content-based  specificity  scores,  we  used  the  yeast  genome 
database as the body of information and measured the frequency of individual 
GO biological process terms associated with the gene entries in the database. 
This frequency value was transformed into an information content (IC) value 
via a log transformation, as described in the introduction section. Although a 
log2 transformation was used instead of the natural log to make sure that the 
Resnik (IC) and GOTrim specificity scores span similar ranges of values and 
may hence be compared against each other.  
 
The result from comparing the Resnik (IC) and GOTrim specificity scores is 
shown  on  Figure  5.3.4-a.  The  regression  line  suggests  that  two  scores  are  
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reasonably  correlated  in  the  sense  that  they  tend  to  increase  together. 
However,  the  fact  that  the  regression  line  appears  to  be  shifted  to  the  left 
indicates  that  the  IC  specificity  scores  are  on  average  higher  than  their 
GOTrim counterparts. This is also evident from examining their distributions 
(Fig  5.3.4-C&D),  where  there  appears  to  be  a  strong  skewing  in  the 
distribution of the IC specificity scores towards higher values.  
 
Next, the similarity scores for pairs of terms were obtained with each method. 
The slightly higher specificity scores by the Resnik method result in similarity 
scores  that  are  occasionally  higher  than  those  obtained  with  the  GOTrim 
metric, as indicated by the scatter in Figure 5.3.4-b. Although, the regression 
analysis suggests that the bias is less dramatic with the pairwise similarity 
scores than with the specificity scores calculated for individual terms using 
this approach. 
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Figure 5.3.4. Comparison of Resnik (IC) and GOTrim methods. (A) A scatter plot of specificity scores. 
(B)  A scatter plot of similarity scores. The lowess regression is shown in red. (C) & (D) Show the 
distributions of the GOTrim and IC specificity scores respectively.  
A 
C 
C  D 
B  
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To investigate the source of bias observed with the IC specificity scores, we 
manually  examined  cases  showing  major  discrepancies  between  the  two 
methods,  which  corresponded  mostly  to  situations  where  the  IC  score 
indicated high specificity while the GOTrim score indicated low specificity. 
The term instances we looked at appeared to reflect a level of semantics that is 
better  captured  by  the  GOTrim  scores  while  the  IC  scores  appeared  to  be 
rather exaggerated. For instance, the term "negative regulation of neurological 
process (GO:0031645)" appears to have a significant IC score (=13.28 out of a 
range of 1 to 14.5) when it clearly has broad semantics; on the other hand, its 
GOTrim score (=5.01) is certainly more believable. One other example is the 
term ‘regulation of cell projection organisation and biogenesis (GO:0031344)’ 
which is given a high specificity score by the IC approach (=13.08) and a 
more reasonable score of 5.96 by the GOTrim method.      
 
To further confirm the exaggeration in the specificity scores by the Resnik IC 
approach,  we  correlated  the  terms  specificity  scores  obtained  with  each 
method with their shortest path distances from the root. Whilst the latter is no 
accurate measure of specificity since, as discussed in the introduction section, 
it ignores the problem of varying edge weights at different levels in the GO 
graph, it may serve as a rough indicator of specificity. Thus, terms only few 
edges away from the root can only have broad semantics whilst those furthest  
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from the root are likely to be more specialised. The results appear in Figure 
5.3.5.  
 
 
 
 
 
 
 
 
 
 
 
 
As a general trend, the GOTrim specificity scores correlate better with the 
shortest path lengths for the varying terms than the IC-based specificity scores 
(Fig  5.3.5).  This  may  seem  rather  expected  since  the  GOTrim  specificity 
scores are partly influenced by the number of ancestral terms and hence the 
number of edges on the path(s) to the root. However, one striking observation 
is that some of the closest terms to the root appear to have extremely high IC-
based specificity scores (corresponding to the data points on the top left hand 
A  B 
Figure 5.3.5. Terms specificity scores versus the length of their shortest paths to the root. (A) Resnik 
(IC). (B) GOTrim. Lowess regression lines appear in red.  
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corner of the plot in Fig 5.3.5-A); which is rather illogical as these terms can 
only have broad semantics. This further confirms the occasional exaggeration 
of term specificity scores by the Resnik IC-based approach. 
 
The explanation for the occasional flaws with the IC approach for measuring 
GO  terms  semantic  specificity  may  lie  in  the  fact  that  the  level  of 
representation of a term in a corpus functional database is not an absolute 
attribute  of  the  term  specificity  as  it  may  potentially  be  influenced  by  a 
number  of  other  factors.  For  instance,  the  extent  of  scientific  interest  in 
characterising the molecular basis of varying biological functions differs and 
as such, a term may be associated with a relatively significant number of genes 
because the function it embodies has been of general interest and hence widely 
investigated.  By  contrast,  terms  encapsulating  fairly  general  functions  may 
turn out to be associated with fewer numbers of genes because their functions 
have  not  yet  been  studied  adequately.  In  addition,  we  know  that  some 
biological functions utilise multiple mechanisms and would naturally employ 
a larger set of genes unlike other functions that are effected by a fewer number 
of genes. This all suggests that our knowledge of gene associations with the 
various terms in GO does not always truly reflect the terms’ level of semantic 
specificity.   
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So far, we have evaluated the GOTrim  method with respect to the Resnik 
approach and attempted to link variations between the two methods to possible 
flaws with the Resnik metric.  However, in order to rigorously validate the 
performance of the GOTrim method, we studied the correlation between the 
method’s  derived  similarity  scores  for  pairs  of  yeast  proteins  and  their 
sequence similarity levels, thereby exploiting the tight relationship between 
sequence identity and functional conservation. This approach has traditionally 
been used for validation of most GO semantic similarity methods, as pointed 
out in the introduction section. 
 
Thus, protein sequences from the yeast genome were compared using BLAST 
to obtain sequence identity scores. The latter were based on the log reciprocal 
of the blast bit scores (LRBS) similar to the study by Pesquita and colleagues 
(Pesquita et al., 2008). Thus, for each pair of proteins A&B, the LRBS is the 
log of the average of the bit score from comparing A against B and B against 
A. It is probably worth mentioning that the BLAST bit score for a pair of 
sequences  is  a  measure  of  significance  that  takes  account  of  the  gaps  and 
substitutions in the query sequence when aligned against the target sequence 
and the higher the bit score, the higher the significance of the alignment from 
the two sequences. As such, the bit score for a pair of sequences changes  
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depending on which sequence in the pair is treated as the query and which is 
treated as the target.  
 
Because  proteins  are  often  annotated  with  more  than  one  GO  biological 
process term, we used the best-match average approach to deduce a summary 
GOTrim  similarity  value  for  each  protein  pair.  As  explained  in  the 
introduction  section,  with  this  approach,  each  term  from  one  protein  is 
matched with its most similar term from the other protein and vice versa; an 
average similarity value is then calculated to denote the summary similarity 
value for the protein pair. 
 
For the sake of comparison, the Resnik semantic similarity scores for the same 
protein pairs were also calculated, similarly using the best-match approach, 
and correlated in a similar fashion with the corresponding LRBS. For both 
methods, the scatter of points from the correlation analysis was summarised by 
applying a lowess regression (Fig 5.3.6-A&B).  The correlation coefficients 
were found to be equal to 0.68 and 0.59 with the GOTrim and Resnik (IC) 
metrics respectively; thus indicating the superiority of the GOTrim approach. 
However,  the  shape  of  the  regression  line  indicates  that  the  relationship 
between the average semantic similarity and sequence similarity scores is not 
linear, which makes the use of correlation coefficients non-optimal.  
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This was also noted by Pesquita and colleagues (Pesquita et al., 2008) who 
suggested an alternative assessment criterion based on sensitivity, that is the 
extent to which, on average, variations in the sequence similarity scale are 
translated  into  the  semantic  similarity  scale.  This  relationship  is  precisely 
modelled by the regression analysis featuring in Figure 5.3.6-A&B. In Figure 
5.3.6-C,  the  regression  lines  from  the  sequence  similarity  and  semantic 
similarity correlation analysis, by both methods, are superimposed. Clearly, 
the  range  of  sequence  similarity  detected  by  either  method  is  the  same 
(roughly 2-3 LRBS). By contrast, this same range of sequence similarity is 
resolved into a higher range of semantic similarity by GOTrim than Resnik,  
(roughly  between  2-9  as  oppose  to  2-7  for  each  method  respectively); 
indicating higher sensitivity by the GOTrim method. 
 
To understand the significance of the range sensitivity criterion, one needs to 
consider a few important facts. First that the similarity scores by both methods 
span  a  similar  range  of  values  (between  0  and  12).  Also,  from  previous 
analysis (Fig 5.3.4-B), the similarity scores by Resnik were shown to be on 
average slightly higher than those by the GOTrim method for pairs of GO 
terms.  Despite  that,  the  average  sequence  similarity  score  by  the  GOTrim 
method appear to show steadily higher values than the Resnik method with 
bins of increasing LRBS scores. This indicates that the GOTrim similarity  
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scores are generally more accurate reflecting more consistently the true extent 
of semantic similarity between pairs of proteins than the Resnik IC similarity 
scores.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  5.3.6.  Correlation  of  the 
log reciprocal blast scores (LRBS) 
from  sequence  comparison  of 
yeast  proteins  arranged  in  pairs 
with their corresponding GOTrim 
(A)  and  Resnik  (B)    semantic 
similarity  scores.  The  lowess 
regression  appears  in  color.  In  C, 
the  regression  lines  from  both 
method  correlation  analyses  are 
overlaid. Dashed arrows indicate the 
range of semantic similarity by each 
method  capturing  variations  in 
sequence similarity. 
A  B 
C  
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5.4.   Discussion 
 
In this work, a GO semantic similarity measure was developed that explores 
the structure of the GO ontology. The basic idea behind the method is that the 
semantic similarity between GO terms may be measured on the basis of the 
extent  of  information  in  common  between  them,  captured  by  the  semantic 
specificity of their immediate common ancestor. The more information shared 
between terms, that is the more specialised the common ancestor, the higher 
the  similarity  between  them.  The  method’s  strategy  for  measuring  the 
semantic  specificity  of  the  common  ancestor  was  designed  to  explore  the 
‘history’ of semantic specialisation by predecessor terms from high up in the 
GO graph.  
 
The  advantage  of  the  GOTrim  method  is  that  because  it  uses  a  different 
approach to information content to measure the level of informativeness of 
individual terms, it avoids potential flaws with the information content based 
approach.  In  particular,  in  case  of  GO,  the  additional  factors  that  could 
influence a term’s level of association with genes in a corpus database other 
than the extent of specialisation of its encapsulated function. For example, the 
complexity  of  the  mechanism  involved  at  the  molecular  level  and  the 
rigorousness with which this mechanism has been investigated. Indeed, we  
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were able to show that the GOTrim method performs better than the IC based 
Resnik method. 
 
However, the GOTrim method has a number of drawbacks. First, its usage of 
the ontology structure makes it susceptible to the problem of varying term 
density across different parts of the GO graph. This is because the ontology is 
under a constant process of refinement and at any given point in time, some 
functions may be better annotated with terms than other functions.  Two more 
disadvantages of the method proposed, also shared by the Resnik approach, 
relate  to  the  fact  that  the  similarity  between  two  terms  is  taken  to  be  the 
specificity of their most specialised common ancestor. Thus, if the two terms 
being  compared  are  identical,  their  similarity  score  would  reduce  to  the 
specificity value of the immediate parent; the latter is a random value that 
gives no indication of the fact that the two terms are in fact identical.  
 
The other problem is that for any ancestor term, all pairs of terms for which 
this  same  ancestor  is  the  most  specialised  ancestor  would  have  the  same 
similarity  value  regardless  of  how  deep  down  they  come  from  in  the  GO 
graph. This could lead to a loss of useful information. For instance, looking at 
Figure  5.3.6  showing  the  correlation  between  semantic  and  sequence 
similarity for pairs of  yeast proteins, where highly similar proteins display  
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unexpectedly low semantic similarity scores, we cannot be sure whether this is 
due to the proteins being associated with completely different terms or to one 
of the proteins being annotated with a rather general term where the common 
ancestor is bound to have a low specificity value. 
 
Ironically, existing GO semantic similarity approaches that provide solutions 
to  this  last  problem,  which  both  our  method  as  well  as  the  Resnik  metric 
appear to suffer from, have their own different limitations. Thus, the Lin, Jiang 
and  Wang  approaches  are  sensitive  to  the  location  of  the  terms  being 
compared on the GO graph; yet, they all suffer from the problem of artificially 
high  similarity  values  at  close  proximity  from  the  root,  as  outlined  in  the 
introduction chapter.   
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CHAPTER VI:  A GO BASED FRAMEWORK FOR 
AUTOMATIC BIOLOGICAL ASSESSMENT OF 
MICROARRAY FUNCTIONAL ANALYSIS  
METHODS. 
 
6.1.   Introduction 
       
6.1.1.   Microarray functional analysis 
 
Following  the  low  level  analysis  of  microarrays  expression  data  whereby 
probeset intensities are processed to eliminate noise and inter-chip variation to 
yield  the  most  optimal  expression  levels  for  the  genes,  statistical  analysis 
usually follows to determine whether the expression levels of genes show any 
significant  change  between  biological  conditions.  The  outcome  from  such 
analysis is usually a substantial list of genes ranked by the statistical evidence 
for their differential expression. To extract useful biological information from 
such  lists  of  genes,  higher-level  analyses  can  be  applied.  For  example,  by 
clustering  the  genes  over  a  number  of  experimental  conditions  and 
reconstructing transcriptional networks to help identify key transcription factor 
coding genes. 
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One important form of high level microarray analysis is functional analysis. 
With functional analysis, the relevance of a functional theme with respect to 
the biological phenomenon investigated in the microarray study is determined 
on the basis of a coordinated behavior of mediating genes in response to the 
phenomenon. Such coordinated behavior is versatile and common examples 
are a concerted change in expression with respect to the normal state or a 
common  expression  profile  over  a  number  of  experimental  conditions 
exploring variations in a particular aspect of the phenomenon, usually detected 
by clustering analysis. In simple words, functional analysis may be defined as 
the study of enrichment of particular functional annotations among selected 
subsets  of  genes  grouped  on  the  basis  of  a  common  biologically  relevant 
feature such as differential expression, correlation with a phenotype of interest 
or common regulatory patterns.     
 
When applied to the list of ranked genes from statistical analysis, functional 
analysis is particularly useful as it helps reduce the resulting sheer amount of 
information  to  a  more  manageable  list  of  functional  categories,  while 
revealing the functional properties of the biological reaction involved. Also, 
functional  analysis  represents  an  improvement  from  traditional  gene-based 
statistical analysis approaches in that it helps highlight instances where genes 
exhibit individually modest changes in expression, but tend to change in a  
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coordinated  manner  as  a  group  of  genes  with  similar  function.  This  is 
important in situations where changes in gene expression are confined to a 
specific subtype of cells within the sampled tissue and may be compromised 
by dilution effects.  
 
One universal advantage of functional analysis is the fact that it helps suppress 
experimental  variation.  Microarray  data  are  known  to  be  influenced  by  a 
variety  of  experimental  factors  such  as  laboratory  equipment,  the 
experimenter’s handling of the experiment, the design of the chip and it is now 
well established in the literature that microarray experiments addressing the 
same biological question often show little gene-specific expression changes in 
common.  By  contrast,  functional  analysis  is  capable  of  highlighting 
similarities  between  independently  generated,  yet  biologically  equivalent 
microarray datasets, by focussing on functional groups of genes instead of the 
genes per se. Also, from the analysis point of view, it has been shown that the 
additional  variability  introduced  by  the  choice  of  the  low-level  analysis 
methods  for  microarray  data  may  be  suppressed  by  functional  analysis 
(Hosack et al., 2003). 
 
In the last ten years, many functional analysis tools have been made available 
to  the  microarray  research  community.  The  main  difference  between  these  
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tools lies in the statistical framework employed by each method to test for 
enrichment  of  gene  functional  categories.  In  addition,  these  methods  may 
display  varying  additional  features  in  order  to  enhance  their  usability.  For 
instance, many provide built-in functional groupings of genes and can handle a 
variety of gene identifiers. One example is FatiGO (Al Shahrour et al., 2004) 
that uses GO as a basis for classifying genes while maintaining links to major 
sequence  databases  such  as  GenBank,  Unigene,  Ensembl  and 
Swissprot/TrEMBL. In addition, many functional analysis tools have evolved 
to allow grouping of genes on the basis of functional vocabularies other than 
GO, common key terms and common biological properties. For instance, the 
revised  version  of  the  functional  analysis  tool  GSEA  (Subramanian  et  al., 
2005)  features  an  integrated  database,  the  Molecular  Signatures  Database 
MSigDB,  containing  gene  sets  derived  from  common  regulatory  motifs, 
chromosomal locations, functional attributes, in addition to common relevance 
to distinct biological states as postulated in literature and from knowledge of 
domain experts.   
 
At the statistical level, assessing the level of representation of a functional 
category c among a subset of selected genes g involves taking into account the 
full size of gene list G from which g was selected as well as the overall level 
of occurrence of category c in G given as C. The hypergeometric distribution  
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(Tavazoie et al., 1999) appropriately models the probability of occurrence of c 
in g by chance given G and C and has been largely used by pioneer functional 
analysis  tools  such  as  CLENCH  (Shah  and  Fedoroff,  2004),  Onto-Express 
(Khatri  et  al.,  2002),  FunSpec  (Robinson  et  al.,  2002)  and  FuncAssociate 
(Berriz et al., 2003). With many densely populated arrays, the hypergeometric 
probability is computationally expensive to calculate and an approximation to 
the binomial probability distribution was used additionally by a number of 
functional analysis methods such as CLENCH and Onto-Express.   
 
Good alternatives to the hypergeometric and binomial distribution statistics 
are  the  χ2  test  for  equality  of  proportions  used  by  CLENCH  and  Onto-
Express, as well as the Fisher’s Exact test used by FatiGO, GOstats (Falcon 
and Gentleman, 2007), GOminer (Zeeberg et al., 2003) and EASE (Hosack et 
al., 2003). These tests are based on a 2 x 2 contingency table specifying the 
observed proportion of genes attributed to c as well as those not attributed to c 
from the chosen subset of genes g and the remaining genes in the list G-g. The 
counts in the table are combined to yield the χ2 statistics for the χ2 test whilst 
the  Fisher’s  test  operates  by  means  of  calculating  the  hypergeometric 
probability of observing these counts. 
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Perhaps,  two  major  advances  in  developing  a  statistical  framework  for 
functional analysis have been the introduction of rank based procedures to 
evaluate enrichment in functions based on the ordering of genes according to a 
chosen ranking metric, as well as multiple testing correction. We shall discuss 
the latter before reverting to the former. Because many functional categories 
are typically tested at once during functional analysis of microarray data, some 
of them will score low p-values by chance alone. By applying multiple testing 
correction, the statistical significance of individual categories is adjusted for 
the size of the database of functional categories tested. Most of the earliest 
functional  analysis  methods  such  as  Onto-Express  and  FunSpec  paid  no 
attention  to  the  problem  of  multiple  testing.  However,  more  recent  tools 
adopted  some  form  of  multiple  testing  correction  procedures,  such  as 
controlling the FDR (Catmap, FuncAssociate..) and/or calculating the FEW 
family  wise  error  rate  as  with  GOCluster  and  GOstats  (more  details  on 
multiple  testing and  correction  procedures are available in  the introduction 
chapter).          
 
The incentive for introducing rank based statistics in functional analysis has 
been the recognition that with many pre-analyses, the relevance of genes is 
indicated by ranking them according to a chosen metric. Thus, unlike with 
many  clustering  approaches  where  subsets  of  jointly  regulated  genes  are  
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readily defined in a deterministic way, differential expression analysis often 
results  in  a  list  of  ranked  genes  where  the  change  in  expression  is  most 
important at the top of the list. With the earliest functional analysis approaches 
employing classical statistics, such as the Fisher’s test and the hypergeometric 
probability, the subset of relevant genes was typically filtered by applying an 
arbitrary cut-off on the list of ranked genes and choosing all genes above that 
cut-off. Such an approach is known to be limited because information from the 
list  below  the  cut-off  is  typically  lost  and  the  choice  of  the  cut-off  is  not 
obvious, in particular with noisy data. 
 
To address this issue, functional analysis procedures were designed to make 
direct use of gene ranks in their statistical framework and avoid selection of 
relevant  subsets  of  genes  beforehand.  The  first  of  such  methods  to  have 
emerged  were  FuncAssociate  and  GSEA.  FuncAssociate,  similar  to  IGA 
(Breitling  et  al.,  2004)  developed  a  year  later,  was  designed  around  the 
concept of minimizing a hypergeometric based probability of enrichment for 
individual categories by means of identifying the subset of genes in a category 
that cluster high at the top of the list.  Effectively, these methods strive to 
optimize a cut-off for each category individually (a full description of IGA 
will follow in section 6.1.2).  
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Along these lines, GSEA uses the Kolmogorov Smirnov rank based statistics 
to  assess  the  observed  versus  expected  ranks  of  category  members  in  the 
ranked list of genes. The test is performed by traversing the list from top to 
bottom and estimating, at each current position, the  cumulative fraction of 
genes  that  are  members  of  the  category  while  separately  calculating  the 
cumulative fraction of genes that are not members of the category. A score is 
then derived on the basis of the maximal difference between the two running 
fractions (see Fig 6.1.1). 
 
 
 
 
 
 
 
Figure 6.1.1. Picture taken from http://www.physics.csbsju.edu/stats/KS-test.html illustrating 
the Kolmogorov Smirnov test. In broad terms, the non-parametric KS-test is used to determine 
whether two datasets differ significantly (treatment versus control or in terms of functional analysis 
category membership versus non-membership) on the basis of cumulative fractions. This is illustrated 
in the plot above. The x-axis shows the actual data values from both datasets ranked on a log scale (in 
the case of functional analysis, the value of the gene ranking metric can be used). At any given rank, 
the cumulative fractions; in other words, the fractions of data from both datasets are given on the y-
axis. A score D is defined where the cumulative fractions from both datasets are most different from 
each other.  
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By using the Kolmogorov-Smirnov statistics, GSEA may thus be regarded as 
adopting a strategy of score optimization, similar to IGA and FunAssociate, 
since a category score may only be drawn at the point in the list where the 
cumulative fractions of category member genes and that of non-member genes 
are most distinct from each other.   
 
A rather different functional analysis rank based approach was later introduced 
by Breslin and colleagues (Breslin et al., 2004) in their functional analysis tool 
Catmap.  Catmap  does  not  select  a  subset  of  optimally  ranked  genes  in  a 
category; rather, it uses a comprehensively derived score that combines the 
ranks of all genes in the category. The score on its own does not reflect the 
significance  of  the  category  but  is  assigned  a  significance  level,  at  a  later 
stage, using permutation analysis.     
 
In this work, we assess the performance of the two major rank-based statistical 
approaches for functional analysis. We use IGA and GSEA as examples of the 
reductionist  approach,  whereby  ranks  from  only  a  subset  of  genes  in  a 
category are used to derive the score for the category. In addition, Catmap is 
taken  to  represent  the  more  global  approach,  which  uses  rank  information 
from all genes in the category. In the following, we discuss all three methods 
in more detail.  
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6.1.1.1.   Catmap 
 
To assess the significance of the ranks of all gene members in a category, 
Catmap calculates a summary score based on their sum, also known as the 
Wilcoxon rank sum. The significance of the score is then calculated as the 
probability p-value of obtaining a lower score for the category assuming the 
null  hypothesis.  The  simplest  null  hypothesis  is  one  based  on  randomly 
shuffling the genes in the gene list; which is equivalent to having the genes in 
the category assigned random ranks.   
 
However, this null hypothesis assumes independency in gene expression level 
in  individual  biological  samples;  which  is  incorrect  considering  that  genes 
may  be  co-expressed.  The  Catmap  algorithm  recommends  a  different  null 
hypothesis based on sample label permutation, whereby random gene lists are 
obtained from fold change statistical analysis of randomly labelled samples. 
Such  null  hypothesis  is  considered  more  suitable  because  it  conserves  the 
dependencies between co-expressed genes at the sample level.  
 
With Catmap, the choice of the null hypothesis is specified by the user since, 
although  the  sample  label  permutation  is  statistically  more  robust,  in 
experiments where few replicates exist for each phenotype, the sample label  
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permutation may not be rigorous enough making the use of randomised gene 
lists inevitable.  
 
Once  the  choice  of  the  null  hypothesis  is  determined,  for  each  category  a 
distribution of scores is obtained by Catmap by summing up the ranks of its 
gene members as they occur in each of the random gene lists. A p-value for 
the category is then calculated by counting the number of times a lower score 
than  the  category  actual  score  is  encountered  (on  average)  under  the  null 
hypothesis. Categories are then ranked by their p-values. 
 
The last step in the Catmap algorithm is that of multiple testing correction. 
Catmap uses two different approaches for multiple testing correction, based on 
controlling  the  family-wise  error  rate  (FWE)  and  the  false  discovery  rate 
(FDR). In this work, we are mostly concerned with the FDR, as it can be 
compared  across  the  different  functional  analysis  methods  in  a  meaningful 
way. Thus, at any given category rank, the method with the lowest FDR is the 
best performing.  
 
With Catmap, the FDR is derived from permutation analysis. First, category 
scores obtained from the random gene lists are assigned p-values similar to the 
way those from the real gene list were given p-values. Thus, for category X  
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with  score  s  from  a  given  random  gene  list,  a  p-value  is  obtained  by 
calculating the number of times X has a lower score than s in the remaining 
random  lists  of  genes  divided  by  their  number.  This  allows  Catmap  to 
determine the range of p-values possibly obtained under the null hypothesis, 
given the number of categories tested. Table 6.1.1 illustrates how the p-value 
for a category is obtained by Catmap for a small number of random gene lists 
as well as the real gene list.   
 
 
  Real gene list  Random 
Gene list 1 
Random 
Gene list 2 
Random 
Gene list 3 
Random 
Gene list 4 
Random 
Gene list 5 
Gene ranks 
{309,567,1098
,14657,20009} 
{5670,8937, 
10987,16789, 
23456} 
{4567,5678, 
9013,13478, 
18976} 
{65,4576, 
8769,14578, 
20980} 
{45,176,457 
9456,15670} 
{13658,16793, 
20987,26009, 
27430} 
Wilcoxon  
rank sum 
36640  65839  51712  48968  25804  104877 
p-values  1/5 = 0.2  3/5 = 0.6  2/5 = 0.4  1/5 = 0.2  0/5 = 0  4/5 = 0.8 
Table 6.1.1. Illustrating the calculation of the p-value for a category on the basis of biologically 
meaningful gene ranks (in red) and random gene ranks (in black). 
 
 
 
Next, given the list C of categories ordered by p-values from the real gene list, 
the FDR for category c with p-value P at rank J is calculated by Catmap as the 
number of times a p-value from any category under the null hypothesis is 
smaller than P divided by the number of random gene lists divided by J. The 
first division serves to obtain an average count of categories scoring a better p-
value than P over the randomised gene lists whilst the second division aims to  
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express such count as a fraction of categories from C at higher rank than J. In 
other words, the FDR gives an estimate of the proportion of categories above 
category c in the ordered list of categories by Catmap expected to occur by 
chance. The diagram on Figure 6.1.2 summarises the different steps in the 
Catmap algorithm. 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Wilcoxon scores are calculated for the various categories 
based on the sum of ranks of their gene members 
Gene  ranking  from  apriori  analysis  is  usually  done  on  the  basis  of 
evidence  of  differential  expression  but  other  ranking  metrics  are  also 
possible. 
Category scores are assigned significance levels 
This is done by reference to the Wilcoxon scores obtained under the null 
hypothesis for each category. The null hypothesis may be based on gene 
permutation or more appropriately sample label permutation.   
An FDR based multiple testing correction is performed 
A category’s p-value is penalised for the occurrence of smaller p-values 
under the null hypothesis owing to the large number of categories tested. 
Figure 6.1.2. A schematic diagram illustrating the Catmap algorithm  
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6.1.1.2.  IGA (Iterative Group Analysis) 
 
In contrast to the Catmap method where a category is assessed on the basis of 
information from all its member genes, IGA analysis of gene categories is 
based on identifying the subset of genes in a category that prove most relevant 
to the biological question investigated in the microarray study. For example, in 
experiments aiming to reveal gene expression regulation in diseased or treated 
biological states with respect to ‘normal’, only genes in each category with 
high evidence of differential expression are typically considered. This reflects 
the view that for a given biological event, not all genes in a functional class 
undergo necessarily a change in expression and it seems more effective from a 
functional analysis point of view to ignore the unaffected genes in a category. 
 
In order to identify the set of potentially important genes in a category, IGA 
uses an iterative approach whereby the ranked list of genes is scanned from 
top to bottom and a summary statistic is recalculated each time a new member 
of  the  category  is  found.  The  summary  statistic  is  calculated  using  the 
hypergeometric  probability  (p)  of  encountering  that  many  member  genes, 
including the currently identified member, at that point in the list by chance 
given the total number of genes in the category.  
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The occurrence of the last category member in the list marks the end of the 
iterative  process.  The  result  is  a  profile  of  p-values  over  the  numbered 
occurrences of category gene member in the list. An example profile is shown 
on  Figure  6.1.3.  The  profile  indicates  that  the  p-value  improves  with  each 
occurrence of gene members from the top of the list, but deteriorates gradually 
when including members from further down the list. This constitutes the basis 
for identifying the potentially important genes in the category and a cut-off 
may  be  set  for  the  category  at  the  point  in  the  profile  where  the  p-value 
reaches its minimal value. Such a value is taken to define the category score 
and is referred to by IGA as the probability of change value or the ‘PC value’.  
 
 
 
 
 
 
Figure 6.1.3. Principle of Iterative Group Analysis (figure from the IGA paper by (Breitling et al., 
2004)). The list of genes ranked by differential expression is shown on the left. The genes member to 
the category,  scored here by IGA, are indicated by black circles. Parameter ‘t’ indicates the ranks of 
the category genes in the list whilst ‘z’ numbers them in the order in which they appear in the list. A 
profile of p-values over z is shown on the right. 
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Unlike Catmap, IGA does not attempt to derive statistical significance for each 
category  score  (or  PC  value)  because  the  latter  is  based  on  p-value.  This 
assumption is rather debatable, as will be discussed later. Instead, categories 
are sorted by their PC values and a multiple testing correction step follows, 
based on controlling the FDR in a similar fashion to Catmap. To do that, IGA 
employs a null model based on randomly shuffling the order of the genes in 
the gene list. For the list of categories ordered by the actual PC values from 
IGA analysis of the real gene list, the FDR at rank J corresponding to PC value 
P is given as the number of times a PC value from the null distribution is 
smaller than P divided by the number of random gene lists divided by J. 
 
6.1.1.3.   GSEA  (Gene set enrichment analysis)  
 
Similar to IGA, the GSEA statistics are based on identifying the subset of 
genes in a category that cluster at the top of the list more than expected by 
chance. In the original version of GSEA (Mootha et al., 2003), a category is 
scored using the Kolmogorov-Smirnov statistic (illustrated earlier, Fig 6.1.1), 
whereby  walking  down  the  ordered  list  of  genes,  a  running  score  is 
incremented by a constant at the occurrence of a category member gene and 
decremented at the occurrence of a gene not a member of the category. The  
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maximal absolute value of the running score denotes the category enrichment 
score (ES).  
 
When the genes in a given category are randomly dispersed along the original 
list of genes, the running score will tend to fluctuate around 0. By contrast, if a 
set of genes in a category cluster higher in the list than expected by chance, the 
running  score  will  tend  to  rise  above  its  background  level,  giving  an 
enrichment  in  the  observed  fraction  of  member  genes.  However,  with  this 
original  scoring  scheme  by  GSEA,  a  marked  concentration  of  category 
members anywhere in the list (not just at the top) would also cause the running 
score to shift from its background level. This is all illustrated in Figure 6.1.4. 
 
Figure 6.1.4-A shows the profile of the running score for a category that is 
truly enriched. The occurrence of many member genes at the top of the list is 
reflected by an increase in the running score, which then decreases gradually 
as lower gene ranks get explored by the scoring process.  This effect is better 
appreciated when considering the profile in Figure 6.1.4-B, corresponding to a 
category  whose  member  genes  occupy  random  ranks  in  the  list  of  genes. 
Figure  6.1.4-C  illustrates  the  weakness  of  this  scoring  process,  where  an 
increase in the running score appears to be triggered by the occurrence of 
category  members  at  the  middle  of  the  list  more  frequently  than  can  be  
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accounted for by chance. Such occurrence has no biological significance, as 
only genes from the top of the list are important. 
 
 
 
 
 
 
 
 
 
 
 
 
The new implementation of GSEA (Subramanian et al., 2005) was intended to 
deal with this problem. This was done by updating the original GSEA scoring 
scheme by applying a weight on the increment, so that the running enrichment 
score is increased to a larger extent when encountering a gene member from 
the top of the list than from lower parts in the list. The exact mathematical 
model used by the new version of GSEA to score gene classes is described in 
equations (1) & (2). Thus, for category S of NH genes and at any position i in 
the list of genes L, 
Figure 6.1.4. Enrichment score profiles by the original version of GSEA. (A) An enriched category, 
(B) a category showing no enrichment (C) a category showing an enrichment in member genes around the 
middle part of the list. Each category member ranks are indicated on a bar at the top of the plot. The arrow 
indicates  the  point  where  the  running  enrichment  score  features  the  maximal  deviation  from  its 
background level. This value denotes the category ES score. 
A  C 
Gene ranks Gene ranks Gene ranks Gene ranks        Gene ranks Gene ranks Gene ranks Gene ranks        Gene ranks Gene ranks Gene ranks Gene ranks       
B  
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  Phit (S, i) = ∑    
   
 
           
 
Pmiss (S, i) = ∑    
             
  
         and the ES for category S is the maximum deviation from 0 of Phit - Pmiss. 
 
gj is the gene at position j, N is the total number of genes in L and rj is the 
value  of  the  ranking  metric  at  position  j  (which  could  be  based  on  the 
correlation to a phenotype of interest, fold change or a significance value). 
Thus,  setting  the  power  parameter  p  to  a  value  equal  to  or  greater  than  1 
causes the increment to be weighted by the value of the ranking metric of 
category gene members whilst setting p to 0 causes the GSEA algorithm to 
simply  count  the  occurrences  of  category  members  in  the  list,  thereby 
reverting to its original version.  
 
Following the calculation of enrichment scores (ES) for gene categories, the 
next step in the GSEA algorithm is to infer statistical significance from these 
scores using permutation analysis. Similar to Catmap, GSEA recommends the 
| rj |
p 
 NR 
gj Є S 
  j ≤ i 
, where NR  = ∑  | rj |
p                                                          (1) 
                    gj Є S     
gj Є S 
  j ≤ i 
      1                                                              
(2) 
(N  -  NH )  
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sample label permutation null hypothesis to generate random lists of genes 
that preserve the dependencies in expression patterns of the varying genes. For 
each category, a distribution of ES is obtained under the null hypothesis and a 
p-value is derived for the category based on the number of ES from the null 
distribution found higher than the category actual ES (from analysis of the real 
gene list) divided by the number of randomised lists of genes analysed.   
 
The  last  step  in  the  GSEA  algorithm  is  that  of  multiple  testing  correction 
whereby the significance of category scores is re-evaluated given the large 
number  of  categories  tested  and  the  inevitable  margin  of  error.  However, 
unlike  most  functional  analysis  methods,  GSEA  argues  that  the  multiple 
testing correction should not be applied on the p-values as the latter are not 
adjusted  for  category  size.  This  is  important,  because  when  correcting  for 
multiple testing, a category’s score is assessed with respect to all scores from 
all categories under the null hypothesis and as such any bias in the scores 
owing to the size of the categories needs to be eliminated beforehand.   
 
Instead,  and  as  a  preliminary  step  to  multiple  testing  correction,  GSEA 
calculates a normalised version of the ES or ‘NES’, obtained by dividing the 
actual  ES  for  a  given  category  by  the  mean  expected  ES  for  the  category 
obtained under the null hypothesis. This allows the value of the observed ES  
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to be evaluated against the expected range of ES values for the category given 
its size; although, from a different angle to classical p-values. 
 
The  GSEA  procedure  for  estimating  the  FDR  from  category  NES  is  here 
outlined. Given a set of randomised gene lists obtained under the sample label 
permutation  null  hypothesis,  a  null  distribution  of  ES  is  obtained  for  each 
category (an ES from each randomised list). A null distribution of NES is then 
obtained for the category by diving the ES from each randomised gene list by 
the mean ES from the rest of the randomised lists. Gene categories are ranked 
by descending order of their observed NES from analysis of the real list of 
genes and walking down the resulting list of categories, the FDR at rank j 
corresponding to NES n is the number of times an NES from any category 
NES null distribution is greater than n divided by the number of randomised 
gene lists, divided by j.  The flow chart in Figure 6.1.5 summarises the various 
steps of the GSEA algorithm: 
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6.1.1.4.   Validation of functional analysis methods 
 
Beyond advocating their statistical theoretical basis, functional analysis tools 
are ultimately judged on the biological validity of their results. Typically, this 
has been performed by means of a test expression dataset whose functional 
properties are well characterised. For instance, a number of publicly available 
Category enrichment scores (ES) are calculated 
For each category, walking down the ordered list of genes, a running score 
is  incremented  by  a  weighted  margin  at  the  occurrence  of  a  category 
member gene and decremented by a constant at the occurrence of a gene 
not a member of the category. The maximal absolute value of the running 
score denotes the category ES.  
The ES scores are assigned p-values 
  This is done on an individual category basis. For each category, a null 
distribution of ES scores is obtained based on a sample label permutation. 
The p-value is the number of times the category features an ES under the 
null hypothesis that is equal or greater than its actual ES from analysis of 
the real list of genes 
An FDR based multiple testing correction is performed 
ES  are  normalised  for  category  size  by  dividing  them  by  the  mean 
expected ES from the null distribution on a category basis. A category’s  
FDR is estimated based on the number of times a higher NES value than 
the category actual NES is encountered under the null hypothesis. 
Figure 6.1.5. A schematic diagram illustrating the GSEA algorithm  
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cancer microarray datasets have been used to validate a significant proportion 
of functional analysis methods in literature such as the Van’t Veer et al (van 
de Vijver et al., 2002) and AML/ALL leukemia datasets (Dazzi et al., 1995). 
Thus, the observation of functions such as cell proliferation, apoptosis, p53 
related pathways and cell cycle control among the best scoring categories is a 
positive indication of the validity of the functional analysis approach used to 
generate these results.  
 
With some functional analysis tools, simpler test datasets with more easily 
anticipated functional outcomes have been used. For instance, with goCluster 
and  GSEA,  validation  has  been  performed  on  expression  profiles  of  male 
versus female germ and lymphoblastoid cells, where sets of genes mediating 
gender specific functions or showing a regulation pattern linked to the Y or X 
chromosome  were  expected  to  show  a  change  in  expression.  Furthermore, 
microarray experiments featuring the knock-out of a well-characterized gene 
may also constitute an ideal setting for validation as it is relatively easy to 
trace the functional implications of the absent gene. For instance, a p53 knock-
out microarray dataset was used among other datasets for the validation of the 
updated version of GSEA. However, the use of such simple test datasets may 
not allow a rigorous validation, which is why they are often used together with 
more complex datasets for the validation process.  
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Other less compelling forms of biological assessment of functional analysis 
methods exist in the literature. For instance, IGA used a semi-blind approach 
where  microarray  datasets  of  unknown  biology  were  obtained  from 
collaborators and the results from functional analysis of these datasets were 
used  to  predict  their  unknown  physiological  states  (Breitling  et  al.,  2004). 
With GOminer, the assessment took the form of validating functions found 
enriched by functional analysis that were not previously linked to the biology 
of the analysed test dataset using wet lab experimental techniques. Further 
evidence of biological validity was sometimes obtained by showing that the 
results from analysing two biologically identical datasets (but independently 
generated) were similar, as used in the GSEA and IGA studies.  
 
A valid point of criticism for these varying forms of biological validation for 
functional analysis is that they are all fairly subjective, requiring human input 
to  trace  the  link  between  the  observed  results  and  the  expected  outcome. 
Moreover, with the more common and most convincing form of validation 
featuring the use of a functionally well-characterised dataset as a test case for 
analysis,  the  results  are  simply  surveyed  for  biological  relevance  but  not 
quantitatively assessed, giving no estimate for the proportion of true and false 
hits among the top results. This is justified by the difficulty in accounting for 
all possible effects occurring at the level of function in the test dataset and  
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while the relevance of certain functions in the results may seem clear, the 
implication  of  other  functions  may  be  rather  subtle.  The  subjective  and 
informal nature of this validation approach makes it unsuitable for use in a 
comparative  context,  where  the  performances  of  a  number  of  functional 
analysis approaches may be desirably compared. 
   
6.1.2.   Aim of the chapter 
 
In this work, we propose an improved strategy for the biological validation of 
functional analysis methods and demonstrate its effectiveness by using it to 
pinpoint  differences  in  the  performance  of  publicly  available  functional 
analysis  tools.  Our  validation  strategy  is  based,  similar  to  the  traditional 
approach, on a test microarray dataset that is biologically well-characterised. 
However, our method has the additional feature of using a fully automated 
protocol to capture the similarity between functions known to be induced in 
the test dataset and the results from functional analysis of this dataset. This is 
achieved by annotating both sets of anticipated and observed functions with 
GO  terms  whilst  using  the  semantic  categorization  by  GO  to  capture  the 
semantic similarity between them.  
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By using an automated procedure to evaluate the link between the observed 
results  and  anticipated  outcome,  our  method  provides  an  alternative  to  the 
subjective  nature  of  the  traditional  approach.  Moreover,  the  proposed 
evaluation method has the additional advantage of yielding useful numerical 
estimates.  Thus,  while  acknowledging  the  difficulty  to  derive  absolute 
statistics  regarding  the  number  of  true  and  false  hits  among  the  observed 
results, primarily owing to the difficulty to account for the full range of truly 
affected  functions,  we  find  that  a  satisfactory  solution  lies  in  gathering 
information on all functions possibly implicated while providing a mechanism 
to  weight  the  evidence  supporting  them.  A  score  may  then  be  derived  to 
express the overall level of confidence in the observed results. 
 
Our strategy to reveal potentially affected functions in the test dataset is based 
on identifying functions associated with genes found differentially expressed 
in a number of published microarray studies, obtained under similar biological 
conditions  to  the  test  dataset.  A  confidence  level  is  then  derived  for  each 
function on the basis of its frequency among these chosen studies as well as 
the  frequency  of  closely  related  functions.  Importantly,  the  optimized 
validation strategy proposed in this work has one additional advantage, which 
is the relative ease with which the anticipated set of functions can be compiled 
from literature without the need to refer to expert biologists.  
6. A GO based framework for automatic biological assessment of microarray          
functional analysis methods 
     6.1. Introduction  
 
 
 
  249
To  our  knowledge,  this  work  constitutes  the  first  attempt  to  construct  a 
quantitative and automated framework that uses real data for the biological 
validation of functional analysis methods. The only earlier attempt to perform 
such automated validation,  made by Alexa et al (Alexa et al., 2006), used 
simulated data. This consisted of a population of random GO categories with a 
small  number  of  deliberately  enriched  categories.  Alexa  and  colleagues 
conducted their evaluation of their proposed functional analysis tool on the 
basis of the fraction of correctly identified GO terms in the simulated category 
dataset. However, this approach is not optimal as simulated data are idealistic 
in  comparison  to  real  data  and  may  cause  the  performance  of  functional 
analysis methods to be overestimated. 
 
Finally and further to developing the methodology for an automatic biological 
assessment of functional analysis tools, one important aim of this chapter is to 
run a comparison of publicly available functional analysis methods utilising 
varying rank based statistics: notably, IGA based on the minimized p-value 
metric,  GSEA  based  on  a  weighted  Kolmogorov-Smirnov  statistics  and 
Catmap featuring the Wilcoxon sum of ranks. Importantly, we hope to address 
the  question  of  whether  the  reductionist  approach  employed  by  IGA  and 
GSEA, that derives a category score on the basis of the ranks of a handful of  
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its member genes, has any advantage at the performance level in comparison 
to the more global approach employed by Catmap.  
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6.2.   Methods 
 
6.2.1. The test expression dataset 
 
To evaluate the performance of all three functional analysis approaches IGA, 
GSEA  and  Catmap,  a  test  microarray  expression  dataset  was  analysed  for 
functional  enrichment  by  all  three  methods.  This  dataset  was  obtained  by 
microarray profiling of DRG tissue from animals that have been subjected to 
the spinal nerve transection procedure (SNT) by LPC experimentalists. The 
dataset  was  considered  suitable  because  a  number  of  expression  datasets 
featuring the same or biologically related nerve injury models were available 
from the literature and conveniently integrated in the LPD. In other words, 
there was considerable knowledge about its functional properties. 
 
The  test  dataset  will  be  referred  to  as  the  SNT  dataset  for  the  rest  of  the 
chapter,  owing  to  the  spinal  nerve  transection  (SNT)  procedure  performed 
during the experimental phase. Whilst the experimental details of the original 
study are described in full in (Maratou et  al., 2009), here we give a brief 
overview.  As  described  in  (Bridges  et  al.,  2001),  the  SNT  procedure  was 
performed by first exposing the L5 segment through the paraspinal muscle 
sheath, ligating tightly the L5 with a silk suture then cutting a few millimeters  
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away  from  the  suture.  Only  SNT  submitted  animals  exhibiting  significant 
levels of mechanical hypersensitivity at day 14 post surgery were included in 
the experiment. In parallel, sham (control) animals were obtained by similarly 
exposing the L5 while keeping it undamaged. The SNT and sham animals 
constitute the two varying biological conditions subject to comparison in this 
microarray study.  
 
For both conditions, mRNA was pooled from ipsilateral L5 DRG tissue from 
three animals and 200 ng was sampled for amplification using the Affymetrix 
small  sample  protocol  VII  (http://affymetrix.com).  Four  replicate 
hybridizations  were  obtained  for  each  condition  using  the  Affymetrix 
GeneChip Rat Genome 230 2.0 arrays (Santa Clara, CA, USA). After staining 
and washing, the arrays were scanned and CEL files containing probe raw 
intensity  values  were  obtained  using  the  Affymetrix  Microarray  Suite 
software.  
 
6.2.2.   Low level analysis of the SNT test dataset.  
 
The raw data from the Affymetrix CEL files were processed with a range of 
microarray low level analysis functions from several Bioconductor packages 
accessible from R, the programming environment for statistical analysis. The  
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first  step  consisted  of  quality  control  (QC),  in  which  outlier  arrays  were 
identified. QC functions from the affy package were used to generate intensity 
scatter plots from all possible pairs of arrays within and across conditions as 
well  as  clustering  arrays  on  the  basis  of  similarity  in  gene  intensity  in  a 
hierarchical setting. 
 
The gcrma function from the GCRMA package was then applied on the raw 
data from quality arrays to achieve background correction, normalization and 
calculation of probeset expression summaries (these steps are described in the 
introduction  chapter).  Statistical  analysis  of  differential  expression  (sham 
versus SNT) was performed using the lmFit and eBayes functions from the 
limma  package  as  detailed  in  the  limma  vignette,  which  can  be  found  on 
http://www.statsci.org/smyth/pubs/limma-biocbook-reprint.pdf.    The  result 
was  a  list  of  probesets  ranked  by  the  estimated  evidence  of  differential 
expression by limma. 
 
6.2.3.   Functional analysis of the SNT dataset. 
 
Two main data files are required for functional analysis by each of the three 
methods being compared GSEA, IGA and Catmap: the gene list file providing 
a list of genes ranked by a chosen metric and the gene annotation file listing  
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associations  between  genes  and  annotations  of  interest.  In  this  work,  the 
ranking of genes was on the basis of significance of differential expression as 
determined by limma log odds values. Though, since the limma output list 
features probeset identifiers instead of gene identifiers and because the gene to 
probesets  mapping  on  Affymetrix  arrays  is  typically  that  of  one  to  many, 
further processing of the list was necessary to remove redundant probesets. 
This is important to assure that the enrichment score for each functional theme 
is  based  on  single  reading  from  individual  member  genes.    To  do  this, 
information on probesets from the RAT230 array was obtained from the LPD 
database, including UniGene identifiers and sequence MD5 digests and where 
two probesets were found mapping to the same gene (on the basis of identical 
UniGene  IDs  or  sequence  MD5s),  the  probeset  with  the  best  rank  was 
retained. This meant that the limma list, originally containing 31100 probeset 
entries, was reduced to 23943 gene entries. It is worth noting though that the 
list  may  still  contain  some  information  redundancy  because  the  less  well-
annotated EST probesets, originating from identical genes, may not have all 
been detected. 
 
As for the gene annotation file, the GO biological process annotations for the 
Rat 230 array were obtained from the LPD database and further processing of 
these  annotations  proved  necessary  before  they  were  used  to  construct  the  
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annotation  file.  This  is  because  while  examining  the  frequency  of  gene 
annotation  co-occurrence,  it  was  found  that  most  of  the  GO  terms  were 
associated with only a small number of genes (this is explored further and 
illustrated with a figure in appendix 6.5.1). This may compromise the power 
of statistics while assessing the likelihood of enrichment of these categories 
using functional analysis.  
 
A common solution to this problem, featuring in many published functional 
analysis studies, consists of back-propagating genes from associated terms to 
all ancestor terms; justified by the fact that the semantics of a parent term are 
applicable to all its progeny terms in GO. This was achieved by means of an R 
script  that  makes  use  of  the  GOBPANCESTOR  environment  object:  a 
precompiled look-up table that links all terms in the GO biological process 
ontology  to  their  ancestral  terms  from  the  Bioconductor  GOstats  package.  
After  the  back-propagation  of  genes,  categories  with  a  consolidated  gene 
count greater than 112 were eliminated because the calculation of IGA and 
GSEA statistics for such large categories proved rather unfeasible. Moreover, 
these categories were too general to be useful. Singleton categories associated 
with single genes were also removed. Also, category terms with the same gene 
content as any of their child terms were removed; in other words, a parent 
category  term  was  only  retained  if  it  featured  at  least  one  additional  gene  
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association  in  comparison  to  all  it  child  terms  (more  details,  including  a 
discussion of the advantages and disadvantages of the back-propagation of 
genes in the GO graph are discussed in appendix 6.5.1). 
 
It is important to note that the different functional analysis methods Catmap, 
IGA  and  GSEA  require  different  file  formats  for  the  gene  list  and  gene 
annotation  files.  Thus,  although  the  information  content  of  these  files  was 
strictly identical with all three method analyses to ensure a fair comparison, 
separate files were created for each method that adhered to the recommended 
file formats. In the following, we give details of how the individual methods 
were run on the SNT dataset. 
 
6.2.3.1.   Functional analysis by Catmap 
 
The Catmap script was download as part of a Perl package accessible from 
http://bioinfo.thep.lu.se/Catmap,  which  also  features  help  files  giving 
instructions on how to run the Catmap script and details of the required file 
formats.    Importantly,  the  Catmap  script  was  run  using  the  --randomnull 
option  to  indicate  the  randomized  gene  list  permutation  null  hypothesis  as 
oppose  to  the  recommended  sample  label  permutation  null  hypothesis  (all 
other options were set as recommended). Our choice of null hypothesis was  
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based on the fact that fewer than four replicate hybridizations remained after 
quality control (QC) for each phenotype (results from QC analysis of the SNT 
dataset arrays are presented in appendix 6.5.2); which limits the number of 
sample label permutations possible. The number of gene list permutations was 
set via the --multiple option to 5000. 
 
6.2.3.2.   Functional analysis by IGA 
 
The  IGA  perl  script  was  obtained  from  the  supplementary  material  that 
accompanies the IGA paper, together with a helper file giving useful notes on 
the script and required file formats. A distinct feature of the IGA program is 
that permutation analysis may only be performed at a separate run following 
an initial run during which categories are assessed for enrichment. Thus, in the 
first instance, the gene list and gene annotation files are submitted to IGA for 
analysis while specifying the value of the sensitivity threshold T. The value of 
T has the range of 1 to n, where n is the total number of categories and only 
categories scoring a PC-value (the probability of change based on a minimized 
p-value) less than T/n are included in the results. Thus, setting T equal to n 
implies  that  the  results  from  all  categories  are  shown  in  the  output  file; 
although, more commonly, T is given a smaller value so that only the most 
significant categories are returned.   
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In this initial run, we have no estimate for the proportion of false positives 
among the returned categories featuring PC-values less than T/n. To get such 
estimate, IGA may be run in permutation mode by specifying the option –R 
while fixing the value of T.  The results from this second run show instances 
of  categories  scoring  PC-values  less  than  T/n  from  analysis  of  a  set  of 
permuted gene lists. The FDR value at the significance level T/n can then be 
estimated by dividing the number of ‘false’ hits from the second run by the 
number of true hits from the first run. 
 
In effect, IGA in its original form is more suitable for use by biologists who 
are only interested in identifying the most significant categories. Notably, a 
biologist may wish to vary the value of the T parameter a few times until a 
satisfactory FDR value is obtained. However, for the sake of our evaluation 
study, calculating the FDR at each possible value T separately is tedious and it 
was deemed far more efficient to change the IGA script to allow permutation 
analysis to be performed on the fly. This modified version of IGA was run on 
the SNT dataset and FDR values were obtained using 5000 permuted gene 
lists, similar to Catmap. 
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6.2.3.3.   Functional analysis by GSEA 
 
With  GSEA,  Java  files  were  downloaded  from  the  GSEA  website  at 
http://www.broad.mit.edu/gsea/, corresponding to the updated version of the 
GSEA algorithm that uses a weighted Kolmogorov-Smirnov statistics to score 
gene  categories.  Documentation  and  help  pages  are  available  at  the  same 
address; in particular, information on input file formats may be accessed at 
http://www.broad.mit.edu/cancer/software/gsea/wiki/index.php/Data_formats. 
 
An important feature of the GSEA software, in comparison to the two other 
methods, is that it was designed to accept probeset expression summary data 
by default while offering a range of different analyses from which various 
meaningful statistics may be used to rank the genes. Thus, effectively, GSEA 
assists the user in ranking the genes prior to performing category enrichment 
analysis.  The standard ranking metric by GSEA is the signal to noise ratio, 
explained in details in appendix 6.5.3. 
 
In this work and in order to assure a fair comparison of all three methods, the 
input for each method has had to be the same. For this particular reason, we 
chose to run the GSEAPreranked tool of the GSEA software that is suitable 
for use with pre-ranked lists of genes. Likewise, the limma ranked list of genes  
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could be used with GSEA just like with Catmap and IGA. More information 
on  the  GSEAPreranked  tool  can  be  found  at 
http://www.broad.mit.edu/gsea/doc/GSEAUserGuideFrame.html.  
 
In  accordance  with  the  notes  on  GSEAPreranked  required  file  formats  at 
http://www.broad.mit.edu/cancer/software/gsea/wiki/index.php/Data_formats, 
a ‘.rnk’ gene list file was created that contained two columns: one listing the 
Affymetrix probeset identifiers and one listing the corresponding values of the 
ranking  metric. The latter was set to the negated log transformed p-values 
from limma because the GSEAPreranked algorithm automatically ranks the 
gene entries in the first column in descending order of the ranking metric in 
the  second  column  during  run  time.  Likewise,  the  most  significantly 
differentially expressed genes will be positioned at the top of the list and GO 
categories enriched among the highly ranked genes will be assigned positive 
ES values.   
 
As  the  GSEA  algorithm  regards  category  gene  enrichment  at  the  top  and 
bottom parts of the list as equally important (in accordance with its default 
signal to noise ranking metric outlined in appendix 6.5.3), in this work and 
since we have chosen instead to rank the genes by differential expression, all 
categories found significant by GSEA for being enriched at the bottom part of  
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the list were discarded (appendix 6.5.3). This explains why some of the GSEA 
plots  in  the  result  section  feature  less  categories  than  the  total  number  of 
categories tested.  
 
In addition to the ‘.rnk’ gene list file, a ‘.gmt’ annotation file was created that 
captured  the  GO  annotations  for  the  genes  from  the  RAT230  array  into  a 
GSEA  suitable  file  format  (refer  to 
http://www.broad.mit.edu/cancer/software/gsea/wiki/index.php/Data_formats 
for more details). It is important to recall that the GSEA analysis package has 
a built-in database of gene sets known as the MsigDB, but we chose not to use 
these gene sets and use our own set of GO categories for consistency with 
Catmap  and  IGA.  Also  for  compatibility  with  the  model  GO  category  set 
against  which  the  results  from  analysing  the  SNT  test  dataset  by  all  three 
functional analysis methods, including GSEA, will be validated.  
   
The GSEAPreranked java tool was run from the command line with the most 
basic  parameters  set  to  their  default  values,  except  for  the  --nperm  option 
which was set to 5000; thus, requesting 5000 gene list permutations for the 
calculation  of  p-values,  NES  and  multiple  testing  correction.  It  is  worth 
mentioning  that  with  GSEAPreranked,  the  choice  of  the  null  hypothesis  is 
restricted to gene list permutations.  
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6.2.4.   Validation of functional analysis results 
 
To validate the results from Catmap, IGA and GSEA analyses of the SNT 
dataset, a set of functional categories was assembled using the GO annotations 
of genes found differentially expressed in similar models of peripheral nerve 
injury in a number of microarray published studies; including (Costigan et al., 
2002; Valder et al., 2003; Wang et al., 2007; Xiao et al., 2002) and one final 
dataset consisting of genes found regulated in a number of sciatic nerve injury 
models using a variety of wet lab techniques compiled by the Costigan study. 
This set of GO functional terms is what was referred to as the ‘gold standard 
set of terms’ in chapter IV and we shall refer to some of the observations from 
this chapter whilst deploying this functional set to validate the results from 
functional analysis methods in the current chapter.  
 
Importantly, the identification of these published datasets was done in liaison 
with LPC experimentalists to ensure biological relevance to the test dataset. 
Thus, in addition to exploring similar peripheral nerve injuries, all datasets 
were  derived  from  analysis  of  the  expression  profile  of  the  DRG  tissue 
ipsilateral to injury. Moreover, the period of time elapsing the nerve injury 
procedure and the extraction of tissue is consistent for the Wang, Xiao, Valder 
and our test SNT dataset and consists of two weeks; with the exception of the  
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Costigan dataset featuring 3 days elapse time and varying times for the dataset 
compiled from experimental work.  
 
As  explained  in  chapter  III,  with  the  four  microarray  datasets  by  Valder, 
Wang, Xiao and Costigan, the raw probeset intensity values were not available 
and the lists of significantly regulated genes were obtained from the published 
versions  of  these  studies.  This  meant  that  we  could  not  ensure  that  these 
varying  lists  of  genes  reflected  a  similar  level  of  statistical  significance, 
because they were derived independently and often using varying statistics. 
Consequently, the relevance of the GO annotations of these genes (together 
forming the gold standard term set) to the biology of nerve injury was not 
certain.  
 
In chapter IV, we explored ways in which a confidence level may be derived 
for individual categories from the gold standard set, notably via the use of the 
term  study  occurrence  measure.  This  was  done  by  first  back-propagating 
genes from terms to their parent terms from the gold standard set and then 
deriving a confidence measure for each term based on combining the number 
of genes associated with the term and the number of different studies featuring 
these associated genes. Such approach was found rather inefficient and a more 
robust alternative was discussed based on pooling evidence for closely related  
6. A GO based framework for automatic biological assessment of microarray          
functional analysis methods 
     6.2. Methods 
 
 
 
  264
terms. In this chapter, we incorporate this concept into a mathematical model 
that  evaluates  the  collective  evidence  from  groups  of  gold  standard  terms 
while  assessing  their  level  of  similarity  with  the  results  from  functional 
analysis of the SNT test dataset, as will be shown in the result section. 
 
The Results from Catmap, IGA and GSEA analyses were captured in table 
structures in R and the top scoring categories from each analysis were selected 
for validation against the gold standard set of terms. Before performing the 
validation, these top scoring categories were processed to remove subsuming 
ancestral categories: thus, if a category and its child are both among these top 
categories, the former is discarded.  This was done via an R function that scans 
the ranked list of categories from each functional analysis top to bottom and 
evaluates the number of non-subsuming categories from the top and up to each 
subsequent position in the list, until X number of non-subsuming categories is 
achieved.  Using  this  function,  the  50  top  most  specialized  categories  were 
distilled from the top results of each analysis. These will be referred to as the 
‘query categories’ that we wish to validate against the gold standard set or 
‘target categories’ during the validation process. 
 
Our  comparison  of  query  and  target  categories  was  optimized  so  that  in 
addition  to  identifying  exact  matches  across  the  two  sets  of  terms,  the  
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semantic relationships between closely related terms were also captured. To 
this  end,  the  GOTrim  semantic  similarity  metric  (described  in  details  in 
chapter V) was used. The GOTrim method was implemented as an R script 
and  used  to  derive  the  similarity  value  for  each  pair  of  query  and  target 
categories. 
 
Since it is the aim of this work to develop a scoring protocol to capture the 
level  of  agreement  between  top  scoring  categories  from  each  functional 
analysis method (i.e. the query terms) and the set of gold standard terms (i.e. 
the target terms), further details on the scoring process are given in the results 
section.  
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6.3.   Results & discussion 
 
The results in this chapter are given in two main parts: the first part compares 
the results from functional analysis of the SNT dataset by all three methods 
Catmap,  IGA  and  GSEA  and  evaluates  them  from  a  purely  statistical 
perspective.  The  second  part  describes  the  biological  validation  of  these 
results, which is the prime aim of this chapter, and features both a description 
of  the  methodology  used  for  the  validation  as  well  as  the  outcome  from 
applying this methodology to the top results from each method analysis.  
 
6.3.1.   Comparison of functional analysis results by Catmap, 
IGA and GSEA 
 
Following the low level analysis of the SNT microarray dataset (outlined in 
Appendix 6.5.2), enrichment of gene functional categories was assessed by 
means  of  three  different  functional  analysis  methods:  Catmap,  IGA  and 
GSEA. Whilst the exact implementation details of these analyses are presented 
in full in the method section; here, we examine and compare their results. 
First, we look at the distribution of resulting p-values for all categories, which 
reflects  on  the  ability  of  each  method  to  identify  enriched  categories  and  
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second, we assess the performance of each method by analysing its profile of 
FDR corrected p-values.  
 
6.3.1.1.   The distribution of p-values 
  
The distribution of p-values by Catmap, GSEA and that of the minimised p-
values (or PC-values, explained in details in section 6.1.1.2) by IGA for all 
categories are shown in Figure 6.3.1. As it can be seen, IGA has a greater peak 
at the low end of the scale, followed by catmap then GSEA. This is better 
shown  in  Figure  6.3.1-D,  where  the  distributions  from  all  three  method 
analyses are overlayed. This sugests that many more categories were assigned 
small p-values by IGA than the rest of the methods.   
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A  B 
C  D 
Figure 6.3.1: Histograms showing the distribution of p-values from (A) catmap, (B) IGA, (C) GSEA.  The 
plot in D is a summary of the three previous plots, the only difference is that it uses lines to show the counts of 
categories over the p-value range instead of bars.  
minimised p-value or PC-value (IGA) 
p-value (for IGA, consisting of PC-value)  
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6.3.1.2.   The FDR profile  
 
In  statistics,  hypothesis  multiplicity  is  characterised  by  the  problem  of 
inevitable occurrences of small p-values purely due to chance. One common 
and least stringent form of multiple testing correction is based on estimating 
the false discovery rate (FDR), expressing the percentage of categories at any 
given  level  of  statistical  significance  expected  to  occur  by  chance,  usually 
estimated by permutation analysis. 
 
In this work, an FDR based multiple testing correction was used with all three 
functional analysis methods. Importantly, the FDR may be used as a basis to 
compare the performance of the methods, whereby at any given rank in the 
resulting lists of categories ordered by evidence of enrichment, the method 
with the smallest FDR is the best performing. 
 
In Figure 6.3.2-A, the FDR profile over the range of p-values by Catmap and 
that of the minimised p-values by IGA is shown. With GSEA, because the 
FDR is derived on the basis of category NES instead of p-values, the FDR 
profile is shown separately on Figure 6.3.2-B (more details about the GSEA 
algorithm may be found in section 6.1.1.3; but briefly, GSEA justifies its use 
of NES for the derivation of the FDR on the basis that the latter accounts for  
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category  size  as  oppose  to  p-values).  In  both  plots,  the  effect  of  multiple 
testing correction is evident in that the FDR appears to deteriorate a lot faster 
than the original significance values, reflecting the effected penalisation of the 
latter for random effects. What is interesting though is that the FDR increases 
more sharply with IGA than Catmap (Fig 6.3.2-A) in that generally speaking, 
the FDR value by IGA is higher than that by Catmap at any given p-value. 
This indicates that IGA statistics are characterised by a higher rate of false 
positives than Catmap.  
 
Importantly, it is possible to compare the FDR from all three method analyses 
by considering the ranks of category significance values (p-values by Catmap, 
minimised p-values by IGA and NES by GSEA), which masks variations in 
the  nature  of  these  values  across  the  methods  (Fig  6.3.2-C).  Importantly, 
Catmap appears to perform the best; for example, if one selects the top 50 
categories from each analysis, the FDR is 0.02, 0.22 and 0.4 for Catmap, IGA 
and  GSEA  respectively  (Fig  6.3.2-C&D).  The  rather  poor  FDR  profile  by 
GSEA  may not be surprising given that the p-value distribution by  GSEA 
indicated a modest peak at the low p-value end of the scale (Fig 6.3.1-C&D); 
implying the inability of GSEA to find much statistical significance among the 
individual categories tested.   
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A  B 
C  D 
Figure  6.3.2.  Assessment  of  method  performances  based  on  false  discovery  rate  (FDR) 
profiles. (A&B) FDR versus significance values: p-value/minimised p-value by Catmap and 
IGA respectively (A) and NES by GSEA (B). (C) FDR versus category rank by significance for 
all three methods. (D) A zoomed version of the plot in C, only showing the FDR for the top 200 
categories from each method.  
D  
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The FDR results from IGA are worthy of more discussion. From the previous 
analysis of the distribution of category p-values from each method analysis 
(Fig 6.3.1), it appeared that IGA finds the highest number of categories with 
small  p-values;  which  suggested  at  the  time  a  good  level  of  performance. 
However,  from  the  current  analysis,  we  know  that  IGA  statistics  are 
characterised with a higher FDR than Catmap and thus, many of the putative 
significant categories from previous analysis may simply be false positives.   
 
The explanation for this phenomenon lies in the nature of the IGA statistics 
that operate by scoring categories on the basis of minimised p-values (or PC-
values) and unlike the rest of the methods, no significance is derived from 
such category scores on the basis that they are based on p-values. Thus, as 
featured  in  the  IGA  paper  by  Breitling  et  al  ‘…the  PC-values  may 
occasionally be underestimating the true probability of changes because they 
are  based  on  determining  the  minimum  p-value  within  each  class 
(category)…’.  Moreover  and  as  suggested  by  Breslin  et  al,  authors  of  the 
Catmap study, these PC-values should not be interpreted as p-values because 
they are biased by the minimisation process and should rather be thought of as 
scores from which statistical significance still needs to be inferred.  
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In fact, the bias in the IGA PC-values is further confirmed by examining the 
distribution  of  PC-values  under  the  null  hypothesis  from  IGA  analysis  of 
categories with random gene ranks, shown in Figure 6.3.3-A. Thus, whereas 
the distribution of p-values from Catmap analysis of categories with similarly 
randomised gene ranks (Fig 6.3.3-B) is uniform as expected under the null 
hypothesis, that of the minimised p-values (or PC-values) by IGA is skewed 
towards the low end of the scale; evidencing an overall underestimation of the 
categories true level of significance.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A  B 
Figure 6.3.3.  Histogram of PC-values/p-values from IGA and Catmap analysis of randomised gene 
lists, A&B respectively. The skewed nature of the distribution by IGA confirms the presence of bias in 
the minimised p-values (also referred to as the PC-values by IGA). 
PC-value (IGA)  
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6.3.1.3.   Correlation in category ranks 
 
Previous  results  indicate  that  there  are  clear  differences  in  the  statistical 
properties of Catmap, IGA and GSEA; which suggests in turn that the ranking 
of categories from analysis of the SNT dataset by all three methods is likely to 
differ. Indeed, there seems to be some discrepancies in category ranks, with 
GSEA  showing  the  least  level  of  agreement  with  the  two  other  methods 
Catmap and IGA (Fig 6.3.4-B&C), consistent with the observation that GSEA 
features  the  highest  FDR  (Fig  6.3.2-C&D)  and  is  thus  least  capable  of 
detecting true hits. On the other hand, the category ranks by Catmap and IGA 
appear to be more correlated  (Fig 6.3.4-A). Interestingly, the fact that the 
most pronounced discrepancies in ranks between Catmap and IGA correspond 
to instances where categories were ranked lower by IGA than Catmap (top left 
corner of the correlation plot, Fig 6.3.4-A) supports the hypothesis that IGA 
statistics are characterised by a tendency to underestimate the true probability 
of category enrichment.  
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Figure  6.3.4:  comparison  of 
category  ranks  by  derived 
evidence  of  enrichment.  (A) 
catmap  versus  IGA.  (B)  catmap 
versus  GSEA.  (C)  IGA  versus 
GSEA.  The  categories  were 
ranked  on  the  basis  of  p-values, 
PC-values  and  NES  by  Catmap, 
IGA and GSEA, respectively 
A 
C 
B  
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The functional analysis of gene categories performed in this study revealed 
important  information  on  the  statistical  properties  of  functional  analysis 
methods used. Thus, GSEA appears to perform least well as it showed the 
highest FDR and identified the lowest number of significant categories (Fig 
6.3.1-C). IGA statistics, on the other hand, appear to have more potential (on 
the basis of showing a smaller FDR than GSEA) but are nonetheless limited 
by the tendency to underestimate the category true probability of enrichement. 
This is due to the nature of the IGA statistics that use minimised p-values as 
the  ultimate  significance  scores  for  the  categories.  Finally,  the  best 
performance was revealed by Catmap owing to the small FDR among its top 
results. 
 
6.3.2.   Biological validation of Catmap, IGA and GSEA   
 
In  this  work,  our  main  aim  was  to  undertake  an  evaluation  of  functional 
analysis methods from a biological perspective, as biological validity is the 
ultimate criterion for quality. We anticipated the results from the biological 
assessment to further confirm the previous conclusions about the performance 
of each method at the statistical level.  
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To assess the biological validity of the results from functional analysis of the 
SNT dataset by each method (denoting the query categories), we compared 
them to the gold standard set of terms (or the target categories) derived from 
GO  annotations  of  genes  reported  differentially  expressed  in  a  number  of 
microarray published studies investigating similar neuropathy models to the 
SNT.  Thus,  whilst  the  functional  analysis  of  the  SNT  dataset  identifies 
potentially  enriched  categories  on  the  basis  of  a  concerted  change  in 
expression of member genes in this unique dataset, the gold standard target 
categories were derived on the basis of occurrence of member genes across a 
number  of  published  datasets;  which  makes  them  more  believable  from  a 
human perspective and justifies their use as a model answer.  
 
However and as shown in chapter IV, the different target categories from the 
gold standard set are representative of the published studies to varying extents 
and are thus associated with varying levels of confidence. This was taken into 
account while developing a scoring protocol to capture the level of similarity 
between query and target categories in this chapter, which is described in full 
in the following section.   
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6.3.2.1.  A  scoring  protocol  to  assess  the  results  from  functional 
analysis using prior knowledge. 
 
As already explained, two main factors are meant to be captured during the 
scoring  process  of  query  categories  from  functional  analysis  of  the  SNT 
dataset:  the  similarity  to  the  target  categories  and  the  evidence  supporting 
these target categories. We use the GOTrim scores (discussed in chapter V) to 
denote  the  similarity  between  categories  from  the  query  and  target  sets. 
However, since the similarity to a target category is given by the GOTrim 
method  as  the  specificity  of  the  most  specialised  ancestor  shared  with  the 
query category and since many target categories may share the same most 
specialised ancestor with the query category, it is more efficient to simply 
consider the specificity of ancestors shared by groups of target categories with 
the query category term. This is illustrated in Figure 6.3.5. 
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Moreover  and  beyond  simplifying  the  scoring  process,  such  clustering  of 
target categories has the important advantage of providing a mechanism for 
pooling evidence across defined sets of target categories. Thus, in chapter IV, 
we came to the conclusion that a large fraction of target categories feature in 
only  one  published  dataset  but  may  have  related  functions  to  other  more 
highly  represented  target  categories  across  the  different  datasets.  This 
indicated  the  importance  of  exploring  the  relationships  between  target 
Figure 6.3.5. Diagram illustrating how target categories (corresponding to nodes filled in red) 
may be organised into clusters during the scoring process of a query category (node filled in 
black) on the basis of the same most specialised ancestors (shown as rectangular nodes) shared 
with the query category. Three of such clusters are visible on the diagram and numbered. Paths from 
the target category terms to the shared common ancestor in each cluster are indicated by dashed lines. 
More distant ancestors are able to capture larger sets of functionally distinct target categories to the 
query category (groups 1&2) whilst groups of closely related target categories are generally smaller in 
size (group 3).  
1 
2 
3  
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categories, possibly by means of consolidating the evidence from groups of 
related  targets.  However,  in  this  chapter  because  the  ultimate  aim  from 
assessing the evidence from the target categories is to evaluate the relevance 
of query categories that match to these target categories, we have opted to 
consolidate the evidence from groups of target categories at the same level of 
similarity with the query (Fig 6.3.6).  
 
In order to derive an evidence measure from groups of target categories, we 
pool the genes from all target categories in the group. Importantly, we slightly 
modify the term occurrence evidence measure used in chapter V so that in 
addition to calculating the number of unique studies featuring this pooled set 
of genes, we also take account of the number of genes in this set (we refer to 
these  two  values  as  the  study  count  and  the  gene  count  respectively). 
Importantly, the study count and the gene count values, illustrated in Figure 
6.3.6, express two different logical entities and may differ from each other. 
This is because more than one gene may be reported by the same study. The 
new measure, which combines the study and gene counts, is referred to as the 
gene/study or ‘GS’ measure and is defined in equation 3. 
 
       GS = study count + (log (gene count /study count))     
(3) 
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Importantly, with the GS measure, the study count is still emphasised to a 
larger extent than the gene count. This reflects our view that the evidence for a 
query  category  is  most  strongly  reflected  by  the  level  of  representation  of 
matching target categories across the selected published studies, rather than 
the count of their associated genes from these studies. In equation 3, we have 
minimised  the  contribution  of  the  gene  count  to  the  GS  value  by  first 
estimating its average value per study and second by log transforming it. The 
reason why we chose these transformations is because they always  yield a 
value of less than 1. This implies that a group of target categories reported by 
x number of unique studies (study count = x) may only score a GS value from 
the range [x, x+1]; meaning that its GS value will always be less than that by 
any  group  of  targets  with  a  study  count  greater  than  x,  regardless  of  the 
corresponding gene counts. On the other hand, the gene count would have a 
decisive role in establishing the evidence for groups of target categories with 
similar study counts; which is why we have chosen to include it in the GS 
measure in the first place.  
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The flow chart in Figure 6.3.7 summarises the various steps of the scoring 
protocol developed in this work to validate the set of query categories from 
functional analysis of the SNT test dataset against expectedly enriched target 
categories  from  published  work,  featuring  similar  models  of  peripheral 
neuropathy.  So far, we have covered the first two steps of the protocol whilst 
the third and last step remains to be explained. This will be the topic of the 
following section. 
  
 
 
query A 
FOS, study ID 1 
NPY, study ID 2 
  
target 1 
ATF3, study ID 3 
 
target 2 
FGF2, study ID 1 
CALCA, study ID 4 
  
target 3 
common ancestor 
Figure 6.3.6. Diagram illustrating the process of deriving an evidence estimate for a set of 
target categories grouped on the basis of being at the same level of similarity with the 
query category. On the diagram, under each target category is a listing of associated genes 
together with the ID of the studies where these genes appear. The evidence for such group of 
target categories is based on deriving the number of genes from all target categories in the group 
(gene count = 5, including FOS, NPY, ATF3, FGF2 and CALCA) and the number of unique 
studies in which these genes appear (study count = 4, consisting of study ID 1, 2, 3, 4).  
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Upon defining groups of target categories at the same level of similarity with 
the  query  and  deriving  their  GS  evidence  estimates,  the  next  step  in  the 
protocol  is  to  combine  the  similarity  and  GS  values  for  groups  of  target 
categories by raising the former to the power of the latter. This allows us to 
weigh out the significance of associations between the query and pre-defined 
sets  of  target  categories.  Finally,  the  cube  root  of  the  sum  of  calculated 
similarity
GS  values  from  groups  of  target  categories  is  taken  to  define  the 
Derive an evidence estimate for each target category from the gold 
standard set 
 
Finally, we derive a score for the query category based on the sum 
of similarity values from groups of targets weighted by their 
corresponding evidence estimates.  
 
Figure  6.3.7.  A  schematic  diagram  illustrating  the  milestones  of  the 
scoring  protocol  designed  to  capture  the  biological  relevance  of  each 
category promoted by functional analysis (or query category). 
To score a query category, we use the GOTrim similarity metric to 
measure similarity to each target category, then we group target 
categories at the same level of similarity with the query.  
We then derive an evidence estimate from groups of target 
categories based on how representative is their pooled set of genes 
of the various published datasets and to a less extent, the number of 
genes in this set.  
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query final score (we have chosen to apply a root transformation as opposed to 
a log transformation because the former has desirable linear characteristics). 
Thus, the score S for query category q is: 
 
    Sq   =         
 
√   ∑    Simg 
GSg                                                                                  (4) 
                            g:1→n 
 
where g is one group of target categories among n groups defined for 
category q during the scoring process and Simg is the similarity value to 
group  g  given  by  the  GOTrim  method  as  the  specificity  of  the  most 
immediate ancestor of the query category that is also an ancestor of the 
target categories in group g. 
 
 
Using the scoring metric shown in equation 4, the most evidenced and highly 
similar groups of target categories to the query category are set to have the 
highest contributions to the query final score, whilst weakly related groups of 
targets would only contribute minimally. Also, the more frequently a query 
category is associated with groups of well substantiated target categories, the 
higher the final score for the category. This implies that by using our proposed 
3  
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scoring  protocol,  we  are  able  to  detect  varying  levels  of  likelihood  of 
biological relevance of query categories promoted by functional analysis. 
 
However, further analysis revealed a possible flaw: arising from the fact that 
the GS value tends to reach its maximal levels at low similarity with the query. 
This can cause contributions from weakly related targets to grow artificially 
high  (equation  4);  causing  in  turn  a  loss  of  protocol  sensitivity.  The 
explanation of this phenomenon may be logically attributed to the complex 
nature of the biological response to nerve injury at the DRG level (analysed in 
depth  in  chapter  IV).  Thus,  among  the  560  target  categories,  reported  in 
literature to be associated with peripheral neuropathy, is a wide spectrum of 
biological functions ranging from a diverse  range of neuronal processes to 
inflammatory and immune functions. As such, for any given query category, 
only few target categories may be closely related whilst the vast majority will 
entail distinct functions. Thus, whilst grouping target categories by the level of 
similarity to the query category, groups of dissimilar targets are likely to be 
bigger,  leveraging  a  substantially  higher  number  of  genes  from  published 
studies; hence a larger GS. This is captured in Figure 6.3.5.  
 
To counteract this effect, the original scoring metric (shown in equation 4) 
was  modified  in  a  way  that  reduces  the  effect  of  the  GS  values  at  weak  
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similarity levels with the query. But, before this was possible, there was a need 
to define a similarity cut-off below which such a modification may take effect. 
Whilst no absolute rule exists to define the boundary between strong and weak 
semantic  associations  between  GO  categories,  in  this  work  we  sought  to 
identify a distinct level of similarity between query and target categories by 
examining the frequency of similarity values at the background level. This was 
done by comparing the original population of GO categories, from which the 
query categories were drawn by functional analysis, against the set of target 
categories.  Such  original  population  consisted  of  the  set  of  GO  categories 
associated with all genes on the array and for each category in this set, we 
obtained  the  maximal  similarity  value  from  comparing  it  to  all  target 
categories. The resulting distribution is shown in Figure 6.3.8.  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Similarity cut-off  
Figure 6.3.8. The distribution 
of  maximal  similarity  value 
from  comparison  of  each 
chip-represented  category 
and  the  gold  standard  set  of   
target categories.   
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Thus, it appears that a considerable proportion of array-associated categories 
feature a level of similarity to the target categories that is at best below 4.7, 
which is the value at the peak of the distribution (Fig 6.3.8). These categories 
may plausibly be taken to represent the substantial proportion of categories on 
the  array  expected  to  entail  genomic  functions  not  part  of  the  functional 
response  to  nerve  injury  and  hence  the  weak  association  with  the  target 
categories. On the other hand, the gradual decrease in the frequency of array 
categories at higher similarity values indicates the significance of this range of 
similarity. On this basis, we set our similarity cut-off to the value of 4.8 just 
above 4.7. 
 
After identifying the similarity cut-off and in order to marginalise the effect of 
increase  in  GS  at  low  similarity  with  the  query  on  the  query  final  score 
(equation 4), a function was developed that reduces the similarity values from 
groups of weakly related target categories (from below the threshold) to small 
fractions of less than 1. Likewise, while adding up the similarity
GS terms from 
groups of target categories, those weakly related to the query will have minor 
contributions  to  the  sum,  since  in  maths,  raising  a  fractional  value  to  any 
power (no matter how large) always returns a smaller fraction. Moreover, this 
function was optimised to ensure that such minor contributions from weakly 
related groups of targets never add up to a value higher than 1. This allows  
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query categories with no significant (above threshold) association to any of the 
target  categories  to  be  characterised  by  scores  of  less  than  1  whilst  those 
showing at least one significant association to be distinguished by scores of 
higher than 1.  This is important as it makes sure that the additive effect from 
weakly related targets may never grow to exert a similar impact on the final 
score as a contribution from a group of strongly related targets. We refer to 
this function as the similarity transformation function and we explain it in 
detail in Appendix 6.5.4. For now, we incorporate the transformation function 
in equation 4 to obtain:  
 
    Sq   =         
 
√   ∑    Tr(Sim)g 
GSg                                                                             (5) 
                            g:1→n 
 
Sq is the score for query category q, g is one target group among n 
groups defined for category q during the scoring process and Tr(Sim) 
is the transformation function applied on the similarity values Sim. 
 
 
Of  course,  one  other  possibility  to  suppress  the  effect  of  high  GS  at  low 
similarity  with  the  query  is  simply  by  discarding  groups  of  targets  at  a 
similarity level below the threshold during the scoring process of the query 
3  
6. A GO based framework for automatic biological assessment of microarray          
functional analysis methods 
     6.3. Results and discussion 
 
 
 
  289
category. Although providing a straight forward solution to the problem, such 
strategy  is  limited  in  the  case  of  query  categories  featuring  no  similarity 
relationship with any groups of targets above the threshold, as it will results in 
these  categories  receiving  no  scores.  Alternatively,  instead  of  completely 
discarding  groups  of  target  categories  from  below  the  threshold,  we  could 
have set their similarity values to 0; likewise, any query category not showing 
a significant association (from above the threshold) to any  group of target 
categories will be given a score based on a sum of 0s amounting to a value of 
0. One apparent drawback from this approach is that a row of null scores will 
be obtained for query categories only weakly related to the target categories; 
which  hinders  the  derivation  of  a  continuous  distribution  of  scores  from  a 
potentially  mixed  population  of  query  categories,  showing  both  strong  and 
weak associations with the target categories. In this work, we have chosen to 
implement a more elegant solution that allows a continuous range of scores to 
be generated for the query categories across the whole range of similarity to 
the  target  categories.  Importantly,  owing  to  the  similarity  transformation 
function incorporated in our scoring metric (equation 5), although the scores 
from query categories showing both strong and weak association(s) with the 
target categories run in a continuous range, they segregate into two disparate 
range of values (above and below 1 respectively); which makes them easily 
distinguishable.  
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6.3.2.2.   Assessment of the scoring protocol 
 
In order to demonstrate the effectiveness of our scoring protocol to reliably 
detect  optimal  similarities  with  the  target  categories,  we  performed  the 
following test. On one hand, we used the scoring protocol to score the set of 
gold standard target categories against themselves and on the other hand, we 
used  the  protocol  to  score  the  overall  population  of  array  associated  GO 
categories against this set of target categories.  
 
Thus, if we were to compare the distributions of resulting scores from both 
comparisons and had our scoring protocol been sensitive enough, we would 
anticipate the former to show high scores (above 1) only whilst the latter to 
yield a combination of high scores as well as low scores (below 1). This is 
because in the first comparison, the target categories are being compared to 
themselves and each category is logically ‘highly similar’ or more precisely 
‘identical’ to itself (we talk about high similarity instead of identity because 
the  GOTRIM  similarity  value  for  a  pair  of  categories  is  based  on  the 
specificity level of the immediate common parent, even when the categories 
are  identical).  As  for  the  second  comparison,  among  the  set  of  categories 
represented on the array, only a fraction will be related to any of the target 
categories (which we hope to capture with functional analysis) because the  
6. A GO based framework for automatic biological assessment of microarray          
functional analysis methods 
     6.3. Results and discussion 
 
 
 
  291
chip is meant to cover the whole set of expressed genes on the rat genome, 
thereby capturing the whole spectrum of biological functions known to this 
organism. 
 
Figure  6.3.9  shows  the  distributions  of  the  resulting  scores  from  both 
comparisons (red, blue respectively). If we first concentrate on the distribution 
in blue where the categories from the array were scored against the target 
categories from the gold standard set, we find that this distribution is bimodal 
and features two distinct population of scores: one at the low range of below 1 
and one at a range higher than 1; in other words, a mixture of low and high 
scores as anticipated. By contrast, the distribution of scores from the target 
categories self-comparison shows a slightly different pattern to that expected. 
Thus, although the vast majority of scores are high (≈ 75%), the remaining 
population of scores (≈ 25%) are from the low range and the question is how 
could this possibly occur given that each target category should be at least 
highly  similar  to  itself?  Examination  of  some  of  these  low  self-scoring 
categories  revealed  that  their  semantics  are  rather  general  as  genes  may 
occasionally be associated with terms that lack precision. Thus, while scoring 
these categories against themselves, which entails taking the specificity value 
of their immediate parents, we are bound to drop below the similarity cut-off 
value of 4.8.   
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Despite this effect, our scoring protocol is capable of revealing a difference 
between the two distributions, which is reflected in the larger proportion of 
high  scores  from  the  target  categories  self-comparison  as  oppose  to  when 
scoring the set of array  represented categories against the target categories 
(75% and 40% respectively).  
 
To highlight the importance of the transformation function to the sensitivity of 
our scoring protocol, we repeat the same comparisons but this time omitting 
the transformation function from our scoring metric; in other words, reverting 
Figure 6.3.9. Distribution 
of  scores  from  a  cross-
comparison  of  target 
categories  from  the  gold 
standard  set  (red)  and  a 
comparison  of  chip 
associated  categories 
against the latter (blue). 
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back to equation 4. The resulting distributions are shown on Figure 6.3.10. 
Clearly, the distributions of scores from the two comparisons appear to be 
alike and show no real difference between them, which suggests  a loss of 
sensitivity. This is because, in the absence of the transformation function, the 
fact that the GS shows typically high values at low similarity with the query 
causes  the  similarity
GS  values  from  groups  of  targets  weakly  and  strongly 
associated with the query to have comparable weights in the final score.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.10. Distribution of 
scores  from  a  cross-
comparison  of  target 
categories  from  the  gold 
standard  set  (red)  and  a 
comparison  of  the  chip 
represented categories against 
the latter (blue), but this time 
omitting  the  transformation 
function  from  our  scoring 
metric.  
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6.3.3.  Applying the scoring protocol to the results from Catmap, 
IGA and GSEA functional analysis. 
 
In  this  section,  we  present  the  results  from  scoring  the  categories  from 
Catmap, IGA and GSEA functional analysis of the SNT dataset against the set 
of  target  categories  reported  to  be  enriched,  in  literature,  under  similar 
conditions of peripheral nerve injury, using our scoring protocol. Initially, top 
categories  from  each  method  analysis  were  processed  to  remove  ancestral 
categories  in  order  to  avoid  information  redundancy.  This  was  done,  as 
described in the method section, by scanning the list of ranked categories from 
each  analysis  top  to  bottom,  each  time  accummulating  the  category  at  the 
current position or eliminating it if it proves to be a predecessor of a category 
from higher ranks, until 50 categories were obtained. This meant that 122, 110 
and 77 categories were filtered in this manner from Catmap, IGA and GSEA 
top  results  before  the  desired  number  of  categories  was  obtained  for  each 
analysis.  
 
Applying the scoring protocol on this set of top 50 most specialised query 
categories from each functional analysis returned a distribution of scores for 
each analysis, shown in Figure 6.3.11. To interpret these distributions, it is 
important  to  recall  that  all  scores  below  1  correspond  to  query  categories  
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showing  no  optimal  similarity  relationship  to  any  of  the  target  categories 
whilst higher scores correspond to query categories at an optimal similarity 
level to one or more groups of target categories.   
 
Clearly, Catmap shows the best performance by yielding the largest proportion 
of high scores, followed by IGA then GSEA. This effectively means that the 
top 50 most specialised categories from Catmap show the highest proportion 
of biologically relevant categories in comparison to the two other methods. 
Interestingly,  Catmap’s  leading  performance  has  previously  been 
characterised,  from  a  statistical  perspective,  from  examination  of  the  FDR 
(section 6.3.1.2). 
 
 
   
 
 
 
 
 
 
 
Figure  6.3.11.  Distribution  of 
scores  from  the  top  50  most 
specialised  categories  from 
Catmap,  IGA  and  GSEA 
analysis  of  the  SNT  dataset, 
obtained  using  our  scoring 
protocol.  
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Even though the bimodality of the resulting distributions makes it difficult to 
derive reliable summary statistics for these distributions, we have chosen to 
use the mean value for the following reasons: There are two main criteria from 
these distributions that reflect on the performances of the methods and ought 
to be captured by the summary statistics: one is the proportion of high scoring 
categories and second is the magnitude of their scores. Thus, beside simply 
counting the number of query categories from functional analysis showing a 
similarity level to one (or more) group of target categories above threshold 
(hence featuring scores greater than 1), it is important to consider the strength 
of these associations as well as the evidence supporting the target categories 
involved, both captured by the magnitude of these scores (refer to equation 5 
for information on how the scores are derived). Importantly, choosing to use 
the mean as the summary statistics for the distributions in question allows both 
criteria to be captured. This is because the mean would tend to increase if the 
distribution  features  a  higher  proportion  of  the  significant  scores  (meaning 
scores greater than 1). Moreover, unlike the median, the mean is sensitive to 
the magnitude of individual scores in the distribution. 
 
The mean scores from Catmap, IGA and GSEA distributions of scores (from 
Figure  6.3.11)  were  found  equal  to  1.74,  1.57  and  1.47  respectively;  thus, 
capturing the anticipated differences in the performances of all three methods.  
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However,  despite  their  informativeness,  these  mean  score  values  imply  no 
significance in their own right and one can not tell whether the mean score by 
Catmap, being the highest, is any different to what could have been obtained 
by  chance.  In  order  to  estimate  the  significance  of  these  mean  scores,  we 
examined  the  range  of  mean  scores  obtained  under  the  null  hypothesis  by 
applying our scoring protocol on the top 50 categories (processed similarly by 
removing  ancestral  categories)  from  5000  random  lists  of  categories.  A  p-
value  was  then  derived  for  each  functional  analysis  method  based  on  the 
average number of times, the mean score value under the null hypothesis is 
higher or equal to that from the actual list of categories ranked by the method 
by evidence of enrichment. The following p-values 0.023, 0.28 and 0.59 were 
obtained  for  Catmap,  IGA  and  GSEA  respectively;  indicating  statistical 
significance for Catmap only. 
 
It is important to note that the random lists of categories used for this analysis 
were not generated by randomly shuffling the order of the categories in the 
lists. That is because such null hypothesis would have been inapropriate as it 
makes the assumption of independency between categories; which is untrue 
given the fact that a substantial overlap in genes between categories may cause 
them to show a similar pattern of enrichment. Instead, we used the lists of 
categories obtained from analysis of permuted list of genes by Catmap, IGA  
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and GSEA. Importantly, with these lists, the order of categories is biologically 
insignificant but the dependency between them is certainly maintained. 
 
To  further  illustrate  the  difference  between  these  lists  of  categories 
randomised in such ‘supervised’ manner and those obtained from pure random 
shuffling  of  categories,  we  generated  5000  lists  of  randomly  shuffled 
categories, then applied the scoring protocol on the top 50 most specialised 
categories from each list. A distribution of 5000 mean score values (a mean 
score  from  the  distribution  of  50  scores  from  each  randomised  list)  was 
obtained. This was compared to the distribution of 5000 mean scores obtained 
from  the  top  50  most  specialised  categories  from  lists  of  categories  by 
Catmap,  IGA  and  GSEA  analyses  of  permuted  gene  lists.  The  results  are 
shown on Figure 6.3.12. There is a clear difference in the mean score value 
distributions from both types of random lists. Importantly, had we chosen to 
use lists of randomly shuffled categories to assess the significance of our mean 
scores from top Catmap, IGA and GSEA results, the p-values would have 
been underestimated. 
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Figure 6.3.12. The distribution of mean scores from running top categories from random 
category lists, generated either via random shuffling of categories or from functional analysis 
of randomly permuted gene lists, through our scoring protocol.  
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6.4.   Conclusion 
 
This  work  has  had  the  important  outcome  of  successfully  automating  the 
biological validation of functional analysis methods thereby eliminating the 
need  for  human  judgement  to  trace  the  link  between  the  observed  and 
expected patterns of functional enrichments.  There are three main dimensions 
to  our  automated  validation  approach:  a  test  case  dataset  featuring  a  well 
characterised  biological  phenomenon,  a  set  of  manually  curated  functional 
categories capturing the range of functions know to be key to the phenomenon 
under  study,  serving  as  ‘model  answer’  and  a  scoring  protocol  aiming  to 
capture the level of concordance between the results from functional analysis 
of the test dataset and the model answer. 
 
Importantly, the proposed automatic validation was used to successfully point 
out  variations  in  the  performance  of  three  different  functional  analysis 
methods,  some  of  which  are  widely  used  by  the  microarray  reseach 
community. Further confirmation of the credibility of these conclusions comes 
from the observation that Catmap’s leading performance was also indicated by 
the FDR, from a statistical perspective. Interestingly, a similar evaluation has 
previously appeared in the Catmap study (Breslin et al., 2004) whereby the top 
10 categories from analysis of the cancer dataset of Van’t Veer by Catmap  
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Wilcoxon  statistics,  GSEA  Kolmogorov  statistics  and  minimized  p-values 
derived in a similar fashion to IGA, were compared. The conclusion was that 
there was a substantial overlap between the top 10 categories from all three 
functional analyses, which suggested that they behaved similarly. However, a 
valid  point  of  criticism  for  this  evaluation  is  that  the  range  of  results 
considered  was  marginal  and  cannot  possibly  lead  to  a  solid  conclusion. 
Moreover, the model dataset used had many ideal features that are far from 
common in ordinary expression datasets, most notably the remarkably high 
number of replicates (51 x 46) and the homogeneity of the profiled tissue. 
Within  such  optimal  experimental  conditions,  functional  differences  are 
striking, which makes their detection by all three functional analysis methods 
rather expected and not necessarily  indicative of high performance. In this 
work, we used a rather noisy dataset to achieve a more rigorous evaluation, 
which has indeed exposed variations between the methods. 
 
One  further  important  conclusion  from  this  work  is  that  in  contrast  to 
expectation,  the  reductionist  approach  employed  by  IGA  and  GSEA,  that 
strives to optimize the score for a category based on selecting the subset of 
genes in the category most likely to have endured a change in expression, is 
less robust than the more comprehensive approach employed by Catmap that 
uses the ranks from all genes member to the category. This could be justified  
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by the fact that gene expression data are inherently noisy and consequently it 
may be best to consider all evidence available for the category then to try to 
distill the most probable piece of evidence for the category.   
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6.5.   Appendices 
 
 
6.5.1.   Functional Category dataset 
 
This  appendix  explores  the  process  of  functional  categorisation  of  genes, 
which preceded the functional analysis performed in this work. In this work, 
we  used  the  GO  biological  process  ontology  terms  as  a  basis  for  this 
categorisation. Thus, genes attributed to the same GO term are members of the 
same  category  denoted  by  the  term.  Figure  6.4.1  shows  the  cumulative 
distribution  of  the  size  of  obtained  categories,  whereby  for  each  value  x 
denoting  size  n,  the  corresponding  y  value  expresses  the  proportion  of 
categories with size less or equal to n. Clearly, categories with low gene count 
are mostly dominant as 75% of all categories appear to have at most 5 gene 
members.  
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The fact that the gene categories are dominated by small categories hinders 
their  use  with  functional  analysis,  as  it  is  difficult  to  deduce  any  reliable 
statistics from categories with low gene count. To overcome this problem, we 
adopted a strategy of back propagating genes to ancestor category terms. Thus, 
where categories A and B and C have a gene each, their ancestor D would 
feature a total gene count of three after the back-propagation. As a result of 
such back-propagation, the average category gene count improved and 75% of 
all categories were found associated with at least 20 gene members as oppose 
to  5  originally.  However,  the  inclusion  of  ancestral  term  categories  as  the 
Figure  6.4.1.  Analysis  of  the  gene  category 
dataset. The cumulative count of category size is 
shown in black whilst the cumulative count of genes 
over increasing category size is shown in blue.  
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result of the back-propagation of genes resulted in a net increase in the overall 
number of gene categories (from 2907 to 3202), which may exacerbate the 
problem of multiple testing with functional analysis.  
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6.5.2.   Overview of the low level analysis of the SNT dataset    
 
 
In  order  to  derive  a  list  of  genes  ranked  by  the  evidence  of  differential 
expression for functional analysis, a series of low-level processing steps were 
performed on the SNT dataset including quality assessment of the individual 
arrays,  data  normalisation,  calculation  of  summary  intensity  values  for 
individual  probesets  and  finally  limma  significance  analysis  of  differential 
expression.  In  the  following,  we  concentrate  on  the  early  step  of  quality 
control  (QC) and discuss the logic that led to the exclusion of certain array 
hybridisations  from  the  dataset  at  this  stage  of  analysis.  This  is  important 
because the size of the dataset has a major influence on the choice of the null 
hypothesis during functional analysis. Thus, where only few replicates exist 
for each condition, the choice of the gene list permutation null hypothesis is 
inevitable as oppose to the sample label permutation null hypothesis, which is 
statistically more robust. 
 
Figure 6.4.2 shows scatter plots of raw probe intensity from SNT arrays across 
and within biological conditions, arranged in a matrix of rows and columns. 
Each slot in the matrix shows the scatter plot from the pair of arrays indicated 
on the labels of the column and row defining the slot in the matrix. Using this 
type  of  analysis,  it  was  possible  to  simultaneously  assess  the  level  of  
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consistency between replicate arrays from each group condition during the QC 
step.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
sham  SNT 
Figure 6.4.2 Quality control of the SNT  microarray dataset. Showing  scatter 
plots  of  raw  probe  intensities  from  all  pairs  of  arrays  from  within  and  across 
conditions. Each scatter plot corresponds to the pair of arrays indicated on the labels 
of the column and row defining the slot featuring the plot. Arrays A131CH5,6,7&8 
correspond to SNT whilst A131CH13,14,15&16 correspond to sham. 
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Visual inspection of the resulting scatter plots (Fig 6.4.2) revealed that with 
the sham group (columns 1-4), arrays 13, 15 and 16 show a good level of 
similarity between them but seem to be poorly correlated with array 14 from 
the same group. On the other hand, the results from the SNT replicate arrays 
(columns 5-8) indicated an overall lower level of consistency, with array 5 
appearing to correlate best with array 7 and array 6 being most similar to array 
8. The less perfect nature of the data from the SNT hybridisations is probably 
justified by the additional variability introduced by the injury to the nerve 
during the SNT procedure that is absent in the sham.  
 
The  above  observations  were  further  confirmed  using  array  clustering 
analysis, which operates by iteratively clustering arrays by decreasing level of 
similarity in gene intensity. The result is a dendrogram (Fig 6.4.3) where each 
successive round of coarser clustering corresponds to moving one level up in 
the dendrogram. The similarity between two arrays is indicated by the lowest 
level  in  the  dendrogram  structure  at  which  they  cluster  together,  which 
corresponds to the point of fusion of their corresponding branches. The lower 
the fusion point in the dendrogram, the higher the similarity between arrays. 
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Thus, as before, we note that with the sham replicates, array 14 seems to be 
more of an outlier. As for the SNT group, we confirm the discrete similarities 
between arrays 5 & 7 and 6 & 8 respectively. However, we also make the 
important observation that the former pair of arrays seems to be more closely 
related  to  the  shams  than  the  latter  pair  of  arrays  (also  visible  but  less 
markedly on Fig 6.4.2 from previous analysis). This suggests that the SNT 
procedure performed on animals used with arrays 6 and 8 may have had more 
Figure 6.4.3. Quality control of the SNT microarray dataset featuring array clustering 
analysis.  Arrays  A131CH5,6,7&8  correspond  to  SNT  whilst  A131CH13,14,15&16 
correspond to sham.  
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pronounced  pathological  effects,  which  is  desirable  from  an  experimental 
point of view. 
 
On the basis of these observations from QC, it seemed sensible to ignore array 
14 from the sham group and arrays 5 & 7 from the SNT group. To further 
substantiate these preliminary decisions, we proceeded further in the analysis 
and  performed  limma  significance  analysis  of  differential  expression,  both 
using the whole set of arrays (4 from each condition) and when excluding 
potentially  outlier  arrays  14,  5  and  7.  In  particular,  with  both  analysis 
scenarios, we studied the correlation between the SNT/sham intensity ratios 
for individual genes and their corresponding log-odds significance values by 
limma. Ideally, the more positive and negative the log intensity ratios the more 
significant  they  are  found,  that  is  the  higher  the  log  odds.  However,  this 
correlation may be less optimal in situations where the within-group variations 
are  high,  thereby  masking  the  significance  of  the  inter-group  variations 
corresponding  to  intensity  ratios.  This  could  be  used  as  a  basis  to  detect 
potentially  noisy  arrays  in  a  microarray  dataset  as  removal  of  such  arrays 
should lead to an improvement in the correlation between the intensity ratios 
and their log-odds significance values by limma. 
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The correlation between the intensity ratios and the limma log-odds values 
from  analysing  the  whole  SNT  dataset  as  well  as  when  excluding  outlier 
arrays is shown on Figures 6.4.4-A&B respectively. Clearly, an improvement 
in the significance levels of the most pronounced intensity ratios (in particular, 
the negative ones) is achieved via exclusion of outlier arrays; which further 
justifies the need for their elimination from the dataset. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4.4. Plots correlating log intensity ratios with limma log odds significance values. 
From analysing all arrays in the SNT dataset (A) and when excluding arrays identified as sub-
optimal during QC analysis (B). In plot B, the negative fold changes are given higher log-odds 
significance values (indicated with red arrow) than in plot A.  
A  B  
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6.5.3.   Additional  notes  on  the  GSEA  algorithm:  GSEA  ranking 
metric    
 
In  the  standard  mode,  the  GSEA  software  is  designed  to  accept  probeset 
intensity  values  and  offer  a  range  of  statistical  metrics  with  which  these 
probesets  may  be  ranked  in  a  biologically  relevant  manner.  The  standard 
ranking metric by GSEA is the signal to noise ratio consisting of the ratio 
between the difference in the gene mean expression in phenotypes A and B 
and the sum of the standard deviation in gene expression from each phenotype 
replicate samples, that is: 
 
    Signal-to-noise = (µA -  µB) / (δA + δB) 
 
In effect, the signal to noise ratio expresses the correlation between a gene 
level of expression and either phenotype: the more positive the signal-to-noise 
ratio the stronger the correlation with phenotype A and the more negative the 
signal-to-noise ratio the stronger the correlation with phenotype B. Using this 
metric, the genes are typically ranked by GSEA in a descending order and 
genes on the top of the list may be considered markers of phenotype A whilst 
those at the bottom of the list markers of phenotype B.   
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An important feature of this ranking scheme is that genes from the top as well 
as the bottom of the list are equally important and categories where member 
genes cluster at the bottom of the list are as important as categories whose 
member genes cluster at the top of the list. Remarkably, the GSEA algorithm 
detects  category  enrichment  in  either  case  whereby  the  stronger  the 
enrichment at the top of the list, the more positive is the ES whilst the stronger 
the enrichment at the bottom of the list the more negative is the ES (more 
details  on  GSEA  ES  are  available  in  the  introduction  part  of  the  chapter, 
section 6.1.1.3). Importantly, both most positive and most negative ES(s) will 
be given small p-values; in other words, identified as significant by the GSEA 
algorithm.   
 
In this work, because the GSEAPreranked option was used to allow our limma 
ranked gene list to be directly used by GSEA, categories with negative ES 
were  discarded  from  the  analysis  because  they  would  only  correspond  to 
instances where the category genes are enriched at the bottom of the list for 
being least differentially expressed.  
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6.5.4.   The similarity transformation function 
 
In this appendix, details of the similarity transformation function, part of the 
scoring protocol developed in chapter VI for evaluation of functional analysis 
results (or query categories) against a set of expectedly enriched categories (or 
target categories), are shown. As explained in chapter VI, the main aim of the 
transformation function is to shrink the similarity values below the similarity 
threshold to fractional values of less than 1. Likewise, whilst scoring each 
query  category,  the  similarity
GS  terms  from  groups  of  target  categories 
showing  weak  similarity  to  the  query  and  typically  high  GS,  have  minor 
contributions to the query final score, which is based on summing up these 
similarity
GS terms from all groups of target categories (equation 4 and 5). One 
way by which this may be achieved is simply by dividing the similarity values 
by the cut-off value. However, further analysis indicated that such a simple 
transformation might not be totally suitable for the task at hand.  
 
To illustrate this, we shall examine the following example taken from real 
data. The tables below correspond to two different query categories and show 
the  original  similarity  values,  the  GS  values,  the  results  of  dividing  the 
similarity values by the cut-off value of 4.8 as well as raising the resulting  
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values to the corresponding GS values for groups of target categories defined 
for each query category: 
 
Query 1    ‘GO:0022402’ 
Target categories 
Group no 
Similarity value  GS  Similarity value / 4.8  (Similarity value / 4.8)
GS 
Group 1  2.40  4.67  0.52  0.04 
Group 2  3.65  5.56  0.79  0.27 
Group 3  3.89  3.90  0.84  0.52 
Group 4  4.01  3.46  0.87  0.62 
Group 5  4.35  2.78  0.94  0.85 
                            Sum = 2.3 
 
Query 2     ‘GO:0050767’ 
Target categories 
Group no 
Similarity 
value 
GS  Similarity value / 4.8  (Similarity value / 4.8)
GS 
Group 1  2.40  4.67  0.52  0.05 
Group 2  3.65  5.56  0.79  0.27 
Group 3  5.03  2.08  1.09  1.19 
                                                                                                                                            Sum = 1.51 
 
 
Thus, unlike query 1, query 2 shows one significant similarity relationship that 
is just above the threshold of 4.8 (indicated in red). However, attempting to 
derive a final score for each query category based on summing up the cut-off 
divided  similarity  values  raised  to  the  GS-th  from  all  groups  of  target 
categories returns inappropriately a higher score for query 1 than query 2 (2.3 
and 1.51 respectively). Therefore, even though dividing the similarity values 
by the cut-off value appears to suppress the individual effects from groups of  
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target categories from below the threshold,  together they  may add up to a 
significant  value  in  the  final  score;  possibly  superseding  the  effect  from 
groups of targets at an optimal similarity level with the query, in particular, if 
just above threshold. 
 
To  make  sure  that  our  protocol  is  sensitive  enough  to  distinguish  query 
categories just about significantly related to any of the target categories from 
those  showing  no  significant  similarity  to  any  of  the  target  categories,  the 
transformation function needs to introduce  a gap between similarity values 
above and below the cut-off. This may be achieved by reducing the similarity 
values below the cut-off to even smaller fractions with many decimal places to 
make sure that their sum is never going to be above 1, which would guarantee 
that a category may only receive a score higher than 1 if it features at least one 
optimal similarity relationship with a group of target categories. Alternatively, 
similarity values above the cut-off may be set to a higher range of values to 
make sure that the occurrence of at least one significant similarity, even if 
borderline,  would  significantly  increase  the  value  of  the  final  score  to  an 
extent that is never matched by the added contributions from groups of targets 
only weakly related to the query. 
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A  search  of  the  literature  did  not  reveal  any  mathematical  function  that 
precisely fits this purpose and no function was found able to create a gap in a 
continuous range of values as desired. Thus, it became clear that such function 
ought  to  be  developed  as  part  of  this  work.  After  trial  and  error  and  by 
exploring the properties of certain mathematical operations, we reached the 
mathematical function shown below: 
 
 
Tr(Sim) = Χ 
[ log2 ( Sim ) - log2 ( cut-off ) + К ]                                         
(6)
 
 
 
where  Tr(Sim)  is  the  transformed  similarity  function,  Sim  is  the  original 
similarity value, cut-off is the similarity cut-off which has the value of 4.8, К is 
a parameter with an absolute constant value (later explained) whilst the base X 
serves to optimise the final range of the transformed similarity values, as will 
be explained later. 
 
Essentially,  the  transformation  function  first  subtracts  the  log2  similarity 
values by the log2 similarity cut-off value. The resulting values, which we 
would  refer  to  as  the  ‘cut-off  subtracted  log2  similarity  values’  run  in  a 
continuous  range  and  shift  from  negative  to  positive  values  at  the  cut-off 
point. To create a discontinuity at the point of cut-off, the function adds a  
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value К that has a constant magnitude but variable sign shifting from negative 
to positive at the cut-off point, similar to the cut-off subtracted log2 similarity 
values. Effectively, adding К to the cut-off subtracted log2 similarity values 
shifts the positives ones higher in the positive range while causing the negative 
ones  to  plunge  further  in  the  negative  range  thereby  achieving  the  desired 
separation.  
 
- Derivation of the К-factor    
 
К is obtained using the following formula:  
 
 
     К = 3 *  [
 
log2 ( sim ) - log2( cut-off ) ] 
( 1 /
 
Кlp )          (7) 
 
If we ignore the Кlp parameter for a moment, we find that К is itself derived 
from the cut-off subtracted log2 similarity values, which explains why К has 
the same sign as these values. However, in this format, К is dependent on the 
original similarity values and is not constant. The reason we want К to have a 
constant magnitude is to make sure that while shifting the cut-off subtracted 
log2 similarity values by К, their order is maintained. This is all achieved by 
introducing the К-factor linearisation parameter Кlp.  
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To understand the significance of the power parameter Кlp, we shall refer to 
equation (7) and basic mathematics. The fact that the cut-off subtracted log2 
similarity values are raised to the inverse of Кlp implies that we are effectively 
taking their Кlp-th root. Recalling the properties of power transformations in 
maths, we find that the nth root of x tends to 1 as n tends to infinity. As such, 
increasing the value of Кlp significantly would cause the cut-off subtracted 
log2 similarity values to approach unity. Moreover, setting the Кlp value to an 
odd number guarantees that the Кlp-root of the negative cut-off subtracted 
log2 similarity values approximates –1, thus remaining negative.  
 
In  summary,  equation  (7)  operates  by  borrowing  the  sign  of  the  cut-off 
subtracted log2 similarity values and subsequently dumping them by deriving 
their lowest possible root. The resulting values approximate 1 and -1 where 
the  similarity  values  are  above  and  below  the  cut-off  respectively  and  are 
scaled up via multiplication by 3 (equation 2) to enhance the magnitude of the 
end result К. Figure 6.4.5 illustrates how К becomes gradually more linear 
over the range of similarity values as we increase the value of Кlp. We fix Кlp 
to the value of 301 in equation (7) as it appears to linearise К to satisfaction 
(Fig 6.4.5-D). 
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Referring back to the similarity transformation function outlined in equation 
(6), it turns out that one more parameter needs to be explained, which is the 
base  X.    From  what  has  been  discussed  sofar,  the  transformation  function 
operates by subtracting the log2 cut-off value from the log2 similarity values 
Figure 6.4.5. К-factor profile over the range of similarity values for varying Кlp 
values. The similarity cut-off is shown with a red arrow. 
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then shifting them by a constant К with the net result of creating two distinct 
sets of values separated by a gap: one lying in the positive range and one lying 
in the negative range, corresponding to similarity values above and below the 
cut-off repectively (Fig 6.4.6-A). 
 
However, the purpose from the transformation function was not only to create 
a separation between similarity values above and below the cut-off but most 
importantly, ensure that the similarity values below the cut-off are reduced to 
the window of fractional values between 0 and 1. This is needed so that during 
the scoring process of query categories, the similarity
GS contributions from 
groups of targets at a level of similarity with the query below the threshold are 
marginal and exert no major influence on the final score.  
 
Thus, there is a need to shift the ‘cut-off subtracted log2 similarity values + 
К’,  corresponding  to  similarity  values  below  threshold,  from  the  negative 
range to positive fractions of less than 1. To do that, we make use of one more 
mathematical property, which is the fact that raising a number to a negative 
value  always  yields  a  fractional  value.  This  justifies  the  use  of  base  X  in 
equation 6. In Figure 6.4.6, we correlate the ‘cut-off subtracted log2 similarity 
values + К’ before and after using them as a power to which X is raised with 
the original similarity values (Fig 6.4.6-A&B, respectively). We would refer to  
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the  latter  as  the  transformed  similarity  values,  as  these  constitute  the  end 
product  of  the  transformation  function  shown  in  equation  6.  The  effect  of 
introducing base X is certainly visible on Figure 6.4.6-B in that all similarity 
values  below  the  cut-off  are  transformed  into  fractions  of  less  than  1  and 
importantly, these are still a distance away from the transformed similarity 
values from above the cut-off.  
 
Interestingly,  increasing  the  value  of  X  helps  expand  the  range  of  the 
transformed similarity values most notably those originally above the cut-off. 
This may be beneficial during the scoring process of query categories as it 
would mean that contributions from target groups at varying similarity levels 
with the query from above the threshold are weighted more finely. We set 
parameter X to the value of 1.45 as it appears to expand the range of the 
transformed similarity values to a reasonable level. 
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Finally,  we  show  a  simplified  version  of  the  transformation  function  after 
incorporating into it the equation  of parameter К. Thus given equation (6) 
from above showing the transformation function: 
 
TrSim = X
[ log2 ( sim ) - log2 ( cut-off ) + К ]        (6) 
     
Figure  6.4.6.  Highlighting  varying  steps  of  the  transformation  function.  (A)  The  log2  similarity 
values are subtracted by the log2 similarity cut-off value of 4.8 then shifted by К, which introduces a gap 
separating  similarity  values  above  and  below  the  cut-off.  (B)  Shows  the  next  and  final  step  in  the 
transformation function where the resulting values from the previous steps are used as a power to which 
parameter X is raised. This causes the similarity values below cut-off to be confined to the window of 
fractional values between 0 and 1. The similarity cut-off is shown with a red arrow 
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and equation (7) specifying how parameter К is  derived: 
 
К = [ 1/ ( 
 
log2 ( sim ) - log2( cut-off ) ) ] 
( 1 / Кlp )                                           (7) 
 
incorporating (7) into (6) and simplifying gives:  
   
TrSim = X
[ y + y                     ]                                                                        (8) 
   
where y =   log2 ( sim ) - log2( cut-off ) 
 
  
- ( 1 / Кlp )      
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CHAPTER VII:       CONCLUSION  
 
 
Microarray  technology  offers  a  fruitful  approach  to  study  gene  expression 
patterns in biological systems owing to its high-throughput screening ability. 
In practise, a microarray study runs through two major phases: experimental, 
involving the handling of the biological material in its varying forms and its 
hybridisation  onto  the  physical  array  and  analytical,  during  which  array 
intensity data are analysed to yield useful biological information.  This work 
has shed light on some important aspects of the technology relating to both 
implementation phases. 
 
At  the  experimental  level,  this  work  has  revealed  the  consequences  of 
amplifying RNA targets prior to their hybridisation to array probes, which is 
instrumental in situations where the quantity of the starting biological material 
is small (chapter I). Importantly, we concluded that amplification can distort 
the expression ratios between two biological tissues. This was found to happen 
when distortions in the signal owing to amplification were inconsistent in the 
two  tissues  because  the  intensity  falls  outside  the  dynamic  range  of  the 
scanner. Important conclusions were extrapolated regarding the suitability of 
the T7 based amplification protocol for microarrays that tie in with the specific 
experimental design of the microarray experiment. 
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Following the experimental phase, intensity data are typically run through a 
pipeline of analytical procedures to extract meaningful biological knowledge. 
This work has explored one important type of high level analysis methods for 
microarray  data  that  strives  to  identify  functions  potentially  enriched  in  a 
microarray expression dataset (chapter VI). Crucially, this work has exposed 
previously  unknown  variation  in  the  performance  of  existing  methods  for 
microarray functional analysis. 
 
The most striking outcome was the observation that GSEA, the most widely 
used  functional  analysis  method,  performs  less  well  than  Catmap:  a  less 
popular  functional  analysis  method  that  has  long  been  undermined  by  the 
microarray community; primarily, owing to poor usability. This highlights the 
importance  of  robust  evaluation  protocols  in  bioinformatics  to  objectively 
identify  the  true  merits  of  methods  and  algorithms  that  may  correct 
preconceived notions.  On another hand, this work  may have the  important 
outcome  of  promoting  Catmap  among  the  microarray  research  community 
thereby  encouraging efforts by the community to address Catmap usability 
issues.   
 
As a future aim, the evaluation protocol for functional analysis methods will 
be  applied  on  a  more  robust  microarray  dataset  with  a  higher  number  of 
replicates  than  the  SNT  dataset  used  in  this  work.    The  reproducibility  of  
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effect, consisting of the superiority of Catmap functional analysis, will further 
validate the effectiveness and robustness of the evaluation protocol proposed 
and  may  encourage  its  use  in  the  future  by  the  wider  microarray 
bioinformatics community as a standard to assess newly developed functional 
analysis methods. 
 
In  addition  to  the  most  forthcoming  outcomes  of  this  work,  other  less 
apparent, though interesting, conclusions were also made. First, the functional 
analysis has by large illustrated the positive effect of integrating microarray 
expression  data  with  other  types  of  useful  biological  data  to  yield  a  more 
comprehensive  picture  of  the  biological  phenomenon  under  investigation. 
Indeed, it was only by incorporating functional information onto the genes 
found  differentially  expressed  in  our  test  SNT  microarray  dataset  that  the 
functional consequences of gene expression regulation following nerve lesion 
in this dataset could be revealed (chapter VI).  
 
Moreover,  such  integrative  approach  has  the  advantage  of  improving  the 
quality  of  the  biological  information  gained  from  microarray  experiments. 
This is particularly important as microarray technology is characterised by a 
high level of variability owing to its multi-step nature. For example, the SNT 
microarray  dataset  used  in  this  work  was  obtained  with  amplified  RNA 
material  and  yet  despite  the  occasional  distortions  in  gene  expression  
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regulation  (anticipated  from  extrapolating  the  findings  from  chapter  II), 
following integration with GO functional terms, the picture at the functional 
level proved rather consistent with what is known in the literature. 
 
At the biological level, this work has had the contribution of highlighting the 
limitations  from  screening  for  pain  related  genes  in  animal  models  of 
peripheral neuropathy using microarray technology. The complex nature of the 
molecular response to nerve injury at the level of gene expression makes it 
difficult to identify pain specific effects. Nonetheless, these limitations can be 
addressed with good experimental design and the use of tailored downstream 
datamining  approaches.  The  latter  defines  research  venues  that  may  be 
appropriately pursued in the future as part of ongoing collaboration with the 
London Pain Consortium. 
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